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ABSTRACT 
Adenovirus is a naked icosahedral viral particle enclosing a double stranded DNA genome. 
Adenoviral genes are classified as early, intermediate and late based on their duration of 
expression. Adenoviruses encode two intermediate gene products, pIX and IVa2. Adenovirus 
IVa2 is one of the conserved proteins encoded by members of the family of Adenoviridae. Prior 
studies indicate that IVa2 localizes to the nucleus\nucleolus and, is involved in adenovirus 
genome packaging and activation of major late promoter (MLP) thus enhancing the expression 
of late adenoviral proteins.  Moreover, IVa2 has been suggested to perform multiple functions by 
interacting with different viral proteins including 33K and DBP (DNA binding protein), 52K and 
pVIII. 
Positional homologs encoded by members of Mastadenovirus genus are different in structure 
and function. Since Bovine adenovirus  (BAdV) -3 IVa2 displays limited homology compared 
with homologs encoded by other members of Mastadenovirus genus, the present study was 
undertaken to characterize IVa2 of BAdV-3, to identify viral protein interacting with IVa2 and to 
determine the role of IVa2 in the virus life cycle. 
As part of characterization, BAdV-IVa2, detected as a 50kDa protein in BAdV-3 infected 
cells (12-18 hrs post infection) and plasmid DNA transfected cells (48 hrs post transfection). 
Although IVa2 could be detected both in the nucleus and nucleolus of virus infected or DNA 
transfected cells, IVa2 appeared predominantly located in the nucleolus. Analysis of IVa2 by 
cNLS mapper program predicted the nuclear localization signals (NLSs) of IVa2 interacting with 
importin. Analysis of mutant IVa2 suggested that N- terminus amino acids 4-18 appear essential 
for the nuclear localization of IVa2. Several lines of evidence suggest that IVa2 N-terminus 
amino acids 1-25 appear to contain functional NLS. First, IVa2 N-terminus amino acids 4-18 are 
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not sufficient to translocate a cytoplasmic fusion protein GFP/β gal to the nucleus of transfected 
cells. Secondly, GST pull-down assay suggested that amino acid 4-18 does not bind to importin 
α-1. Thirdly, N-terminus 25 amino acids bind to importin α-1 and translocate GFP/β gal to the 
nucleus of the transfected cells. Analysis of mutant IVa2 proteins also suggested that C-terminal 
amino acids 373-448 appear essential for the nucleolar localization of IVa2 in transfected cells. 
While amino acids 373-448 appear to contain multiple nucleolar localization signals (NoLSs), 
the NLS and NoLS of IVa2 does not appear to be overlapping. 
The identified nuclear localization signal of IVa2 contains clusters of basic amino acids,  
(6RRK8), similar to that of classical nuclear localization signal. The substitution of arginine or 
lysine residues to glycine did not alter the nuclear localization of IVa2 in DNA transfected cells 
or mutant BAdV-3 infected cells indicating that 6RRK8) residues are not essential for nuclear 
localization of BAdV-3 IVa2. 
To identify the viral proteins interacting with IVa2, initially we attempted to use affinity tag 
purification method. However, repeated attempts to isolate recombinant BAdV-3 expressing 
IVa2 containing Step Tag were not successful. Instead, using Bi molecular Fluorescence 
Complementation (BiFC) assay, we identified several viral proteins including pV that interact 
with IVa2. Mass spectrometry also indicated that pV interacts with IVa2. Finally, the interaction 
of IVa2 with pV was confirmed by co-immunoprecipitation (Co-IP) assay in DNA transfected 
and BAdV-3 infected cells. Further analysis identified IVa2 amino acids 121-140 as the domain 
involved in the interaction with pV.  
Several lines of evidences suggest that IVa2 protein is sensitive to any addition \deletion. To 
assess the role of IVa2 in the virus life cycle, we attempted to isolate IVa2 deleted BAdV-3 in 
non-IVa2 complementing cells. First, transfection of cells with full-length BAdV-3 genomic 
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clone containing deletion of IVa2 region overlapping polymerase region did not result in the 
isolation of viable virus. Second, transfection of cells with full-length BAdV-3 genomic clone 
containing addition of Cre recombinase recognition loxP sequence in-frame to IVa2 coding 
sequence did not result in the rescue of viable virus. Third, transfection of cells with individual 
full length BAdV-3 genomic clone containing insertion of Strep tag at amino acids 146,242 or 
448 did not result in the isolation of viable virus. However, transient expression of BAdV-3 IVa2 
complemented the defect of IVa2 in BAV304a.dIVa2 in cotton rat lung (CRL) cells suggesting 
that IVa2 is essential for replication of BAdV-3. 
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1.0 LITERATURE REVIEW 
The literature review comprises four sections: adenovirus, nuclear pore complex and 
nucleoporins, nuclear import of protein, and nucleolus and its functions. The adenovirus section 
describes the classification of adenoviruses, structure of adenovirus virion as well as 
adenovirus life cycle using well-studied adenovirus type A2 and adenovirus type C of the 
human adenoviruses. This section also deals with further classification and genome 
organization of human as well as bovine adenoviruses. Function/functional interaction of 
human, as well as bovine adenoviral proteins, also summarized. In the nuclear pore complex 
and nucleoporins section, the role of the nuclear pore complex and organization of nucleoporins 
described in detail. The section that talks about the nuclear import of protein discuss the 
mechanism of nuclear import of protein across the nuclear pore complex. The last part 
describes the nucleolus and its functions, the nucleolus structure and function; in particular, the 
role of nucleolus in ribosome biogenesis is discussed. 
 
1.1. Introduction to adenovirus 
Adenoviruses are medium-sized, naked icosahedral viruses with a double-strand DNA 
genome (Harrach, 2014). They acquired their name from the original tissue (adenoid) where the 
virus was isolated (Enders et al., 1956; Hilleman and Werner, 1954; Rowe et al., 1953). 
Adenoviruses are mostly isolated from different animals and humans with ailments such as 
respiratory infection, conjunctivitis, or encephalitis. Except in fowl (Schachner et al., 2018) and 
deer (Woods et al., 2014), adenoviruses do not lead to severe disease outcomes in most of the 
farm animals (Maclachlan et al., 2017). However, in humans specifically, in young and 
immunocompromised individuals, adenoviruses are important disease-causing agents (Lion, 
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2014). Though not observed in humans, adenoviruses are also known to induce malignancies in 
different animal models (Hohlweg et al., 2004; Javier, 1994). Compared to its role as a disease-
causing agent, adenoviruses are known for being a model organism in molecular virology as 
well as viral vectors (Greber et al., 2013). For the last two decades, adenovirus has been serving 
as a viral vector platform for vaccination as well as gene therapy (Alonso-Padilla et al., 2016; 
Singh et al., 2019; Wold and Toth, 2013;	  Zhang and Zhou, 2016). 
 
1.1.1 Classification of Adenoviruses 
The family of Adenoviridae comprises more than 100 adenovirus serotypes (Greber et 
al., 2013).  They are classified based on host origin and constitution of the DNA under the 
genus Mastadenovirus, Atadenovirus, Aviadenovirus, Siadenovirus, Ichtadenovirus, and the 
recently proposed genus Testadenovirus (Davison et al., 2003; Harrach, 2014; Harrach et al., 
2012). 
The genus Mastadenovirus is the largest genus of the family of Adenoviridae, known to 
include 1/3 of the adenovirus species infecting only mammals (Harrach et al., 2012). Their 
genome size ranges between 30.5-37.8 Kbps with GC content that varies from 43.6 to 63.9%. 
The genus also characterized by having complex inverted terminal repeats that range from 93 to 
371bp. In addition, viral protein V, IX, and most of the proteins encoded by early viral mRNA 
(E1A, E1B, E3, and E4) are unique to the genus (Harrach, 2014). 
Members of Aviadenovirus genus only infect birds and are cause diseases in birds, 
including hydro-pericardium syndrome, inclusion body hepatitis, edema, pulmonary 
congestion, and gizzard erosion (Grgic, et al., 2014; Harrach, 2014). They possess a large 
genome size (25-40% greater) than members of the Mastadenovirus genus (Harrach et al., 
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2012). Despite a bigger genome size, the ITR region is relatively shorter than the members of 
Mastadenovirus. Moreover, genes encoding protein V and IX, as well as those encoded by E1 
and E3 region of Mastadenovirus, are absent in members of the Aviadenovirus genus (Harrach 
et al., 2012). Except for some members of the Aviadenovirus genus (Grgic, et al., 2011), most 
of the members of Aviadenovirus contain two fibers that extend from the penton base (Chiocca 
et al., 1996; Griffin and Nagy, 2011; Kajan et al., 2012; Kajan et al., 2010; Marek et al., 2012). 
Members of the Atadenovirus genus include adenoviruses isolated from a wider host 
range, including reptiles, birds, ruminants, and marsupials (Berk, 2013; Davison et al., 2003). 
The genome size of adenovirus in the Atadenovirus genus ranges from 29.5 to 33.2 kbps with 
relatively low GC content and high AT content (Harrach et al., 2012). Unlike members of 
Mastadenovirus, protein V and IX are absent in members of this genus (Davison et al., 2003; 
Gorman et al., 2005). Moreover, there is a marked difference regarding the right and left 
extremities of the genome between members of Atadenovirus and Mastadenovirus (Both, 2011; 
Harrach, 2014). Among the unique genes, p32K (Elo et al., 2003) and LH3 (Gorman et al., 
2005) are conserved at the genus level and serve as viral structural components. Due to some 
similarities in their sequence, it has been assumed that LH3 as a homolog of Mastadenovirus 
E1B 55K protein. However, they are functionally distinct as E2B 55K serve as an anti-
apoptotic protein in infected cells (Gorman et al., 2005). 
Members of the Siadenovirus genus comprise adenovirus isolated from amphibians and 
birds (Harrach et al., 2012). The genus acquires its name in relation to a unique protein 
sialidase encoded by the members of the genus (Davison et al., 2003). Some members of the 
genus are characterized by having the shortest genome size (26.1 to 26.2kbps). The members of 
this genus also contain short ITRs (29-39bps) (Harrach et al., 2012; Kovacs and Benko, 2009).  
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While members of Siadenovirus encode five proteins that are unique (Harrach et al., 2012), 
the homologs of proteins V and IX and proteins encoded by E1, E3, and E4 regions of 
members of the Mastadenovirus are absent (Harrach et al., 2012). Only a single adenovirus 
isolate, white sturgeon AdV-1 (WSAdV-1), belongs to this genus (Benko et al., 2002). 
WSAdV-1 possesses the adenoviral genome of 48,395bp (Harrach, 2014). Although there is a 
similarity with members of non-Mastadenovirus genus regarding the organization of the middle 
part of the genome, there is a marked difference in terms of hexon and protease sequences 
(Kovacs et al., 2003). In addition, the right part of the genome of WSAdV-1 encodes multiple 
novel genes (Harrach, 2014). Adenovirus infection in different chelonians (Turtles and 
Tortoise) species has been reported (Doszpoly et al., 2013; Farkas & Gal, 2009; Rivera et al., 
2009; Schumacher et al., 2012). Though isolation of adenovirus from the various chelonians 
was not successful, partial sequence analysis using hexon as well as viral DNA polymerase 
genes indicate that the putative adenovirus is distinct genetically from the five officially 
accepted genera of Adenoviridae (Doszpoly et al., 2013). As a result, a sixth genus" 
Testadenovirus" is proposed for the novel adenovirus of chelonians in the superfamily 
Testudinoidea (Doszpoly et al., 2013; Harrach, 2014). 
 
1.1.2 Structure of adenoviral virion (viral particle) 
Structurally, adenoviral particle is composed of an outer capsid and inner core structure (Fig 
1.1). The capsid structure besides protecting the viral genome interacts with the host cell 
structure to deliver the viral genome (Roos et al., 2007). Composition wise, the adenoviral 
capsid is consists of major and minor proteins. The major proteins include hexon, penton base 
and fiber (Liu et al., 2010; Russell, 2009). 
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While 240 trimeric hexon organized to form the surface of the icosahedron, pentameric penton 
base (capsomeres) held to occupy the vertices of the icosahedron, with a protruding fiber at 
each vertex of the icosahedron (Berk, 2013). 
Minor adenoviral capsid protein includes proteins IIIa, VI, VIII, and IX. Although minor 
capsid proteins serve as cement to strengthen the capsid structure, some are involved in linking 
the core structure to the capsid and also play a role in viral entry (Flatt and Butcher, 2019; 
Reddy and Nemerow, 2014; Vellinga et al., 2005). 
The core of adenovirus consists of linear double-stranded DNA (genome) and associated 
proteins, including protein VII, V, X, Mu terminal protein (TP), and viral protease (San Martin, 
2012). Most of the core proteins are composed of basic amino acids that enable them to interact 
and condense the viral genome (Perez-Berna et al., 2015). Besides, some core proteins link the 
core to the capsid components (structure) (Liu et al., 2010). Moreover, core protein, such as TP, 
is involved in the replication of the viral genome (de Jong et al., 2003). 
 
1.1.3 Adenovirus life cycle 
The adenovirus life cycle is a coordinated process that involves both viral and cellular 
components (Pied and Wodrich, 2019). The host cell nucleus is the site of adenovirus 
replication or major events in the virus life cycle, including gene expression, viral DNA 
replication, assembly, packaging, and maturation (Pied and Wodrich, 2019). As a result, 
adenoviral particle undergoes pre-nuclear steps, including attachment and entry, uncoating, and 
transport to the host cell nucleus (Cassany et al., 2015; Flatt and Butcher, 2019; Greber and 
Flatt, 2019). 
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Fig. 1.1 A schematic illustration of human adenoviral particle showing capsid and core 
structural components. Re printed from Reddy and Numerow, 2014. Proc Natl Acad Sci, 111(32): 
11715-20  (Publisher PNAS) 
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1.1.3.1 Attachment and entry 
Adenovirus life cycle (Fig. 1.2) starts with the entry of the virus into the target cell, which is 
initiated by the primary attachment of fiber to the cell surface receptor. Coxcakie adenovirus 
receptor (CAR) is used as a primary receptor by most adenovirus spices except group D 
adenoviruses (Bergelson et al., 1997; Roelvink et al., 1998). In addition to CAR, different 
human adenoviruses use receptors such as desmoglein (Wang et al., 2011), heparin sulfate 
(Dechecchi et al., 2001), CD 46 (Gaggar et al., 2003; Marttila et al., 2005), sialic acid (Arnberg 
et al., 2000; Lenman et al., 2018). Following primary attachment, virus entry commences by 
the secondary interaction of the RGD motif of adenovirus penton base with cellular integrin 
receptors (Wolfrum and Greber, 2013). Integrin penton base interaction results in the release of 
fiber and also initiates a signalling cascade that ends up in uptake of virus particle via clathrin-
mediated endocytosis (Meier and Greber, 2004). Uptake of adenoviruses also involves 
alternatively via micropinocytosis (Meier et al., 2002).  
Adenoviral particle escapes from the endosomal compartment using membrane lytic protein 
pVI (Wiethoff et al., 2005). Also, a signalling cascade initiated at the time of attachment helps 
the process of viral escape via inducing a membrane drift (Burckhardt et al., 2011; Wolfrum 
and Greber, 2013). Prior reports indicates that exposure of adenoviral particle to low pH 
induces a conformation change in the adenoviral particle that leads to destabilization of the 
endosomal membrane (Greber et al., 1993). However, recent studies indicate that endosomal 
membrane penetration is pH independent (Suomalainen et al., 2013).  
After the endosomal escape, partially uncoated capsid (capsid without fiber, penton base and 
VI) joins the cytoplasm where hexon mediated interaction with microtubule dynein motor 
directs the movement of partially uncoated capsid to the nucleus (Bremner et al., 2009; Leopold 
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et al., 2000). Final capsids disassembly occurs at the nuclear pore complex (NPC) where 
partially disassembled capsids dock at the NPC through the interaction of hexon with NUP 214 
of the NPC (Cassany et al., 2015). 
Further disassembly of the viral capsid is achieved via the coordinated interaction involving 
kinesin light and heavy chains with pIX of docked adenovirus and nup358, respectively 
(Strunze et al., 2011). 
After the process of uncoating, pVII of the viral protein, which strongly associates and 
condenses the viral genome mediate interaction with soluble receptors to use the nuclear import 
machinery and deliver the viral genome to the nucleus (Wodrich et al., 2006). In addition to 
facilitating the entrance of adenoviral genome via NPC by dismantling the viral capsid 
structure, interaction or docking the partially disassembled capsid is associated with 
displacement of nup214, nup62 and nup358 resulting in a transient increase in permeability of 
the NPC and translocation of the viral genome (Strunze et al., 2011; Strunze et al., 2005). 
 
1.1.3.2 Human adenovirus genome organization 
Human adenoviruses belong to the genus Mastadenovirus (Harrach, 2014). Like other 
adenoviruses, human adenoviruses contain a single linear double-stranded genome that ranges 
in size from 26–46 kbps (Ghebremedhin, 2014). The viral genome organized as early, 
intermediate, and late transcription units based on their duration of expression (Berk, 2013) 
(Fig 1.3). 
 
1.1.3.2. 1 Early gene expression  
The early (E) regions include E1-E4 (E1A, E1B, E2, E3, and E4) (Berk, 2013). 
	   9	  
 
 
Fig. 1.2 Schematic illustration of human adenovirus life cycle. Re printed from Waye and 
Sing, 2010, Pharmaceuticals (Basel). 2010 Oct; 3(10): 3343–3354 (2 (Publisher MDPI). 
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After the localization of the viral genome to the nucleus, the first gene to be transcribed is 
E1A. As a result, it is also called an immediate early gene (Zhao et al., 2014). Initial E1A pre-
mRNA transcript, produces several mRNA transcripts including 13S, 12S, 11S, and 9S via 
alternate splicing that has the potential to encode proteins of 289, 243, 217, 117, and 55 
residues, respectively (Stephens and Harlow, 1987; Ulfendahl et al., 1987). 
While the 13S and 12S mRNA transcripts are abundant during early times, the rest of the 
mRNA transcript predominates at a later time (Zhao et al., 2014). Most of the function of E1A 
is attributed to 13S and 12S translation products, while the rest of the transcripts play a minor 
role and are dispensable for lytic infection (Radko et al., 2015). E1A involves several protein-
protein interactions that play a role in the transcriptional activation of other viral gene products, 
protection of infected cells from host antiviral response, control of cell cycle, and apoptosis 
(King et al., 2018b) (Table 1.1). Adenoviral E1B encodes E155K and E1 19K proteins, both of 
which prevent cellular apoptosis. Besides, E1B 55K undergoes a variety of protein-protein 
interactions with viral as well as cellular proteins (Hung and Flint, 2017) intending to protect 
infected cells from antiviral mechanisms launched by the host (Table 1.2).  
Adenovirus E2 region produces mRNAs that encode DNA binding protein (DBP), precursor 
terminal protein (pTP), and adenovirus polymerase (Ad-pol), which are involved in viral DNA 
replication (de Jong et al., 2003) (Table 1.3). 
Adenovirus E3 region of human adenovirus produces seven mRNA transcripts from its 
precursor mRNA (Wold et al., 1995; Zhao et al., 2014) the translation products of which play a  
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Fig. 1.3 Schematic diagram of the Ad5 transcription map. Transcripts shown in red and yellow 
color represent early and late transcripts respectively. Re printed from Biasiotto and Akusjarvi, 
2015. Int J Mol Sci.; 16(2): 2893–2912 (Publisher MDPI). 
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Table 1.1 Role of adenovirus E1A in the virus life cycle 
Function /Functional interaction of Adenovirus E1A Reference 
E1A locates to nucleus by interacting with cellular soluble 
transport receptors using its classical or non-consensus 
nuclear localization signal(s)  
(Cohen et al., 2014; Marshall 
et al., 2014) 
E1A interacts with an adaptor protein DECAF 7 and 
manipulate localization and activity of cellular kinases 
DYRIKA, DYRIKB and HIPK2 involved in cellular 
transformation, proliferation or transcription. 
(Glenewinkel et al., 2016; 
Miyata and Nishida, 2011; 
Ritterhoff et al., 2010) 
E1A   interacts with PKA; sequester PKA to the nucleus and 
favor viral replication cycle. 
(Fax et al., 2001; King et al., 
2016; King et al., 2018; Taylor 
et al., 2013) 
E1A bind competitively with cellular transcriptional co-
repressors CtBP1 and CtBP2 to relieve host gene transcription 
involved in cell growth and apoptosis. 
(Chinnadurai, 2009; 
Subramanian et al., 2013) 
E1A interact with MED23 or pfa1 in elongation of adenovirus 
transcripts.   In addition, E1A recruiting other components of 
super elongation complexes elongate adenovirus transcripts. 
(Fonseca et al., 2014; Fonseca 
et al., 2013; Vijayalingam and 
Chinnadurai, 2013) 
E1A via association with FOXK1/2, DCAF7 and CtBP 
suppress activation of interferon-stimulated genes.  
(Zemke and Berk, 2017) 
E1A   p300/CBP, PCAF, Bre1, GCN5, p400 and BS69 control 
transcription from specific loci that stimulate cell cycle or 
interfere with host defense mechanism.  
(Ablack et al., 2012; Fonseca 
et al., 2013; Lang and Hearing, 
2003; Pelka et al., 2009; Zhang 
et al., 2018; Zhao et al., 2017) 
E1A interact with UBC9 and interfere its SUMOylation role 
affecting the reorganization of nuclear PML bodies. 
(Yousef et al., 2010) 
E1A interacts with pRB and prevents its SUMOylation 
counteracting its role in cell cycle control. 
(Ledl et al., 2005) 
E1Ainteracts an antiviral DREF and delocalize it away from 
adenoviral replication center. 
(Radko et al., 2014) 
E1A interact with BS69   and prevent degradation of E1A.  (Isobe et al., 2006) 
E1A interact with a tumor suppressor protein and Fbw7, and 
increase the stability of Fbw7 recognized cellular targets 
involved in cellular proliferation. 
(Isobe et al., 2009) 
E1A through up regulation of ubiquitin ligase SCF  (β-TrCP), 
enhance the degradation of tumor suppressor protein RESET 
thereby enhancing cell proliferation. 
(Guan and Ricciardi, 2012) 
E1A bound with pRB enhance cellular proliferation. E1A  
interact with DP-1 recruit E2F/DP-1 complex to E2F-
regulated promoters and activate cell cycle gene. 
(Bayley and Mymryk, 1994; 
Pelka et al., 2011) 
E1A interacts with Nek9 and down regulate expression of 
GADD45A involved in cell cycle arrest.  
(Jung et al., 2016; Pelka et al., 
2007) 
E1A interact with FUBP1 and prevent p53 mediated antiviral 
response.  
(Frost et al., 2018) 
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role in the protection of infected cells from the host defense mechanism (Horwitz, 2004; 
Lichtenstein et al., 2004) (Table 1.4). 
Adenovirus E4 region undergoes complex splicing process that encodes products with 
multiple functions, including RNA splicing, nucleo-cytoplasmic transport, and translation of 
mRNA as well as transcriptional activation (Berk, 2013). 
Generally, early gene products create a favorable environment for viral replication via 
activation of viral genes, inducing host cell to synthesis phase to supply necessary input for 
viral replication, mediating viral replication, blocking apoptosis, and counteracting host 
antiviral defense mechanism (Table 1.1- 1.4). 
 
1.1.3.2. 2 Replication of the adenoviral genome 
Once early gene products create a favorable environment, the process of viral replication 
commences (Radko et al., 2015). Both cellular and viral proteins take part in the process of 
replication. Cellular proteins NFI and OctI via binding of TP and viral polymerase respectively, 
recruit the TP–polymerase heterodimer to the origin of replication and by doing so increase the 
replication by 200 fold (de Jong et al., 2003; Hoeben and Uil, 2013; Mysiak et al., 2004). E2A 
product DNA binding protein (DBP) also plays a role in the attachment of TP-Pol to the 
replication origin via manipulating the double-strand DNA (de Jong et al., 2003).  
The process of viral DNA replication initiated with the formation of a covalent linkage 
between hydroxyl groups of pTP to the terminal dCMP of the GAGA template of the viral 
DNA catalyzed by viral polymerase (Hoeben and Uil, 2013). After initiation of replication, 
pTP-trinucleotide (pTP-CAT) jumps back to base-pair with a template base.  
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Table 1.2.  Role of adenovirus E1B in the virus life cycle 
Protein Function/Functional interactions Reference 
 
 
 
E1B 55K 
  
Through direct binding with p53, as well as disruption 
of p53 interaction with cellular factors involved in its 
acetylation and activation, E1B 55K inhibit p53-
induced transcription of apoptotic factors. 
(Blackford and 
Grand, 2009) 
Through its involvement in the porteasomal 
degradation of proapoptotic cellular factor Daxx, E1B 
55K inhibit the transcription factors that act as cell 
cycle checkpoints. 
(Schreiner et al., 
2010; Wimmer 
et al., 2012) 
Undergoes SUMOylation via SUMO E1 and its 
SUMOylation thought to be essential for its anti 
apoptotic functions that involve various approaches.  
 
(Wimmer et al., 
2012) 
E1B 19K 
 
Inhibit apoptosis through TNF-α and Fas ligand 
pathways by influencing downstream mediators BAX 
and BAK. 
(Debbas and 
White, 1993; 
Sundararajan et 
al., 2001) 
 In a similar fashion with cellular anti apoptotic BCL2, 
it bind and inactivate proapoptotic proteins BAX and 
BAK. 
(Cuconati et al., 
2002; White, 
2006) 
 
Table 1.3.  Role of adenovirus E2 in the virus life cycle 
Protein  Function/Functional interaction  
 
 
 
E2 DBP 
 Helps in the formation of initiation through assisting 
the binding of cellular NFI to the origin of replication.  
(de Jong et al., 
2003; Hoeben 
and Uil, 2013) 
 Helps to protect the viral polymerase from nucleases. (Hoeben and 
Uil, 2013) 
It has a role in unwinding   double strand of viral DNA 
and during elongation step of viral replication. 
(de Jong et al., 
2003; Dekker et 
al., 1997) 
E2 pTP Interacts with viral polymerase and involve in the 
formation of initiation complex and serve as a primer 
for viral DNA replication.  It also interacts with 
cellular protein Oct-1 for its recruitment to the origin 
of replication. 
(de Jong et al., 
2003) Mysiak et 
al.,2004,van 
Breukelen et al., 
2003 
E2 Ad-pol Initiate Viral DNA replication via coupling dCTP to 
pTP. It also interacts cellular NFI for its recruitment to 
the origin of replication. 
(de Jong et al., 
2003) 
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Table 1.4.  Role of adenovirus intermediate region in the virus life cycle 
Protein Function/functional interaction Reference 
 
IVa2  
IVa2 binds with packaging domain of viral DNA and 
involves in packaging viral genome.  
(Ostapchuk et al., 
2005; Perez-Romero et 
al., 2005; Tyler et al., 
2007; Zhang and 
Imperiale, 2000) 
 
 
 
 
 
 
 
IVa2 possesses a conserved ATPase motif; bind with 
ATP and occupy a single vertex of icosahedron. 
Mutation in its ATPase motif known to interfere with 
packaging of viral genome.  
(Ahi et al., 2013; 
Christensen et al., 
2008; Ostapchuk et al., 
2011; Ostapchuk and 
Hearing, 2008) 
IVa2 interacts with 33K and DBP.  Interaction of 
IVa2 with 33K shown to activate its ATPase activity 
suggesting that IVa2 might serve as a motor protein 
for stuffing of viral DNA. 
(Ahi et al., 2015; Ahi et 
al., 2013) 
Adenovirus IVa2 interacts with L1 52/55 kDa 
protein and may play role in recruiting 52/55 kDa to 
the viral DNA packaging domain. 
(Gustin et al., 1996; 
Wu et al., 2012) 
IVa2 acts as a trans-acting factor   to activate the 
major late promoter (MLP) via binding downstream 
region of MLP. 
(Lutz and Kedinger, 
1996) 
pIX Involve in stabilization of capsid via cementing 
groups of hexon.   
(Furcinitti et al., 1989; 
Reddy and Nemerow, 
2014; Rosa-Calatrava 
et al., 2001) 
It also acts as a transcriptional activator of TATA 
containing viral promoters. 
(Lutz et al., 1997; 
Rosa-Calatrava et al., 
2001) 
Through sequestration of antiviral PML pIX involve 
in efficient replication of adenovirus. 
(Rosa-Calatrava et al., 
2003) 
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While pTP dissociates from the complex, the viral polymerase undertakes the elongation 
step (Hoeben and Uil, 2013). Through its involvement in unwinding the double helix structure, 
DBP assists the process of elongation. Besides, DBP plays a role in the stabilization of single-
strand DNA via binding and protecting it from degradation (de Jong et al., 2003). A cellular 
protein named topoisomerase also known to play a role in the production of genome length 
products (de Jong et al., 2003).  
 
1.1.3.2. 3 Expression of late genes 
Late (L) adenoviral gene expression is detected mostly after the onset of viral DNA 
replication (Zhao et al., 2014). The late gene of adenovirus isexpressed from the MLP that 
produces a single transcriptional unit called MLTU (Akusjarvi, 2008). The primary transcript 
undergoes differential polyadenylation providing five different mRNA transcripts with similar 
3' ends (Akusjarvi, 2008; Biasiotto and Akusjarvi, 2015). Each of mRNAs (L1-L5) undergoes 
differential splicing producing at least 20 mRNA (Zhao et al., 2014). Each of the late mRNA 
transcripts acquires a non-coding region called tripartite leader sequence (TPL), which is 
known to enhance translation of the late mRNA products. The role of late adenoviral proteins 
summarized in Table 1.5. 
 
1.1.3.2. 4. Genome encapsidation 
Following viral DNA replication, most of the proteins involved in capsid formation and 
genome encapsidation are produced in the cytoplasm and transported to the nucleus where 
assembly and packaging take place (Ding et al., 2010; Li et al., 2019; Tessier et al., 2019). 
Major capsid protein, hexon undergoes trimerization in the cytoplasm with the help of 100K 
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protein (Hong et al., 2005). Another late adenoviral protein, pVI, mediates the nuclear import 
of hexon (Wodrich et al., 2003). Similarly, the penton base and fiber protein join to form a 
complex before nuclear entry (Hunter, 2012). In addition to major capsid proteins, minor capsid 
protein pIIIa, pVI, pVIII, IX also take part in the process of capsid formation (Vellinga et al., 
2005). Viral genome condensed with core adenovirus proteins interacts with packaging protein 
IVa2, 22K, 33K, and 52K to affect packaging. Currently, two models try to explain adenovirus 
morphogenesis (Ahi and Mittal, 2016; Condezo and San Martin, 2017; Ostapchuk et al., 2011).  
According to the concerted model, capsid formation and genome encapsidation is a coupled 
process. Initiation of capsid formation and genome packing occurs in a separate pool, and L1 
52K tethers the two pools, and capsid formation continues around the genome via the addition 
of capsomeres (Condezo and San Martin, 2017). In support of this model, a thermo-conditional 
mutation on DNA binding affects the synthesis of viral DNA and the reduction of virus particle 
production (D'Halluin et al., 1978). Also, the presence of L1 52/55 kDa in genome-less 
adenovirus particle together with the ability of this protein to interact in vivo with packaging 
domain and protein IIIa in vitro is indicative of the role of L1 52/55 kDa in tethering the core 
structures with capsid fragments signifying that packaging in adenovirus is of concerted type 
(Condezo et al., 2015; Condezo and San Martin, 2017; Ma and Hearing, 2011). 
According to the sequential packaging of the adenovirus model, an empty capsid formed 
first, and viral genome packaging follows as a result of the interaction of packaging proteins 
with the packaging sequence located close to the left end of the viral genome (Ahi and Mittal, 
2016).  It has been reported that the adenovirus IVa2 displays ATPase activity, binds with ATP 
and occupy a single vertex of an icosahedron (Christensen et al., 2008; Ostapchuk and Hearing, 
2008).  
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     Table 1.5.  Role of adenovirus late region in the virus life cycle 
 
 
 
	
Protein  Function/functional interaction Reference 
 
 
 
52/55K 
Involved in encapsidation of viral DNA by 
interacting with genome packaging domain. 
(Perez-Romero et al., 
2005) 
Interacts with IVa2 possibly for its recruitment of 
the packaging domain. 
(Gustin et al., 1996; Wu et 
al., 2012) 
Interacts with and cleaved by viral protease.  (Perez-Berna et al., 2014) 
Interacts with IIIa connecting core with capsid 
structures. 
(Condezo and San 
Martin, 2017; Ma and 
Hearing, 2011) 
 It is also found in empty capsid indicating its 
potential role in capsid formation. 
(Condezo et al., 2015) 
 
 
IIIa 
Stabilize capsid by connecting group of hexon and 
interacting with minor protein pVIII. 
(Reddy and Nemerow, 
2014; San Martin, 2012) 
Interact with 52K and viral packaging sequence: a 
role in genome packaging 
(Crosby and Barry, 2014; 
Ma and Hearing, 2011) 
pX  High proportion of basic residues and it bind and 
condense viral genome. 
(Perez-Berna et al., 2015) 
 
pIII 
Penton base, a major capsid component involved in 
capsid formation.  
(Russell, 2009) 
Penton base interact with integrin receptor 
facilitating adenovirus internalization 
(Russell, 2009) 
 
 
 
pVII 
 
 
 
 
pVII interacts with transport receptors and  
incoming viral DNA and translocate viral DNA 
across the NPC to the nucleus. 
(Hindley et al., 2007; 
Wodrich et al., 2006) 
pVII protect adenoviral DNA from detector system 
of the DDR; interacts with SPOC1,  involved in 
detection of Double Strand Break.  
(Karen and Hearing, 
2011; Schreiner et al., 
2013) 
pVII interacts with viral DNA, condenses DNA 
and also acts as a transcriptional suppressor. 
(Johnson et al., 2004) 
pVII play role a role in early stage of adenoviral 
infection via adenoviral endosomal escape. 
(Ostapchuk et al., 2017) 
 
 
 
pV 
pV interacts with pVI and pVII, and links core with 
capsid structure. 
 
(Chatterjee et al., 1985; 
Matthews Russell, 1998). 
pV translocate B23.1 to viral replication center and 
enhance viral replication. 
(Ugai et al., 2012)  
 
pV interacts p32, which might play a role in the 
nuclear import of adenoviral DNA. 
(Matthews and Russell, 
1998) 
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    Table 1.5   ------Continued  
 
 
 
 
 
 
Protein  Function /Functional interaction  References 
 
 
 
 
 
 
pVI 
 
pVI help in transport of hexon to nucleus. And 
stabilization of capsid structure. 
(Wodrich et al., 2003) 
Interaction of pVI pV and pVIII link the 
capsid structure with Virion core structure. 
(Reddy and Nemerow, 
2014) 
pVI serve as a cofactor for activation of 
adenoviral proteinase activity. 
(Mangel et al., 1993) 
pVI as a membrane lytic protein involved in 
endosomal membrane disruption and escape 
of viral particle from endosome. 
(Maier et al., 2010; 
Wiethoff et al., 2005) 
pVI interact with Daxx, and enhance E1A  
transcription  activation function. 
(Schreiner et al., 2012) 
Protease   Cleavage adenoviral proteins before Virion 
maturation of progeny Virion. 
(Mangel and San Martin, 
2014) 
Hexon Interact with minor capsid components to 
stabilize capsid structure. 
 
(Liu et al., 2010; Reddy 
and Nemerow, 2014; San 
Martin,2012) 
Interacts with 100K and pVI for hexon trimer 
formation and transport into the nucleus, 
respectively. 
(Hong et al., 2005 Wodrich 
et al., 2003) 
 
pVIII 
A minor capsid protein located in the interior 
aspect of the viral capsid. It associates with 
pVI and stabilize capsid and links the capsid 
with core structure. 
(Reddy and Nemerow, 
2014; Vellinga et al., 2005) 
Fiber  Structural protein used as the mediator of viral 
entry to host cell. 
(Arnberg, 2012) 
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Table 1.5   Continued  
 
 
 
 
 
 
 
33K 
33K bind to MLP and activate transcription  (Ali et al., 2007; Wu et al., 
2013) 
33K involve in early late switch in the temporal 
pattern of viral gene expression.  
(Farley et al., 2004; 
Tormanen et al., 2006) 
33K interact with IVa2 and DBP and occupy a 
single vertex of an icosahedron.  Involve in viral 
genome encapsidation and appears essential for 
the virus lifecycle. 
(Ahi et al., 2013; Fessler 
and Young, 1999; Finnen et 
al., 2001; Wu et al., 2013) 
33K interacts with PKA and DNA-PK enhancing 
and inhibiting its splicing function  
(Tormanen Persson et al., 
2012) 
 
 
 
22K 
22K protein binds to the viral  packaging  domain  
in the presence of IVa2 and involve in packaging 
of adenoviral genome 
(Guimet and Hearing, 2013; 
Ostapchuk et al., 2006; Wu 
et al., 2012)  
22K also interact with DE elements of adenovirus 
MLP and activate transcription of MLTU.  
 
(Backstrom et al., 2010; 
Guimet and Hearing, 2013; 
Morris and Leppard, 2009; 
Wu et al., 2012) 
22K also enhance late gene expression from 
MLTU post-transcriptionally. 
(Guimet and Hearing, 2013) 
 
22K involved in virus induced cell lysis by 
regulation of adenovirus death protein (ADP) 
(Wu et al., 2012) 
 
 
 
 
 
100K 
 
100K interact with hexon and assist in hexon 
trimer formation.  
 
 
 
Hong et al., 2005 
(Hong et al., 2005; 
Koyuncu and Dobner, 2009; 
Morin and Boulanger, 
1986)  
100K interact with eIF4G and PABP, recruit 40S 
ribosome, favoring viral mRNA translation via 
ribosome shunting while inhibiting cap mediated 
cellular mRNA translation 
 
(Cuesta et al., 2004; Hayes 
et al., 1990; Xi et al., 2004 
 
 
 
100K via interacting and stabilizing granzyme B 
it prevents infected cell from cytotoxic T cell 
mediated destruction. 
(Andrage et al., 2001, 2003) 
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These observations indicate that adenovirus contains a packaging component similar to 
those that use a sequential genome packaging approach (Ahi and Mittal, 2016). Another 
evidence in support of this model is the detection of low-density viral particles (empty capsids)  
during adenovirus purification as well as accumulation of empty capsids as a result of 
encapsidation failure in cells infected with mutant viruses containing mutation in the viral 
proteins that interact with the packaging sequence (Ahi et al., 2013; Ostapchuk et al., 2011; 
Stilwell et al., 2003; Wu et al., 2013; Wu et al., 2012). 
Lack of portal protein is one of the weaknesses attributed to the sequential model of 
adenovirus packaging; however, a recent report indicates that adenovirus E4 34K displays a 
higher degree of similarity with a portal protein of bacteriophages that are known to package 
their genome in a preformed capsid. The presence of the protein in a single vertex of the 
icosahedron and its interaction with packaging proteins indicate that E4 34K may be acting as a 
portal protein of adenoviruses strengthening the sequential model of adenovirus packaging (Ahi 
et al., 2017). 
 
1.1. 4 Bovine adenovirus 
       Bovine adenovirus isolated for the first time in the year 1959 (Klein et al., 1959). Since 
then, the virus isolated from apparently healthy as well as cattle with respiratory and enteric 
aliments (Graham et al., 2005; Smyth et al., 1996; Thomson, 1994). Experimental studies 
indicate that infection with bovine adenoviruses results in from inapparent to mild/moderate 
clinical manifestation (Caswell and Williams 2016; Lehmkuhl et al., 1975; Mittal et al., 1999). 
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1.1.4.1 Classification  
Since the first report, a total of 14 bovine adenovirus serotypes reported so far (Lehmkuhl 
and Hobbs, 2008; Sibley et al., 2011). Historically, based on sharing common complement-
fixing antigen or not and based on growth characteristics in tissue culture, bovine adenoviruses 
were classified into two groups group I and group II (Bartha, 1969). According to the current 
nomenclature, on the basis of genome organization or phylogenetic analysis, bovine adenovirus 
serotypes fall under either Mastadenovirus or Atadenovirus genus (Harrach et al., 2012; 
Harrach, 2014). 
 
1.1.4.2 Genome organization of bovine adenovirus -3 
Bovine adenovirus (BAdV)-3 classified within the genus of Mastadenovirus (Davison et al., 
2003; Harrach, 2014). BAdV-3 was isolated from healthy cattle as well as from cattle 
manifesting or having respiratory or enteric infections (Darbyshire et al., 1965). However, no 
significant clinical manifestation observed upon experimental infection (Lehmkuhl et al., 1975; 
Mittal et al., 1999). 
BAdV-3 contains a double-strand linear DNA genome of 34446 bp (Reddy et al., 1998). The 
double-strand viral DNA is flanked by an inverted terminal repeat (ITR), which is longer than 
human adenovirus (HAdV)-2 and -5 (Reddy et al., 1998). BAdV-3 ITR contains E1A 
transcriptional control elements and also plays a role in the packaging of the viral genome 
(Xing and Tikoo, 2007). Similar to other adenoviruses, gene expression patterns in BAdV-3, is 
temporally regulated (Fig. 1.4), where early genes transcribed first, followed by intermediate 
and late genes (Reddy et al., 1998).  
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1.1.4.2.1 Early genes of bovine adenovirus -3  
Early (E) region of BAdV-3 divided into four regions (E1-E4) (Baxi et al., 1998; Idamakanti 
et al., 1999; Reddy et al., 1999a). Similar to HAdV-5, E1 region of BAdV-3 divided into E1A 
and E1B (Reddy et al., 1999a). However, unlike HAdV-5, E1A, and E1B regions, BAdV-3 
E1A and E1B are obtained from overlapping transcriptional units (Reddy et al., 1999a) 
controlled by separate promoters and share the same polyA sites (Reddy et al., 1999a). 
The E1A region produces 211, 115, and 100R mRNA transcripts detected as 43, 57, and 65 
kDa protein respectively from BAdV-3 infected cells, all of which sharing N terminus 93 
amino acids (Reddy et al., 1999a). While the 43kDa expressed as early as 6 hr, the rest of the 
E1A protein expression starts from 24 hours onwards (Reddy et al., 1999a). Function wise E1A 
involve in transactivation of other BAdV-3 early genes (Zhou and Tikoo, 2001). Moreover, 
E1A is indispensable for BAdV-3 life cycle (Reddy et al., 1999b; Zhou and Tikoo, 2001). 
Though the significance of phosphorylation is not studied, E1A of BAdV-3 appeared to be 
phosphorylated (Reddy et al., 1999a; Reddy et al., 1998). E1B of BAdV-3 encodes one small 
(157R) and one large (420R) protein that encode 19kDa and 48 kDa proteins, respectively 
(Reddy et al., 1999a; van Olphen et al., 2002). Their expression kinetics indicates that the 
19kDa protein expressed earlier than the 48kDa protein. E1B proteins of BAdV-3 are highly 
phosphorylated (Reddy et al., 1999a). While 19kDa is not essential for the replication of 
BAdV-3, the 48 kDa E1B protein appears to be necessary for BAdV-3 life cycle (Reddy et al., 
1999b; Zhou and Tikoo, 2001). The E2A region of BAdV-3 divided into two regions: E2A and 
E2B that encode protein involved in viral replication (Reddy et al., 1998). E2A encodes for 
DBP, a 423 amino acid long protein displaying less than 50% similarity with the homologous 
protein encoded by HAdV-5. The conserved C-terminus region is involved in DNA binding 
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and viral replication (Kitchingman, 1985; Reddy et al., 1998). The protein also contain cluster 
of basic amino acids as well as serine and arginine repeats that may potentially serve as nuclear 
localization signal and phosphorylation sites, respectively (Reddy et al., 1998).  
The E2B of BAdV-3 produces precursor terminal protein (pTP) and viral DNA polymerase 
(pol) mRNAs that are 3' co-terminal (Baxi et al., 1998; Reddy et al., 1998). BAdV-3 pTP and 
pol encodes 649 and 1023 amino acid long protein, respectively, with significant homology 
with homologs encoded by other adenoviruses (Baxi et al., 1998; Reddy et al., 1998). BAdV-3 
pTP contains a conserved amino acid sequence (YSRLVYR), which contains amino acids 
involved in initiation complex formation (Hsieh et al., 1990). In addition to the conserved 
sequence involved in the initial stage of adenoviral DNA replication, BAdV-3 pTP contains a 
partially conserved sequence used as a nuclear localization signal in HAdV-5 pTP (Zhao and 
Padmanabhan, 1988).  Moreover, among the three potential pTP cleavage sites of HAdV-5 
pTP, two of them are conserved in BAdV3-pTP (Baxi et al., 1998; Zhao and Padmanabhan, 
1988). The E3 region of BAdV-3 encodes for 284, 121, 86, and 82R proteins (Idamakanti et al., 
1999; Reddy et al., 1998). Among the four proteins, 121R, expressed as 14.5kDa in infected 
cells, show limited homology with HAdV-5 14.7kDa protein (Idamakanti et al., 1999; 
Zakhartchouk et al., 2001) while 284R appeared to be unique to BAdV-3 (Idamakanti et al., 
1999). Similar to HAdV-5 E3 14.7 kDa protein, 121R of BAdV-3 displays serological 
similarity and prevent TNF-α mediated cell lysis (Zakhartchouk et al., 2001). The E3 region of 
BAdV-3 is dispensable for the propagation of the virus in tissue culture (Mittal et al., 1993; 
Zakhartchouk et al., 1998).  
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Fig. 1.4 Transcriptional map of BAdV-3.   
The double line represent   double stranded DNA genome and the arrows indicate transcripts from 
both strands. Major late promoter (MLP), a promoter where late mRNA transcript are driven.  
Tripartite leader (TPL) sequence, none coding regions where late mRNA transcripts acquire it via 
alternate splicing Horizontal arrows represent direction of transcription. Re printed from Ayalew et 
al., 2015. Vaccine, 15; 33(4):493-9 ( with permission from Elsivier) 
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The E4 region of BAdV-3 located in the right end of the genome, transcribed from the 
complementary (l) strand and has a potential to encode five different transcripts that encode 
proteins with amino acid length of 143, 69, 289, 143 and 219, respectively (Lee et al., 1998; 
Reddy et al., 1998). While BAdV-3 E4 Orf 3 and 5 show partial homology with HAdV-2 34K 
protein (Lee et al., 1998), the remaining Orfs are unique to the BAdV-3 (Lee et al., 1998).  
Though deletion of individual Orf 1, 2, 3, or 4 showed no effect on BAdV-3, deletion of E4 Orf 
5, orf1-3 or orf3-5 region affected BAdV-3 replication (Baxi et al., 2001). 
 
1.1.4.2.2 Intermediate genes bovine adenovirus -3 
Similar to other adenoviruses in the genus Mastadenovirus, BAdV-3 encodes two 
intermediate genes, pIX and IVa2 (Baxi et al., 1998; Reddy et al., 1999a). Like the E2 and E4 
genes, IVa2 transcribed from the complementary strand. Reports indicate that BAdV-3 IVa2 
encodes 376 amino acids long protein with its C-terminus 22 amino acids overlapping with N-
terminus of the viral polymerase (Baxi et al., 1998). However, further analysis of reported 
BAdV-3 genome sequence indicates that 80 amino acids of IVa2 overlap with the polymerase 
region, and 13 nucleotides of IVa2 obtained via alternate splicing from the polymerase coding 
region (Davison et al., 2003). BAdV-3 pIX is 125 amino acid long protein, and its transcripts 
overlap with E1 region (Baxi et al., 1998; Zheng et al., 1994). The protein has the potential to 
accommodate foreign genes as recombinant BAdV-3 containing EYFP or RGD motif fused to 
C-terminus of pIX could be successfully rescued, indicating that its potential as a site of 
insertion of foreign genes (Zakhartchouk et al., 2004). 
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1.1.4.2.3 Late genes of bovine adenovirus -3 
The late (L) genes of adenovirus, in general, encode structural components of the viral 
capsid and non-structural proteins involved in the formation of capsids. The late genes 
transcribed from the major late promoter, the activation of which produce a major late 
transcription unit that undergoes alternate spicing and polyadenylation to produce multiple 
transcripts (Berk, 2013). Unlike the HAd-5 major late transcriptional unit (MLTU), which 
produces five transcripts (L1-L5), BAdV-3 MLTU produces seven transcripts L1-L7. Each of 
the transcripts acquires a tripartite leader (TPL) sequence via alternate splicing from three exon 
regions (Reddy et al., 1998).The L1 region of BAdV-3 encodes for two structural (pIIIa and 
pIII), one core (pVII), and one non-structural (52K) protein (Reddy et al., 1998). The pIII is 
568 amino acids long protein with 25-57 % homology with pIIIa encoded by other 
adenoviruses and has a consensus protease cleavage site (Reddy et al., 1998). The pIII (penton 
base) is 482 amino acid long protein with 44-64% homology with a penton base encoded by 
other adenoviruses (Reddy et al., 1998). Unlike conserved RGD and LDV motifs involved in 
the secondary interaction of penton base with integrin family of receptors in HAdV-5, BAdV-3 
penton known to have MDV motif that may have a role in the entry of the virus into target cells 
(Komoriya et al., 1991; Reddy et al., 1998). Moreover, BAdV-3 pIII possesses a conserved 
sequence used by other members of adenoviruses in the interaction of penton base with fiber 
(Reddy et al., 1998). The pVII of BAdV-3 is 171 amino acids and shows 33.3% to 53.2% 
homology with pVII encoded by other adenoviruses (Reddy et al., 1998). The pVII contains a 
mitochondrial localization signal, localizes to mitochondria, and prevents infected cells from 
mitochondrial-mediated apoptosis (Anand et al., 2014). The BAdV-3 pVII also shown to 
interact with viral protein 52K (Paterson, 2010).  
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The 52K protein of BAdV-3 consists of 370 amino acids and show homology of 56.8% to 
61.6 % with 52K encoded by other adenoviruses (Reddy et al., 1998). The 52K detected as a 40 
kDa protein in infected as well as transfected cells (Paterson et al., 2012). The 52K contains a 
bipartite nuclear localization signal, which interacts with α-3 importin for nuclear transport of 
52K (Paterson et al., 2012). The 52K protein interacts with cellular protein NF-kB binding 
protein (NFBP) (Paterson, 2010) and viral proteins pVII (Paterson, 2010), 33K, and 22K (Said 
et al., 2018a) in BAdV-3 infected cells.  
The L2 region encodes a single protein pV, which contains a high content of basic amino 
acids (Reddy et al., 1998). BAdV-3 pV is 423 amino acid long protein-containing nuclear and 
nucleolar localization signals (Zhao and Tikoo, 2016). The protein displays three nucleolar 
localization signals with redundant function as the deletion of the entire nucleolar localization 
signal rather than individual nucleolar localization signals affected viral replication (Zhao, 
2016). The protein interacts with cellular transport receptor importin α-3 to cross the nuclear 
pore complex towards the nucleus. Moreover, pV interacts with viral protein 100K and cellular 
protein nucleolin (Zhao, 2016). BAdV-3 pV appears to be essential for BAdV-3 replication as 
its deletion affects virus assembly, reduced late adenoviral protein expression, and reduced 
thermostability (Zhao and Tikoo, 2016). 
The L3 region of BAdV-3 encodes 80 amino acid long, basic proteins, pX (Reddy et al., 
1998). The protein shows 38-64 % homology with pX of other adenoviruses (Reddy et al., 
1998). The protein also displays sequences potentially involved in protease cleavage and 
nuclear localization of pX, indicated by its conserved nature among similar sequences present 
in pX encoded by other adenoviruses (Anderson et al., 1989; Reddy et al., 1998) 
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The L4 region of BAdV-3 encodes pVI protein showing 15-38% homology with pVI 
encoded by other adenoviruses (Reddy et al., 1998). BAdV-3 pVI displays significant 
homology with C-terminus of HAdV- 2 counterpart suggesting potential functional similarity 
(Reddy et al., 1998). Moreover, pVI of BAdV-3 contains consensus protease cleavage sites 
(Reddy et al., 1998). 
The L5 region of BAdV-3 encodes a structural protein, hexon (Reddy et al., 1998). It is a 
major structural protein of 910 amino acids, detected with a molecular weight of 98kDa protein 
in mature virus (Kulshreshtha et al., 2004). The protein shows 45 to 70% homology with hexon 
encoded by other adenoviruses (Reddy et al., 1998). BAdV-3 L5 region also encodes protease 
of 204 amino acid long that shows significant homology with proteases encoded by other 
adenoviruses (Reddy et al., 1998). BAdV-3 precursor proteins pIIIa, pVI, pVII, pIX and pTP 
contain conserved consensus protease cleavage site(s) (Reddy et al., 1998). Recent, report 
shows that BAdV- 3 protease cleave pVIII (Gaba et al., 2017) and non-structural protein 100K 
(Makadiya et al., 2015). 
The L6 region of BAdV-3 encodes three non-structural (22K, 33K,100K) and one structural 
(pVIII) protein (Reddy et al., 1998). BAdV-3 100K, a non-structural protein, is detected as 130 
kDa protein at early and late times post-infection (Makadiya et al., 2015). The 100K localizes 
both in the nucleus and cytoplasm in the infected cells. The 100K protein interacts with viral 
protein pV and cellular protein dynein light chain 1 (DYNLT1) (Makadiya, 2013). The 100K 
protein contains two consensus protease cleavage sites, which are cleaved by BAdV-3 protease. 
The cleaved C-terminus of 100K utilizes NLS (amino acid 789-811) to localize to the nucleus 
(Makadiya et al., 2015). However, cleavage of 100K appears to be dispensable for the 
replication of BAdV-3 (Makadiya et al., 2015). Two other non-structural proteins encoded by 
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L6 region of BAdV-3 include 22K and 33K, which are encoded by an un-spliced transcript and 
spliced 33K transcript, respectively (Kulshreshtha, 2009; Reddy et al., 1998). The BAdV-3 
33K and 22K share the N-terminus region of 138 amino acids (Kulshreshtha and Tikoo, 2008). 
The 22K is 274 amino acids long, expressed as 42kDa and 37 kDa proteins in infected cells 
(Kulshreshtha et al., 2015). BAdV-3 22K localize to the nucleus by interacting with cellular 
transport proteins, importin α-5 and α-7 (Said et al., 2018a). Amino acids 238-241 are essential 
for nuclear localization of 22K, which appears necessary for the replication of BAdV-3 (Said et 
al., 2018a). Besides, amino acid 35-65 of BAdV-3 22K interacts with BAdV-3 52K (Said et al., 
2018a). 
The 33K of BAdV-3 is 279 amino acids long and expressed as 42 kDa, 38 kDa, and 33 kDa 
proteins in infected cells (Kulshreshtha et al., 2015). The conserved C-terminus of BAdV-3 
33K contains leucine residues, which appear to bind with the downstream element of the MLP 
and stimulate transcription activity from the MLP (Kulshreshtha et al., 2015). The conserved C-
terminus of BAdV-3 also contains RS (Arginine, Serine) repeats, which bind to the transportin 
receptor and localize 33K to the nucleus (Kulshreshtha et al., 2014). Besides, BAdV-3 33K 
appears to interact with viral protein 52K (Said et al., 2018a) and cellular proteins importin α-5 
(Kulshreshtha et al., 2014) and bovine presenilin-1-associated protein (BoPSAP) (Kulshrestha, 
2009). Additionally, BAdV-3 33K appears to be indispensable for virus replication 
(Kulshreshtha et al., 2004; 2008; Kulshreshtha, 2009).  
The pVIII is a structural protein encoded by L6 region of BAdV-3 (Reddy et al., 1998). The 
protein consists of 216 amino acids, detected as 24 kDa and 8kDa proteins in infected cells 
(Ayalew et al., 2014). BAdV-3 pVIII displays two consensus protease cleavage sites with 
redundant function (Gaba et al., 2017). Although mutation of single-site produces thermolabile 
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progeny virus, mutation of both sites is lethal for progeny virus production (Gaba et al., 2017). 
Earlier, we demonstrated that pVIII interacts with cellular dead box family of RNA helicases 
(DDX3) and interfere translation of capped mRNA (Ayalew et al., 2016). Recently, we 
reported that pVIII interacts with eukaryotic initiation factor 6 (eIF6) and delays the joining of 
60S ribosomes to 40S ribosome to form a mature 80S ribosome (Gaba et al., 2018). 
BAdV-3 fiber is the only protein encoded by the L7 region of BAdV-3. The protein is 976 
amino acid long with lower degree of homology with the fiber of other adenoviruses (Reddy et 
al., 1998).  BAdV-3 fiber detected as 102 kDa glycoprotein in the infected cell (Wu et al., 
2004a). It is localized in the nucleus using basic amino acid located in the N-terminus 41 amino 
acids (Wu et al., 2004a). BAdV-3 fiber protein is involved in the initial viral interaction with 
host cell sialic acid receptors (Li et al., 2009). Moreover, the replacement of the cell receptor-
binding region of BAdV-3 with cell receptor binding region of HAdV-5 fiber alters the tropism 
of BAdV-3 (Wu and Tikoo, 2004b). 
 
1.1.4.2.4 Protein-protein interaction in bovine adenovirus -3  
Viruses undergo viral-viral or viral-cellular protein-protein interaction at different stages of 
their life cycle (Cook et al., 2018). As they have limited genetic information, viral-cellular 
protein-protein interactions are crucial for tapping cellular resources (Halehalli and 
Nagarajaram, 2015). In this regard, knowledge of viral protein-protein interactions increases 
our understanding of virus biology (Cook et al., 2018). Present knowledge regarding protein-
protein interactions in BAdV-3 summarized below in Table 1.6 (a)(b (Paterson, 2010). 
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Table 1.6 BAdV-3 interactions with viral\cellular proteins. (a) Interaction of non 
structural proteins of BAdV-3 with viral\cellular proteins. 
 
Protein  Viral\cellular interacting proteins Reference 
52K  Viral proteins: 22K, pVII 
Cellular protein: Importin α-3, NF-kB-binding 
protein (NFBP) 
 
Paterson, 2010; 
Paterson et al., 2012; 
Said et al., 2018a 
100K Viral protein: 33K 
Cellular protein: Importin α-3,  Dynin (DYNLT1) 
light chain1; 
 
Makadiya, 2013. 
Makadiya et al., 2015 
22K  Viral protein: 52K. 
Cellular protein: Importin α-5; importin α-7 
Said et al., 2018a 
33K Viral protein: 100K, pV, 52K 
Cellular protein: Importin α-5; Transportin; bovine 
presenilin-1-associated protein / mitochondrial 
carrier homolog (BoPSAP/BoMtch1) 
Kulshreshtha and 
Tikoo, 2008; 
Kulshrestha, 2009; 
Said et al., 2018a 
 
      (b). BAdV-3 structural proteins interaction with viral\cellular proteins 
pVIII Viral protein: 
Cellular protein: Importin α-3; DDX3; eIF-6 
 
Ayalew et al., 2016; 
Gaba et al., 2018 
pV Viral protein:33K 
 Cellular protein: Nucleolin,  
Zhao, 2016 
pVII Viral protein: 52K Paterson , 2010 
Fiber Cellular protein: sialic acid receptors (Li et al., 2009) 
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1.1.5 Adenovirus IVa2 
Adenovirus IVa2 is one of the conserved viral proteins of adenoviruses, transcribed from 
the complementary viral DNA (Davison et al., 2003). It is a product of the intermediate region 
the expression of which is suppressed by an unknown cellular factor (Davison et al., 2003; 
Huang et al., 2003; Iftode and Flint, 2004). Earlier reports indicated that IVa2 displays a 
nucleolar and nucleoplasmic distribution (Lutz et al., 1996). Studies in human adenovirus IVa2 
shown that the viral protein is involved in the transcriptional activation of late adenoviral 
proteins involved in the formation of viral capsid via associating with the viral major late 
promoter region (Lutz and Kedinger, 1996; Pardo-Mateos and Young, 2004; Tribouley et al., 
1994). Besides, IVa2 is involved in the packaging of the viral genome via sequence-specific 
interaction of the viral protein with the packaging domain located at the left end of the 
adenoviral sequence (Hammarskjold and Winberg, 1980; Ostapchuk and Hearing, 2005). The 
viral protein IVa2 localizes at the unique vertex of the icosahedron (Christensen et al., 2008) 
and has conserved ATPase motifs with an essential role in the virus life cycle (Ostapchuk and 
Hearing, 2008). Recent findings are also in support of the hypothesis where IVa2 localize at a 
unique vertex of the icosahedral capsid, forming a complex with other viral proteins (Ahi et al., 
2013).  
Previous reports have shown that human adenovirus IVa2 cooperatively with 22K protein 
interacts with viral packaging sequence for efficient packaging of the viral genome (Ewing et 
al., 2007; Ostapchuk et al., 2006; Yang and Maluf, 2012). Similarly, interactions of IVa2 with 
33K as well as 52K proteins, which have known to be involved in enhancing gene expression 
and packaging of adenovirus respectively, have been documented (Ali et al., 2007; Gustin and 
Imperiale, 1998; Gustin et al., 1996). Recently, via in vivo crosslinking approach IVa2 protein 
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shown to associate with 22K, 33K and DNA binding protein with localization of the complex at 
a single vertex of adenoviral capsid further indicating that IVa2 carries out its function via 
forming a functional association with other adenoviral proteins (Ahi et al., 2013).  
 
1.2 Nuclear pore complex and nucleoporins 
One of the characteristic features of eukaryotic cells is the presence of a membrane-bound 
nucleus that creates a controlled environment for activities taking place in the nuclear and 
cytosolic compartments (Anderson and Hetzer, 2007). However, the bidirectional transport of 
materials between the nucleus and cytoplasm is essential for coordinated cellular function. For 
instance, transcription products, as well as other macromolecules that are essential for cytosolic 
translation of messenger RNA, need to get access to the cytoplasm, and proteins required for 
nuclear function have to transverse the nuclear membrane to reach the nucleus (Nakielny and 
Dreyfuss, 1999).  
The nuclear pore complex (NPC) mediates the movement of materials between the nucleus 
and cytoplasm (Wente and Rout, 2010). NPC is a macromolecular protein assembly embedded 
within the nuclear envelope.  Multiple copies of about 34 nucleoporins (nups) involved in the 
formation of functional units of the NPC  (Hoelz et al., 2011). As revealed by cryo-ET studies, 
NPC consists of an asymmetric core (comprising cytoplasmic, inner and nuclear rings), and 
asymmetric cytoplasmic filaments and nuclear basket (Fig. 1.5). Nuceolporins are named using 
a three-letter Nup followed by a number that indicates the molecular protein weight (Schwartz, 
2016). Based on their location, within the nuclear pore complex, nucleoporins are classified as 
coat nucleoporins (nups) transmembrane nups, adaptor nups, channel nups, cytoplasmic 
filament nups, and basket nucleoporins (Hoelz et al., 2011; Hsia et al., 2007) (Fig. 1.5).  
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Fig 1.5 Schematic representation of the nuclear pore complex. Re printed from Lin and 
Hoelz, 2019 Annu Rev Biochem. 20; 88: 725–783.  (With permission from Annual Review) 
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Nucleoporins consist of a structural domain, including β-propellers, α-helical solenoid, and 
phenylalanine-glycine (FG) repeats (Hoelz et al., 2011; Lin and Hoelz, 2019). While all the 
nucleoporins consist of FG repeats, nucleoporins that form the symmetric core of the NPC 
mainly consist of α- helical regions and β-propellers (Lin and Hoelz, 2019). Nucleoporins are 
known to organize themselves as subcomplexes dictated by the stability of protein interaction, 
which eventually joined each other to form the nuclear pore complex. So far, four nucleoporins 
subcomplexes have been reported (Lin and Hoelz, 2019). The first one is the coat nucleoporins 
subcomplex, also known as the Y complex, and it is a major constituent of the outer ring 
(Hoelz et al., 2011). In humans, the Y complex is known to comprise (Sec13, Seh1, Nup96, 
Nup75, Nup107, Nup160, Nup133, Nup37, Nup43, and ELYS (Lin and Hoelz, 2019). The 
second subcomplex is known as the inner ring subcomplex, also called the nup93 
subcomplexes. Unlike the coat nucleoporins subcomplex, the inner ring subcomplex displays 
different conformation (Lin and Hoelz, 2019; Stuwe et al., 2015). The subcomplex includes 
Nup53, Nup93, Nup155, Nup205, Nup188, Nup98. In addition to these nucleoporins, the inner 
ring subcomplex consists of Nup54, Nup58, and Nup62, which contribute FG repeats that form 
a molecular sieve structure within the central channel (Lin and Hoelz, 2019). The third group of 
subcomplex is nucleoporins that form the cytoplasmic filaments. Nucleoporins that form the 
cytoplasmic filaments include Nup214, Nup88, Nup62, Gle1, Nup42, Rae1, and Nup98 
(D'Angelo and Hetzer, 2008; Hoelz et al., 2011). These nucleoporins are characterized by 
having long flexible extension that protrudes into the cytoplasm (Jarnik and Aebi, 1991). 
Cytoplasmic filament nucleoporins, in particular, FG repeats within these nucleoporins, serve 
as attachment sites with transport receptors. Cytoplasmic filament nucleoporins play a role in 
the control of mRNA export (Bonnet and Palancade, 2014). Another nucleoporins sub-complex 
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that forms the asymmetric portion of the NPC is the nups that form the nuclear basket of the 
NPC (Umlauf et al., 2013). Basket Nucleoporins include nucleoporins that form the nuclear 
face of the nuclear pore complex. In humans, the components include Nup50, Nup153, and Tpr 
(Meszaros et al., 2015; Schwartz, 2016). The nuclear basket nucleoporins beside their role in 
the nucleocytoplasmic transport of mRNA; they are involved in transcriptional regulation 
(Kohler and Hurt, 2010). 
 
1.3 Nuclear import of proteins 
The nuclear pore complex (NPC) allows passive transport of small molecules less than 
40kDa, whereas the transport of macromolecules across the NPC involves an active transport 
system   known as the nuclear transport system (Christie et al., 2016). (Fig.1.6). The 
components of the system include a protein Ran (create a gradient which in turn determines the 
directionality of transport), cargo molecule displaying a stretch of recognition sequence called 
localization signals, and soluble transport receptors (Christie et al., 2016).  A small GTPase, 
Ran, has ATP and GDP bound forms (RanGTP and RanGDP) (Gorlich et al., 1996). There is 
high concentration gradient of RanGTP in the nucleus, which is achieved by a combined action 
of RanGAP (RanGTPase activating protein) that is present only in the cytoplasm and converts 
RanGTP to RanGDP where the latter is transported into the nucleus using cellular protein 
NTF2 (Bischoff et al., 1995; Ribbeck et al., 1998). In the nucleus using a protein present only 
in the nucleus, Ran guanine exchange factor 1, also called regulator of chromosome 
condensation 1 (RCC1), facilitates the reconstituting RanGTP (Bischoff et al., 1995). For 
instance, for the transport of the protein to the nucleus across the NPC, cargo protein using its 
nuclear localization signal interacts with soluble transport receptors (karyopherins). Interaction 
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can be mediated by adaptor transport protein such as importin-α or directly via interaction of 
cargo with karyopherins-β (Gorlich et al., 1995; Xu et al., 2010). Importin α consists of three 
conserved structural domains (Miyamoto et al., 2016; Oka and Yoneda, 2018).  The first is the 
N terminus part, also called the importin β binding domain, involved in the interaction with 
importin β1 (Lott and Cingolani, 2011; Miyamoto et al., 2016). The middle portions is involved 
in the interaction with the NLS of cargo protein (Miyamoto et al., 2016; Xu et al., 2010).  In a 
majority of the cases, importin α binds with classical NLS, NLS containing clusters of basic 
amino acids that can be of monopartite (consisting single clusters of basic amino acids) or 
bipartite  (containing two stretches of basic amino acids separated by a linker (Lange et al., 
2007). The last domain of importin α is the C terminus part, the domain of importin α that 
serves as a binding site for the exportin, cellular apoptosis susceptibility protein (CAS) 
(Goldfarb et al., 2004; Stewart, 2006).  The middle and C terminus portions of importin α are 
made of armadillo (ARM) repeats, each of which consists of 42-43 amino acids (Oka and 
Yoneda, 2018). Although importin α serves as a receptor for protein with classical nuclear 
localization signals, a protein with a non-classical nuclear localization signal has shown to 
utilize the adaptor protein (Nakada et al., 2015). Proteins with monopartite NLS usually bind to 
the major groove of the helical structure of importin α (middle portion of importin α containing 
2-4 of the ARM repeats), and protein with bipartite classical NLS binds to both major and 
minor groove of importin α (the part made from 6-8 ARM repeats)(Kosugi et al., 2009b). 
Nuclear import of many proteins with non-classical nuclear localization signals is mediated by 
direct interaction with importin β2 (Xu et al., 2010).  Protein that interacts with importin β2 
though they lack conserved consensus motif unlike classical NLS, it has been shown that these 
proteins contain proline and tyrosine residues at the end of their sequence (Lange et al., 2008).   
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Ternary complex consisting of cargo protein, importin-α and  karyopherin-β1 or cargo 
protein karyopherin-β2 complex docks at the nuclear pore complex via interaction of 
karyopherin-β with nucleoporins residing on the cytoplasmic side of the NPC. After the 
complex traverse, the NPC, disassembly of cargo achieved by the binding of RanGTP 
(Moroianu et al., 1996; Rexach and Blobel, 1995). The RanGTP bound soluble transporter 
transported back into the cytoplasm (Arnold et al., 2006). The principle of nuclear export of 
protein is the same except the cargo displaying nuclear export signal is recognized by a 
different class of transporter called exportin and the fact that binding of cargo with nuclear 
export receptors requires the binding of Ran GTP (Matsuura, 2016). Exportin docks cargo 
complex to the nuclear basket of the nuclear complex, and the whole complex translocated to 
the cytoplasm (Matsuura, 2016). In the cytoplasm, RanGAP act on RanGTP to be converted 
into its GDP form for dissociation of the complex and RanGDP transported back to the nucleus 
to maintain high RanGTP concentration gradient (Christie et al., 2016). 
 
1.4 Nucleolus 
The nucleolus is a membrane-less structure organized around a tandem array of ribosomal 
DNA (rDNA) genes (Hernandez-Verdun et al., 2010). Electron microscopic observation 
revealed three distinct subcompartments named as a fibrillar center (FC), dense fibrillar 
centered (DFC), and granular center (GC) (Boisvert et al., 2007; Hernandez-Verdun et al., 
2010). Though several non-canonical functions of nucleolus come into to picture, historically, 
the nucleolus is associated with the biogenesis of protein, translating machinery called 
ribosomes (Boisvert et al., 2007). 
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Fig. 1.6 Schematic illustration of the cellular nucleocytoplasmic transport. Re printed from 
Caly et al., 2015 Front Microbiol. 14;6:848.  (Publisher MDPI). 
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1.4.1 Nucleolus and ribosome biogenesis 
The process of ribosome biogenesis involves coordinated activities of RNA polymerase I , 
RNA polymerase II, and RNA polymerase III  (Ciganda and Williams, 2011; Martin et al., 
2006). In addition to the three RNA polymerases, many transacting factors, such as small 
nucleolar RNA and non-ribosomal proteins, are involved in the process fig. 1.7 (Matera et al., 
2007).  Ribosome biogenesis starts with the transcription of 47S precursor ribosomal RNA 
(pre-rRNA) from ribosomal DNA (rDNA) using RNA polymerase I and associated 
transcription factors in the nucleolus. Concurrent to transcription or post-transcriptionally two 
important nucleotide modifications, namely 2'-O-ribose methylation and pseudouridylation 
carried out on selected nucleotide bases using conserved small nucleolar ribonucleoprotein 
containing methyltransferases and pseudouridylase respectively. The pre-rRNA transcript, in 
addition to the coding sequences of the mature rRNAs, consists of two external transcribed 
spacers at the 3' and 5' end and an internal transcribed spacer 1 and 2 (ITS1 and ITS2) flanked 
by the 5.8S rRNA. Besides base modification, 47S pre-rRNA undergoes processing, which 
involves the removal of internal and external transcribed spacer sequences resulting in the 
production of 28S, 18S, and 5.8S mature ribosomal RNAs. Ribosomal RNA encoding 
messenger RNA and 5S ribosomal RNA are transcribed in the nucleus using RNA polymerase 
II and RNA polymerase III, respectively. Ribosomal protein-encoding mRNA exported to the 
cytoplasm and translated products (ribosomal proteins) imported back to the nucleus and 
incorporated with rRNAs to form ribosomal subunits (Henras et al., 2015; Matera et al., 2017). 
In mammals, the ribosome comprises 40S (small) and 60S (large) ribosomal subunits.  While 
28S, 5.8S, 5S together with ribosomal protein form the 60S subunit, 18S rRNA, and its protein 
form the 40S subunits. 
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Generally, most of the process of ribosome biogenesis takes place in the nucleolus. While 
transcription of polycistronic RNA takes place at the junction of FC and DFC, modification, 
processing, and assembly processes take place in DFC and GC region of the nucleolus. Finally, 
the two subunits leave the nucleolus and exported to the cytoplasm, where it undergoes further 
maturation and formation of the 80S subunit (Boulon et al., 2010; Henras et al., 2015; Matera et 
al., 2007). Proteomic analysis of nucleolus indicates nucleolus possess more than 4500 resident 
proteins, of which only 30% of them linked with ribosome biogenesis role (Ahmad et al., 
2009). Although reports indicate the involvement of nucleolus in various cellular processes 
(Boisvert et al., 2007), the role of the nucleolus as a sensor of nucleolar stress and its 
relationship in cell cycle control is well established (Boulon et al., 2010). 
 
1.4.2 Role of nucleolus as the sensor of nucleolar stress and cell cycle control 
The concept of nucleolar stress started since 2001, where Pestov and colleagues found that 
mutation in a nucleolar protein block of proliferation 1 (Bop1) interferes with the process of 
ribosome biogenesis. From that observation, they proposed that defects in ribosome biogenesis  
results in nucleolar stress leading to p53 dependent cell cycle arrest (Pestov et al., 2001).  Later, 
Rubbi and miller undertook several studies and strengthened the concept of nucleolar stress 
(Rubbi and Milner, 2003). It is now well established that stress factors such as radiation, toxic 
agents that inflict DNA damage, nutrient depletion, hypoxia, and heat shock interfere with the 
process of ribosome biogenesis resulting in nucleolar stress (Boulon et al., 2010; Rubbi and 
Milner, 2003). The outcome in response to nucleolar stress can be DNA repair, cell cycle arrest 
or apoptosis which depend on the magnitude of damage (Chen, 2016), and the response can be 
mediated with or without the involvement of p53 (James et al., 2014). 
	   43	  
 
 
 
 
Fig. 1.7 |Schematic illustration of the process of ribosome biogenesis. 
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1.4.2.1 Nucleolar stress and the role of p53 in the process 
P53, the guardian of the cell, plays a role in the protection of the cellular DNA (Lane, 1992). 
Under normal condition, the level of p53 is kept at low level by the action of mouse/human 
double minute 2 (MDM2/HDM2) protein which bind and facilitate its degradation by the 
proteasomal degradation system (Haupt et al., 1997; Kubbutat et al., 1997) as well as via 
binding and shielding its transcriptional activation function (Oliner et al., 1993). However, at 
times of stress, various players involved in the process of p53 activation, including protein-
protein interaction that relief the suppressive action of its negative regulator MDM2 through 
mechanisms that allow selective translation of p53’s mRNA as well as via posttranslational 
modification based enhancement of p53 activity. (Hafner et al., 2019). 
The major players in protein-protein interaction-based activation of p53 are ribosomal 
proteins (Liu et al., 2016). During nucleolar stress, ribosomal proteins translocate from the 
nucleolus to the nucleoplasm, where they bind with MDM2 and increase free form of p53 
where the later increase the translation of genes activated by p21 leading to cell cycle arrest or 
apoptosis (Deisenroth and Zhang, 2010; Zhang and Lu, 2009). Although the significance of 
interaction was not well established, the interaction of the ribosomal protein (RP) with MDM2 
dates back in 1994 (Marechal et al., 1994).  Currently, there is a growing list of ribosomal 
proteins involved in p53 activation via interacting with MDM2; however, most of them are 
targeted by the proteasomal degradation system (Kim et al., 2014; Lam et al., 2007). Among 
the ribosomal proteins RP5, RP11 alone or, more importantly as a complex with 5S RNA 
proven to have a significant effect in activating the p53 signalling pathway in response to 
nucleolar stress (Donati et al., 2013; Nicolas et al., 2016; Sloan et al., 2013). In agreement with 
this, unlike RP5 and RP11, depletion of most of the ribosomal proteins did not affect the 
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activity of p53 indicating the significant role of RPL5 and RPL 11 as mediators of p53 
mediated nucleolar stress signalling pathway (Bursac et al., 2012). In addition to ribosomal 
proteins, other nucleolar proteins are known to translocate and activate p53 (Daniely et al., 
2002; Yang et al., 2016). 
One of the nucleolar proteins is a tumor-suppressive protein alternative reading frame (Arf), 
a protein normally sequestrated in the nucleolus via its interaction with another nucleolar 
protein nucleophosmin (Bertwistle et al., 2004). Arf transcription increases in response to 
oncogenes and release to the nucleoplasm and interact with MDM2, thereby stabilizing p53 
(Palmero et al., 1998; Weber et al., 1999).  Another nucleolar protein known to act as a 
mediator of nucleolar stress is nucleophosmin (Avitabile et al., 2011). Nucleophosmin is a 
multifunctional protein that involves in the various steps of ribosome biogenesis (Lindstrom, 
2011).  The protein directly interacts with p53 resulting in its stabilization and enhancing its 
transcriptional activity (Colombo et al., 2002). Besides to its direct action on p53, 
nucleophosmin interacts with MDM2 and counteracts its inhibitory action on p53 (Kurki et al., 
2004). Similarly, nucleolin and nucleostemin, nucleolar proteins involved in the process of 
ribosome biogenesis (Romanova et al., 2009; Tajrishi et al., 2011), interact with MDM2/HDM2 
and activate p53 (Dai et al., 2008; Saxena et al., 2006). In addition to MDM2 mediated 
activation of p53, ribosomal protein, such as RPL26, enhances the activity of p53 through a 
selective translation of p53 mRNA vial binding to its 5’-terminal oligopyrimidine tracts mRNA 
(Takagi et al., 2005). Another mechanism that influences p53 activity involves posttranslational 
modifications (Liu et al., 2019). 
During stress, p53 undergoes posttranslational modification, including phosphorylation, 
acetylation, ubiquitination, SUMOylation, and NEDDylation (Kruse and Gu, 2008; Liu et al., 
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2019; Meek and Anderson, 2009). Ubiquitination has an inhibitory role in p53 activity where 
mono and polyubiquitination involve in nuclear export and degradation of p53, respectively (Li 
et al., 2003). In response to genotoxic damage by radiation, p53 undergoes phosphorylation at 
multiple sites in particular in its N terminus region reviewed in (Moll and Petrenko, 2003). 
Such phosphorylation was shown to stabilize and enhance p53 transcriptional activity via 
weakening its interaction with MDM2 (Moll and Petrenko, 2003). Another posttranslational 
modification that enhances p53 activity is acetylation (Reed and Quelle, 2014). Acetylation via 
competitive occupation of the ubiquitination site as well as through interfering p53 association 
with MDM2 prevents p53 degradation (Li et al., 2002). In addition, acetylation also increases 
p53 activity by facilitating its transcription (Barlev et al., 2001). On the other hand, the effect of 
methylation on p53 activity is determined by the site of modification (Chuikov et al., 2004). 
Two ubiquitination-like modifications, SUMOylation and NEEDylation, reported modifying 
p53 activity (Kruse and Gu, 2008). Though NEDDylation shown to positively regulate p53, the 
effect of SUMOylation on p53 activity is not conclusively established (Abida et al., 2007). 
 
1.4.2.2 Nucleolar stress-mediated independent of p53 
Although most of the outcomes of nucleolar stress are mediated mainly involving p53, there 
are reports where nucleolar stress outcomes managed independently of p53 (James et al., 2014). 
It has been shown that in p53 silenced cells, interference with pol I transcription machinery end 
up in cell cycle arrest, mediated by phosphorylation of pRB and down-regulation of genes 
activated by E2F transcription factor 1 (E2f1) (Donati et al., 2011). In cells treated with 5-
fluorouracil, extracellular signal-regulated kinases (ERK)-mediated phosphorylation of RPL3 
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and specificity protein 1 (SP1) enhance their binding to p21 promoter activating expression of 
p21, leading to cell cycle arrest and apoptosis without involving p53 (Pagliara et al., 2016). 
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2.0 Hypothesis and objectives 
 
2.1 The rationale of the hypothesis  
Bovine adenovirus-3 (BAdV-3) is one of the potential viral vectors for use in human as 
well as veterinary vaccination. The development of an efficient BAdV-3 viral vector needs 
detailed knowledge about the biology of BAdV-3. For better understanding of the basic biology 
of BAdV-3, we and others have begun to determine the protein-protein interaction involving 
both BAdV-3 non-structural and structural proteins, and its biological significance in BAdV-3 
life cycle (Ayalew et al., 2016; Gaba et al., 2018; Kulshreshtha et al., 2004; Kulshreshtha and 
Tikoo, 2008; Makadiya, 2013; Makadiya et al., 2015; Paterson, 2010; Paterson et al., 2012; 
Said et al., 2018a; Zhao, 2016). Despite having a similar genomic organization, BAdV-3 
exhibits distinct features compared to human adenoviruses (Reddy et al., 1998; Li et al., 2009). 
The present study focuses on BAdV-3 IVa2 that would potentially contribute to the better 
understating of the viral biology and hence to the design of better viral vector. 
 
2.2. Hypothesis 
Given the conserved nature IVa2 in the family of Adenoviridae and its multifunctional 
role in human adenoviruses, we hypothesize that IVa2 of BAdV-3 is indispensable for the 
BAdV-3 life cycle and involves protein-protein interaction to accomplish its role. 
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2.3 Objectives  
The objectives of this study are: 
1. To characterize of IVa2 of BAdV-3 
2. To identify other BAdV-3 proteins that interact with IVa2 
3. To determine significance of IVa2 in the BAdV-3 lifecycle. 
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3.0 NUCLEAR AND NUCLEOLAR LOCALIZATION OF BOVINE ADENOVIRUS-3 
IVA2 
 
3.1 Introduction 
Bovine adenovirus-3 (BAdV-3), a non-enveloped icosahedral virus, contains a double-
stranded DNA genome of 34446 bp (Reddy et al., 1998). Despite having similar genomic 
organization into early, intermediate and late regions, the BAdV-3 late transcriptional unit 
organized into seven (L1-L7) regions (Reddy et al., 1998) instead of five (L1-L5) regions 
reported in human adenovirus (HAdV)-5, In addition, several unique features reported for other 
regions of BAdV-3 including E3 region, E4 region, location of cis-acting packaging signals and 
E1A promoter (Bangari and Mittal, 2006; Idamakanti et al., 1999; Reddy et al., 1998; Xing and 
Tikoo, 2006, 2007; Xing et al., 2003). 
Since assembly of progeny adenovirus occurs in the nucleus of cell and involves 
encapsidation of viral genome into capsids (Cassany et al., 2015; Condezo and San Martin, 
2017), the formation of viral capsids in the nucleus require transport of newly synthesized 
adenovirus proteins from cytoplasm to the nucleus of infected cells (Ding et al., 2010; Tessier 
et al., 2019). Transport of macromolecules including viral proteins between cytoplasm and 
nucleus requires viral proteins to pass through nuclear pore complex (NPC), which acts as a 
gatekeeper for import or export of macromolecules including proteins from the nucleus (Lin 
and Hoelz, 2019). Transport of proteins to the nucleus can occur passively or actively 
depending upon the size of the protein and presence\absence of NLS (Lin and Hoelz, 2019). 
Although surface characteristics of protein including introduction of hydrophobic residues can 
help larger proteins (70 kDa-110 kDa) devoid of nuclear localization signal (NLS) to cross 
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NPC passively (Frey et al., 2018; Naim et al., 2009), usually proteins larger than 40 kDa and 
devoid of NLS cannot passively diffuse in the nucleus (Samudram et al., 2016). 
While active nuclear localization of viral proteins require interaction of nuclear localization 
signals (NLSs) of transported protein with importins and transportin 3 receptors in the cell, the 
translocation of viral proteins to nucleolus require the interaction of nucleolar localization 
signals (NoLSs) of a protein with bonafide nucleolar protein(s) or rRNA so that viral protein 
retained in the nucleolus of the cell (Reed et al., 2006). 
The intermediate region of HAdV-5 encodes structural proteins pIX and IVa2 (Parks, 2005). 
Protein IVa2 presented as few copies per virion (Russell, 2009) and expressed as 50 kDa and 
40 kDa protein in virus-infected cells (Pardo-Mateos and Young, 2004), and contains Walker A 
and B motifs required for binding ATP (Ostapchuk and Hearing, 2008). Although the role of 
HAdV-5 IVa2 in adenovirus DNA packaging is not clear, it may act as adenovirus packaging 
ATPase (Ostapchuk et al., 2011). In addition, IVa2 appears to act as a transcriptional activator 
of the HAdV-5 major late promoter (Lutz and Kedinger, 1996). Although viral protein 
homologs are present in all members of Mastadenovirus genomes, they appear be less 
conserved in protein function, use of protein domains\]motifs for subcellular localization and 
interaction with other viral\cellular proteins (Blanchette et al., 2013; Cheng et al., 2013; 
Stracker et al., 2005). Since BAdV-3 IVa2 shows 29 to 69% homology with IVa2 encoded by 
other members of Mastadenovirus (Reddy et al., 1998), we sought to characterize BAdV-3 
IVa2, a protein of 448 amino acids. Here, we report the identification of BAdV-3 IVa2 
domain(s) involved in nuclear \ nucleolar localization. 
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3.2 Materials and Methods 
3.2.1 Cell lines and Viruses 
Madin-Darby bovine kidney (MDBK) (ATCC CCL22), cotton rat lung (CRL), (Papp et al., 
1997) and VIDO DT1 (CRL cells expressing endonuclease I-SceI) cells were propagated at 
37°C in minimal essential medium (MEM; Sigma) with 5% CO2. The HEK 293T (ATCC CRL-
11268) and African green monkey kidney (Vero) (ATCC CCL-81) cells cultured using 
Dulbecco's modified minimal essential medium (DMEM; Sigma). All the cell lines 
supplemented with heat-inactivated 10% fetal bovine serum (FBS; SAFC industries, Sigma), 
0.1mM nonessential amino acids (NEAA; Gibco), and 10mM HEPES (Gibco) and 50ug/ml 
gentamicin (Bio Basics). Wild type and recombinant BAdV-3 viruses propagated as described 
previously (Reddy et al., 1998).  
 
3.2.2 Antibodies 
Anti-replication protein A (RPA) MAb (sc-48425) purchased from Santa Cruz. Anti-HA 
antibody (A1978) and anti-actin β antibody (H9658) obtained from Sigma. Alexa 488 goat 
anti-mouse antibody (catalog #	  115-545-003) and Cy3 conjugated goat-anti mouse antibody (# 
115-165-146) and alkaline phosphatase-conjugated goat anti-rabbit (111-055-003) antibody 
bought from Jackson Immune Research. Rabbit anti-GST antibody (ab19256) and Alexa Fluor 
647-conjugated goat anti-rabbit IgG were also obtained from Abcam and Invitrogen, 
respectively.  
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3.2.3. Sequence analysis of BAdV-3 IVa2  
Initially, to assess the extent of sequence similarity between BAdV-3 IVa2 protein and IVa2 
protein of adenoviruses isolated from different domestic animals and humans, multiple 
sequence alignment were carried out using Clone manager version 9.3 (BLOSUM 62). Besides, 
the presence of potential nuclear localization signal/s of IVa2 was assessed using cNLS mapper 
(Kosugi et al., 2009a). 
 
3.2.4 Production of BAdV-3 IVa2 serum 
The GST.IVa2 fusion produced and characterized as described earlier (Kulshreshtha and 
Tikoo, 2008; Said et al., 2018b). Briefly, a 1363 bp DNA fragment containing BAdV-3 IVa2 
coding sequence amplified by PCR (using forward EcoRI FP and XhoI RP primers and plasmid 
pC.Va2 DNA as a template, appendix 1). The PCR product digested with EcoRI - XhoI and 
ligated to EcoRI - XhoI digested plasmid pGEX-5x-1 (GE Healthcare) DNA creating plasmid 
pGEX-IVa2. The junction of IVa2 and Glutathione-S-transferase (GST) fusion protein 
confirmed by DNA sequencing. For the production of GST IVa2 fusion production, E. coli 
(BL-21) transformed with pGEX-IVa2 DNA and plated out in Luria-Bertani (LB) plate 
containing 100ug/µl of ampicillin (Sigma). A single colony of BL21 cell transformed with 
pGEX-IVa2 inoculated in 14 mL culture tube containing 3mL of LB broth added with 50µg/µl 
kanamycin and 100ug/µl of ampicillin (Sigma). After overnight incubation, the 3 mL culture 
used to inoculate 500mL LB broth in the presence of the kanamycin and ampicillin as 
described. The culture allowed to grow at 37°C on a rotary shaker until the OD600 value 
reaches 0.6. Then, Fusion protein expression induced with the addition of 0.5mM isopropyl-β-
D-thiogalactopyranoside (IPTG; Sigma). After 2hr incubation, cells were pelleted by 
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centrifugation at 6,000 RPM for 15 min. The cell pellet was then resuspended in 30mL of 
Glutathione S-transferase (GST) binding buffer in the presence of protease inhibitor cocktail 
(Roche) transferred into a 50mL disposable tubes and sonicated three times for 30 seconds 
under cold condition. The Sonicated sample was transferred into 50mL Nalgene polycarbonate 
tube and centrifuged at 12,000 RPM for 15 min at 40C. The supernatant was further centrifuged 
under the same condition after being transferred into similar tubes. Finally, 200ul of prewashed 
GST beads (GE health care) added to the supernatant, and the mixture was incubated overnight 
on a nutator at 40C. After overnight incubation, beads were washed 4X (10 min each) using 
GST binding buffer and pelleted at 1000 RPM for 2 min. After the final wash, beads were 
transferred into 1.5 mL Eppendorf tube, and protein was eluted by incubating beads for 20min 
with the addition of 200ul of elution buffer. Elution was repeated using a similar volume of 
buffer. In the end, the protein concentration of eluted protein measured by Bradford assay (Bio-
Rad) and Libra S22UV/Vis Spectrophotometer (Biochrom). Expression of GST IVa2 fusion 
protein was confirmed via coomassie brilliant blue G250 (Bio-Rad) staining and through 
western blotting using Rabbit anti-GST antibody. 
Rabbit immunized intradermally with 500ug of purified GST.IVa2 fusion protein 
emulsified with Freund's complete adjuvant (Sigma). The immunized rabbits boosted twice 
with 300ug GST.IVa2 fusion protein emulsified in Freund's incomplete adjuvant (Sigma) 
subcutaneously at 21 and 35 days post-primary immunization. Two weeks after the last 
immunization, serum was collected, aliquoted, and stored at -800C. 
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3.2.5 Plasmid construction 
Plasmids used to study a) the subcellular localization of IVa2 and map regions of IVa2 
involved in the nuclear and nucleolar localization of IVa2, b) the effect of amino acid 
substitution on the localization of IVa2 and c) the nuclear import pathway of IVa2 were 
constructed using standard molecular techniques as described earlier (Sambrook and. Russell, 
2000)  and are described in Appendix 1. 
 
Construction of plasmids containing full length BAdV-3 genomic DNA. The primers 
sequences used to construct plasmids are described in Table 1, Appendix 1.  
pMCS.3821. Initially, a 7162 bp AarI DNA fragment containing the IVa2 coding sequence 
was isolated by the digestion of plasmid pUC304a+ DNA with AarI.  Finally, a 3821 bp SphI-
SacII DNA fragment (containing IVa2 coding sequence flanked by 1463 bps and 1022 bp) of 
7162 bp DNA fragment was isolated and ligated to SphI - SacII digested plasmid pMCS 
(Thanbichler et al., 2007) DNA creating a plasmid pMCS.3821. 
pUC304a.dIVA2SbfI. Using SphI FP and IRPΔIVa2 primers (Table 1), and plasmid 
pMCS.3821 DNA, as a template, a 1501 bp DNA fragment (P1), was amplified by PCR. 
Similarly, using primers IFPΔIVa2 and SacII RP (Table 1), and plasmid pMCS.3821 DNA as a 
template, a 1286 bp DNA fragment (P2) was amplified by PCR. The P1 and P2 DNA 
fragments were annealed, and a, 2635 bp DNA fragment was amplified by PCR using SphI FP 
and SacII RP as primers (Table 1). The 2635 bp DNA fragment was digested with SphI -SacII 
and ligated to SphI-SacII digested plasmid pMCS DNA, creating plasmid 
pMCS.3821.dIVA2SbfI (SbfI restriction site introduced). A 1240 bp SbfI DNA fragment of 
plasmid pUKC4K (Taylor and Rose, 1988) containing Kanamycin resistant gene was isolated 
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and ligated to SbfI linearized plasmid pMCS.3821dIVA2SbfI DNA creating plasmid 
pMCS.3821.dIVA2Kan.  
Homologous recombination in Escherichia coli BJ5183 (Chartier et al., 1996) between 3860 
bp SphI - SacII DNA fragment of plasmid pMCS.3821dIVA2Kan and pUC304a+ (Du and 
Tikoo, 2010) DNA resulted in creating plasmid pUC304a.dIVA2Kan which could grow in LB 
plates containing ampicillin and kanamycin.  The plasmid pUC304a.dIVA2Kan was digested 
with SbfI, and the large fragment was religated, resulting in creating plasmid 
pUC304a.dIVA2SbfI (plasmid pUC304a+ containing unique SbfI site in IVa2). 
pUC304aM1. Using primers SphI FP and IRP6M (Table 1), and plasmid pMCS.3821 DNA 
as a template, a 2814 bp DNA fragment (P1) was amplified by PCR. Similarly, using primers 
IFP 6M and SacII RP, and plasmid pMCS.3821 DNA as a template, a1064 bp DNA fragment 
(P2) was amplified by PCR. The P1 and P2 DNA fragments were annealed, and a 3836 bp 
DNA fragment was amplified by PCR using primers SphI FP and SacII RP (Table 1). The 3836 
bp DNA fragment was digested with SphI-SacII and ligated to SphI-SacII digested plasmid 
pMCS DNA creating plasmid pMCS.3821.RM (containing a substitution of 6th amino acid of 
IVa2 from R to G). 
Escherichia coli BJ5183 based homologous recombination between 3821 bp SphI-SacII 
DNA fragment of plasmid pMCS.3821.RM and SbfI digested plasmid pUC304a.dIVA2.SbfI  
(described above) resulted in the isolation of plasmid pUC304aM1 (pUC304a+ containing a 
substitution of 6th amino acid of IVa2 from R.to G). 
pUC304aM2. Using primers SphI FP and IRP7M (Table 1), and plasmid pMCS.3821 DNA 
as a template, a 2831 bp DNA fragment (P1), was amplified by PCR. Similarly, using primers 
IFP7M and SacII RP (Table 1), and plasmid pMCS.3821 DNA as a template, a 1052 bp DNA 
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fragment (P2), was amplified by PCR.   The P1 and P2 DNA fragments were annealed and a 
3836 bp DNA fragment was amplified by PCR using primers SphI FP and SacII RP (Table 1). 
The 3836 bp DNA fragment was digested with SphI-SacII and ligated to SphI-SacII digested 
plasmid pMCS DNA creating plasmid pMCS.3821.R2M (containing a substitution of 7th amino 
acid of IVa2 from R to G). 
Escherichia coli BJ5183 based homologous recombination between 3821 bp SphI-SacII 
DNA fragment of plasmid pMCS.3821.R2M and SbfI linearized plasmid pUC304a.dIVA2.SbfI 
(described above) DNA resulted in the isolation of plasmid pUC304aM2 (pUC304a+ 
containing a substitution of 7th amino acid of IVa2 from R to G). 
pUC304aM3. Using primers SphI FP and IRP8M (Table 1), plasmid pMCS.3821 DNA as a 
template, a 2831 bp DNA fragment (P1), was amplified by PCR. Similarly, using primers 
IFP8M and SacII RP (Table 1), and plasmid pMCS.3821 DNA as a template, a 1052 bp DNA 
fragment  (P2), was amplified by PCR. The P1 and P2 DNA fragments were annealed, and a 
3836 bp DNA fragment was amplified by PCR using primers SphI FP and SacII RP (Table 1). 
The 3836 bp DNA fragment was digested with and ligated to SphI-SacII digested plasmid 
pMCS DNA, creating a plasmid pMCS.3821.KM (containing a substitution of 8th amino acid 
of IVa2 from K to G).  
Escherichia coli BJ5183 based homologous recombination between 3821 bp SphI-SacII 
DNA fragment of plasmid pMCS.3821.KM and SbfI linearized plasmid pUC304a.dIVA2SbfI 
(described above) DNA resulted in isolating plasmid pUC304aM3 (pUC304a+ containing 
substitution of 8th amino acid of IVa2 from K to G) 
pUC304aM4. Using primers SphI FP and IRP6-8M (Table 1), and plasmid pMCS.3821 
DNA as a template, a 2831 bp DNA fragment (P1), was amplified by PCR. Similarly, using 
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IFP6-8M and SacII RP (Table 1), and plasmid pMCS.3821 DNA as a template, a 1052 bp DNA 
fragment (P2) was amplified by PCR. Using primers SphI FP and SacII RP, and The P1 and P2 
DNA fragments were annealed, and a 3836 bp DNA fragment was amplified using primers 
SphI FP and SacII RP (Table 1). The 3836 bp DNA fragment was digested with SphI-SacII and 
ligated to SphI-SacII digested plasmid pMCS DNA creating plasmids pMCS.3821.RRK 
(containing a substitution of 6th, 7th & 8th amino acid of IVa2 from RRK to GGG). 
Escherichia coli BJ5183 based homologous recombination between 3821 bp SphI-SacII 
DNA fragment of plasmid pMCS.3821.RRK and SbfI linearized pUC304a.dIVA2SbfI 
(described above) DNA resulted in the isolation of plasmid pUC304aM4 (pUC304a+ 
containing a substitution of 6th, 7th & 8th amino acid of IVa2 from RRK to GGG). 
pMCS.loxpIVa2 448. Using primers SphI FP and IRP loxp448, and template DNA pMCS-
3821 1508 bp PCR product  (P1) amplified. Similarly, using primers IFPloxp448 and SacII RP, 
and template DNA pMCS.3821 2134 bp PCR product  (P2) generated. Using primers SphI FP 
and SacII RP, and P1 and P2 DNA mix as a template 3606 bp PCR product (P3) generated. 
SphI-SacII digested P3 ligated into SphI-SacII digested pMCS, creating a plasmid 
pMCS.loxpIVa2448 (loxp sequence introduced at the end of IVa2). 
pUC304A.loxpIVa2C.75. Using primers SphI FP and IRP loxp373, and plasmid pMCS-
loxpIVa2448 DNA as a template, a 1777 bp DNA fragment (P1) was amplified by PCR. 
Similarly, using primers IFP loxp373 and SacII RP, and plasmid pMCS.loxpIVa2 448 DNA as 
a template, a 2171 bp DNA fragment (P2) was amplified by PCR. The P1 and P2 DNA 
fragments were annealed and a 3912 bp DNA fragment was amplified by PCR using primers 
SphI FP and SacII RP (Table 1). The 3912 bp DNA fragment was digested with SphI-SacII and 
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ligated to SphI-SacII digested plasmid pMCS, creating a plasmid pMCS.3821loxp.IVa2C.75 
(loxP flanked IVa2 nucleolar localization signal).   
Escherichia coli BJ5183 based homologous recombination between 3896 bp SphI-SacII 
fragment of plasmid pMCS.loxpIVa2C.75 and SbfI linearized plasmid pUC304a.dIVA2SbfI 
DNA resulted in isolation of plasmid pUC304a.loxpIVa2C.75 (pUC304a+ containing loxP 
flanked IVa2 nucleolar localization signal). 
 
3.2.6 Transfection 
For transfection of cells plasmid DNA of interest or full-length genomic clones, an 
appropriate amount of DNA diluted with the corresponding amount of optimum in one tube.  
Similarly, the recommended volume of lipofectamine 2000 diluted with the corresponding 
amount of optimum in another tube.  Diluted DNA sample mixed with lipofectamine solution 
and incubated for five to ten minutes. After incubation, the DNA lipofectamine mixture added 
into a culture dish or slides in a dropwise manner. Based on the sensitivity of cells for 
lipofectamine, the transfection medium replaced with culture medium after 4 to 8 hrs.  
 
3.2.7 Isolation of recombinant BAdV-3 viruses 
Isolation of recombinant BAdV-3 carried out in VIDODT1 cells (Du and Tikoo, 2010) or 
CRL cells as described earlier in (Zhao and Tikoo, 2016).  VIDODT1 cells grown in 6 well 
tissue culture dish transfected with 5ug of indicated plasmid DNA using lipofectamine 2000.  
Alternatively, CRL cells grown in 6 well culture dishes transfected with PacI digested 
indicated plasmid DNA using lipofectamine 2000.  After 4 hrs of transfection, the transfection 
medium was replaced with MEM containing 5% fetal bovine serum and the cells were 
	   60	  
incubated at 370C in the presence of 5% CO2. The medium was replaced with MEM containing 
2% fetal bovine serum) every 48 hrs and the cells were observed for the appearance of 
cytopathic effect. 
 
3.2.8. Western blotting  
Western blotting was carried out as described in (Kulshreshtha et al., 2004) with slight 
modification. At indicated times post infection or transfection, the cells were rinsed with ice-
cold PBS, collected and lysed after the addition of the appropriate amount of 
radioimmunoprecipitation assay (RIPA) buffer in the presence of protease inhibitor cocktail 
(Roche) for 30 min at 40C. The cell lysate was then separated by centrifugation at 12000 
revolutions per minute  (RPM) for 15 minutes. The supernatant was collected, mixed with 
sodium dodecyl sulfate (SDS) loading buffer containing 10 % β-mercaptoethanol and boiled 
for 5 minutes. The proteins in the mixture were resolved using 12% sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes 
(Bio-Rad). The membrane was blocked with 5% skim milk in 1x tris buffered saline containing 
1% tween 20  (TBST) for 1hr.  Following blocking, the membranes were rinsed with 1x TBST 
and incubated with anti primary antibody of interest for 2hrs on a shaker at room temperature 
or overnight at 4 0C. Following a repeated wash with 1x TBST, the membranes further 
incubated with appropriate secondary antibody conjugated alkaline phosphatase for 1.5 hrs 
After washing, the membranes were developed using BCIP/NBT solution (Sigma) to visualize 
protein bands.  
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3.2.9. Immunofluorescence assay 
Direct immunofluorescence. About 1X105cells transfected grown in 4-well chamber slides, 
Thermo Scientific (Cat #, 1256517) transfected with individual plasmid DNA using 
LipofectamineTM 2000 [Invitrogen]) as per manufacturer's instructions. After 36 hrs post-
transfection, the cells fixed with a 3.7% formaldehyde solution in 0.1M PBS and mounted 
using mounting media (Vectashield) containing 4', 6-diamidino-2-phenylindole (DAPI) and 
examined using Zeiss LSM 5 Laser scanning confocal microscope. 
Indirect immunofluorescence assay.  The protocol in virus-infected or plasmid transfected 
cells described earlier (Ayalew et al., 2014). Briefly, MDBK cells infected with BAdV-3 (MOI 
of 2) or Vero cells transfected with individual plasmid DNA using LipofectamineTM 2000 
[Invitrogen]) as per manufacturer's instructions and incubated for 36 hrs.  Thirty-six hrs post-
infection or transfection, growth medium removed, cells rinsed with PBS and fixed with 3.7% 
paraformaldehyde for 15 minutes. After fixation, cells rinsed with PBS and permeablized with 
0.25% Triton X-100 for 10 minutes at room temperature. After permeabilization, cells rinsed 
with PBS and incubated with 5% goat serum for an hour to block non-specific binding of 
antibodies. Following blocking, cells incubated with a primary antibody of interest for two 
hours. After 3x wash (10 minutes each) with PBS, cells further incubated with corresponding 
secondary antibody for 1.5 hrs At last, after repeated wash with PBS, slides allotted to dry, and 
coverslips then mounted on glass slides with VectaShield mounting medium containing 4', 6-
diamidino-2-phenylindole (DAPI) as a nuclear counterstaining. Finally, images visualized 
using a Leica confocal microscope. 
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3.2.10. In-vitro nuclear import assay 
 In vitro nuclear import assay was carried out as described earlier (Wu and Tikoo, 2004).  
Briefly, Vero cells in two well chamber slides were transfected with the control plasmid 
(pCMVGFP/βgal) DNA, plasmid pGFP/bgal1.NLS (GFP/Bgal fused with N-terminus 1-25 
amino acids of IVa2) DNA or plasmid pGFP/bgal1.NLS1 (GFP/Bgal fused with N-terminus 4-
18 amino acids of IVa2) DNA (Appendix1). Twenty-four hrs post-transfection, the slides were 
processed for direct confocal microscopic observation. 
 
3.2.11 GST pull-down assay 
The GST pull-down assay performed as described previously  (Paterson et al., 2012; Said et 
al., 2018a; Zhou and Tikoo, 2001) to assess the interaction of BAdV-3 IVa2 with nuclear 
transport proteins. GST fusions of importin α1, α3, α5, α7 and importin β were obtained from 
Dr. M. Köhler and described in (Depping et al., 2008). GST-transportin phusion plasmid also a 
gift from Dr. Woan-Yuh Tarn  and described in (Lai et al., 2001). The production of GST or 
GST fusion protein carried out as described elsewhere (Said et al., 2018a).  Invitro transcribed, 
translated and radiolabeled full–length IVa2, IVa2 with N-terminus 25 amino acid, GFP/Bgal 
containing inframe fusion of N-terminus 25 or N terminus 4-18 amino acid of IVa2 or protein 
produced by in-vitro transcription and translation of plasmid pC.IVa2 DNA using TNT T7 
Coupled Reticulocyte Lysate System (Promega) in the presence of [35S]-methionine (Perkin 
Elmer). Fifteen µgs of purified GST or GST fusions (GST fused to importin- α-1, α-3, α-5, α-7, 
β1 or transportin-3) were incubated individually with 20µl of prewashed glutathione sepharose 
beads plus 10µl of in-vitro synthesized IVa2. The mixture was incubated overnight at + 40C on 
a nutator. The beads were washed three times (10 min each) with GST binding buffer, boiled 
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for 5 min in the presence of boiled in 2x SDS loading buffer containing 5% β-mercaptoethanol 
and the radiolabeled proteins resolved using 12% SDS-PAGE. Subsequently, the gel was fixed 
in fixative solution (methanol, acetic acid, and water mixed in 50:10:40 ratio respectively) for 
30min, dried onto filter paper at 800C for 2hrs and visualized using F-X Molecular Imager 
(Bio-Rad).  
 
3.2.1.2 Virus purification 
The recombinant BAdV-3s were purified by CsCl gradient centrifugation as described 
earlier (Gaba et al., 2018). Briefly, freshly confluent monolayers of MDBK cells in multiple T-
150 flasks were infected individually with BAV304a or  mutant virus at MOI of 5. After 48 hrs 
of infection, the cells were collected and resuspended in 10 ml of culture medium. After 
repeated (4X) freeze thawing, the supernatant was collected, loaded on top of pollyallomer tube 
containing CsCl density gradient and subjected to ultracentrifugation at 35 000 rpm for 1 hr at 40C. 
The bands containing viruses were collected, and subjected to a second round of CsCl density 
gradient centrifugation at 35 000 rpm for 16 hrs at 40C.  Finally, the virus band was collected, 
dialyzed and stored in small aliquots at -80°C. 
 
3.2.13 Virus growth kinetic determination 
Gowth kinetics of recombinant BAdV-3 was determined as described earlier (Kulshreshtha 
et al., 2004, Gaba et al., 2017). Briefly, MDBK cells were infected with individual virus at 2 
MOI. At different times (0, 6, 12, 24, 36 and 48) post infection, the infected cell lysates were 
collected, freeze thawed and virus was titrated on MDBK cells in 96 well culture plates. After 
5-7 days post infection, the cells were observed for the appearance of fluorescent foci. The data 
obtained was used to determine the viral titer using TCID50  (Reed and Muench, 1938). 
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3.3 Results 
 
3.3.1 Sequence analysis of IVa2 
Multiple sequence alignment of BAdV-3 IVa2 protein sequence with its homologs encoded 
by different adenoviruses carried out as indicated in Fig. 3.1a.  Except the highly conserved 
middle portion of IVa2, which corresponds to the different ATPase motifs (Ostapchuk and 
Hearing, 2008), N- and C- terminus of IVa2 shows a lower degree of similarity with the IVa2 
encoded by members of Mastadenovirus genus. Secondly, analysis of BAdV-3 IVa2 protein 
sequence by cNLS mapper program predicted the presence of potential nuclear localization 
signals (NLSs) located at amino acid 6-35 and amino acids 64-73 Fig. 3.1b).  
 
3.3.2 Expression of BAdV-3 IVa2 
To characterize BAdV-3 pC.IVa2 protein, affinity-purified GST-IVa2 fusion protein (Fig. 
3.2, panel a, b) expressing 448 amino acids of IVa2 used to produce anti-IVa2 serum in rabbits. 
The specificity of the sera (designated as IVa2gst sera) collected and analyzed after the last 
boost. Infected MDBK cells (MOI 2) also analyzed by Western blot using IVa2gst sera. As 
seen in Fig. 3.2 (panel c), IVa2gst serum detected a protein of 50 kDa in BAdV-3 infected 
cells. No such protein could be detected in mock-infected cells. Moreover, the expression of 
IVa2 could be detected at 24-48 hrs post-infection but not at 18 hrs post-infection (Fig.3.2, 
panel d).  
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Fig. 3.1 Analysis of BAdV-3 IVa2 amino acid sequence (a) Amino acid sequence homology of 
BAdV-3 IVa2. Alignment of amino acid sequences of BAdV-3 IVa2 (GenBank Accession # 
(AP_000025.1) with homologs encoded by ovine adenovirus (OAV)-A (AP_000005.1), porcine 
adenovirus (PAdV)-3 (YP_009200.1), canine adenovirus (CAdV)-2 IVa2 (AP_000612.1), human 
adenovirus (HAdV)-2 IVa2 (AP_000165.1) and HAdV-55 IVa2 (AP_000201.1). The identical 
amino acids are marked yellow. 
 
 
 
 
a)#
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Fig. 3.1 Analysis of BAdV-3 IVa2 amino acid sequence (b) Identification of potential BAdV-3 
IVa2 nuclear localization signal (NLS). Potential NLS is shown in bold and underlined.  
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3.3.3 Sub cellular localization of IVa2 
To assess the subcellular localization of IVa2, mock-infected, or BAdV-3 infected cells were 
analyzed at 36 hrs post-infection by indirect immunofluorescence using IVa2gst serum. As 
seen in Fig. 3.2e, BAdV-3 IVa2 localized in the nucleus of the infected cells (panels a1-a3). No 
such fluorescence could be detected in mock-infected cells (panels, b1-b3). To determine if 
IVa2 localized in the nucleolus of infected cells, MDBK cells were infected with BAdV-3 and 
analyzed by dual-label immunofluorescence using IVa2gst serum and anti- replication protein 
A (RPA) serum. As seen in Fig. 3.2e, IVa2 co-localized with nucleolar protein RPA in the  
nucleolus of BAdV-3 infected cells (panels c1-c4). No IVa2 protein could be detected in mock-
infected cells (panels, d1-d4). 
To exclude the possibility of involvement of other BAdV-3 proteins in the sub cellular 
localization of IVa2, Vero cells transfected with plasmid pDR.IVa2 (IVa2 coding sequence 
fused in frame with DsRed) and analyzed by direct immunofluorescence. As seen in Fig. 3.3, 
IVa2 localized to the nucleus\nucleolus of plasmid pDR.IVa2 DNA transfected cells   (panels, 
a1-a3). In contrast, DsRed protein localized to both cytoplasm and nucleus of plasmid pDR 
DNA transfected cells (panel c1-c3). No such protein could be localized in pcDNA3-
transfected cells (panels, b1-b3). Similarly, dual-label immunofluorescence using IVa2gst 
serum and anti- replication protein A (RPA) serum detected IVa2 co-localized with nucleolar 
RPA protein in the nucleolus of plasmid pDR.IVa2 transfected cells (Fig. 3.3, panels, d1-d4). 
No IVa2 protein could be detected in pCDNA3 transfected cells (Fig. 3.3, panels, e1-e4).  
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Fig. 3.2. Expression of IVa2 in BAdV-3 infected cells. (a,b,c,d) Western Blot. Purified GST.IVa2 
fusion proteins were separated by 12% and (a) stained with 0.25% Coomassie blue stain SDS-
PAGE or (b) transferred to nitrocellulose and analysed in Western blot using Anti-GST serum. 
Proteins from the lysates of BAdV-3 infected MDBK cells harvested (c) at 36 hrs post infection or 
(d) at various times post infection were separated by 12% SDS-PAGE transferred to nitrocellulose 
and probed in Western blot using IVa2gst serum. The single arrow shows IVa2 protein (panels, c 
and d). The double arrow shows GST.IVa2 protein (panel, b), 
.  
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Fig. 3.2. Expression of IVa2 in BAdV-3 infected cells e) Nuclear\nucleolar localization. MDBK 
cells were infected with BAdV-3 (panels a1-a3; c1-c4) or mock infected (panels b1-b3; d1-d4) and 
fixed at 36hrs post infection. The subcellular localization of IVa2 was visualized by indirect 
immunofluorescence using IVa2gst serum. The nuclei were stained with DAPI (panels a2, b2, 
c3,d3) and nucleoli were visualized by staining with anti-RPA antibody and Cy-3 conjugated goat 
anti-mouse antibody (panels,c2,d2). A merge of the images is shown in panels a3, b3, c4, d4. 
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Fig. 3.3 Expression of BAdV-3 IVa2 in transfected cells. Sub-cellular localization of IVa2. 
Vero cells were transfected with plasmid pDR. IVa2 DNA (panels a1-a3; d1-d4), plasmid 
pcDNA3 DNA (panels b1-b3;e1-e4) or plasmid pDR DNA (panel c1-c3) and sub cellular 
localization was visualized after 36 hrs post transfection by direct fluorescence using confocal 
microscope. The nuclei were stained with DAPI (panels a2, b2, c2, d3,e3) and nucleoli were 
visualized by staining with anti-RPA antibody and Alexa 488 conjugated goat anti-mouse 
antibody (panels d2,e2). A merge of the images is shown in panels a3, b3, c3, d4 and e4.  
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3.3.4 Mapping IVa2 nuclear localization signal  
To map nuclear localization signal (NLS) of IVa2, plasmids expressing truncated or deleted 
mutant IVa2 were constructed and individually fused to gene encoding DsRed. Based on the 
analysis of nuclear localization domain(s) of HAdV-5 IVa2 (Lutz and Kedinger, 1996) and 
computer program predicted NLS of BAdV-3, we constructed plasmids  (Fig. 3.4a) containing 
C-terminus truncations (amino acids 424-448 or 398-448) and two N-terminus truncations 
(amino acids 2-25 and 2-75). Vero cells were transfected with individual plasmid DNA and 
examined by direct immunofluorescence. As seen in Fig. 3.4b, wild-type IVa2 expressed in the 
cells transfected with plasmid pDR.IVa2 (panels, a1-a3) localized to the nucleus of the 
transfected cells. Similarly, mutant IVa2 expressed in cells transfected with plasmid 
pDR.IVa2d1 DNA (panels, b1-b3)  as well as pDR.IVa2d2 DNA (panels, c1-c3) localized to 
the nucleus of the transfected cells.  In contrast, mutant IVa2 expressed in the cells transfected 
with either plasmid pDR.IVa2.d3 DNA (panels, d1-d3) or plasmid pDR.IVa2d4 DNA (panels, 
e1-e3) localized to the cytoplasm of the transfected cells.  
To confirm if N-terminus 25 amino acids are sufficient to localize IVa2 to the nucleus, 
plasmid pGFP/βgal.NLS containing N-terminus 25 amino acids of IVa2 fused in frame with a 
heterologous cytoplasmic green fluorescent protein-beta galactosidase (GFP/βGal) fusion 
protein (Fig. 3.4c) constructed. Vero cells transfected with either of pCMVGFP/βgal or 
pGFP/βgal.NLS plasmid DNA and analyzed by direct immunofluorescence. As expected, 
GFP/βGal protein expressed in the cells transfected with plasmid pCMVGFP/βgal DNA 
localized predominantly in the cytoplasm of transfected cells (Fig. 3.4d, panels a1-a3.) 
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Fig. 3.4 Sub-cellular localization of mutant IVa2 in transfected cells. (a) Schematic 
diagram of plasmid DNAs. Amino acid numbers are depicted. The name of the plasmids is 
depicted on the right of the panel. The thick black line represents deleted region (s) of IVa2. 
(b). Direct immunofluorescence. Vero cells were transfected with indicated plasmid DNA. At 
36 hrs post transfection, the cells were fixed and the subcellular localization of IVa2 was 
observed by direct fluorescence using confocal microscope. DF (direct fluorescence). (c). 
Schematic diagram of plasmid DNAs. The name of the plasmid is depicted on the right. Amino 
acid numbers are depicted on top of schematic diagram. NLS (nuclear localization signal) of 
IVa2; GFP (green fluorescent protein). (d). Direct Immunofluorescence. Vero cells were 
transfected with indicated plasmid DNA. At 36 hrs post transfection, the cells were fixed and 
analysed by direct immunofluorescence using confocal microscope. 
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In contrast, fusion protein (containing N-terminus 25 amino acids of IVa2 fused to 
GFP/βGal) expressed in the cells transfected with plasmid pGFP/βgal.NLS DNA and localized 
predominantly to the nucleus of the transfected cells (Fig. 3.4d, panels b1-b3).  
To further narrow down the amino acid sequence involved in the translocation of IVa2 to the 
nucleus, plasmids expressing mutant IVa2 proteins (containing internal deletions within N-
terminus amino acids 1-25 of IVa2) fused in-frame to DsRed were constructed (Fig. 3.5a). 
Vero cells were transfected with individual plasmid DNA and analyzed by direct 
immunofluorescence. The mutant protein expressed in the cells transfected with plasmid 
pDR.IVa2d3.1 DNA (Fig. 3.5b, panels a1-a3) or plasmid pDR.IVa2d3.2 DNA (Fig. 3.5b, 
panels, b1-b3) localized predominantly in the nucleus\nucleolus of the transfected cells. The 
mutant protein expressed in cells transfected with plasmid pDR.IVa2d3.3 DNA localized in 
both nucleus\nucleolus and cytoplasm of the transfected cells (Fig. 3.5b, panels, c1-c3). The 
mutant protein expressed in the cells transfected with plasmid pDR.IVa2d3.4 DNA localized in 
the cytoplasm (predominantly) and in the nucleus\nucleolus of the transfected cells (Fig. 3.5b, 
panels d1-d3). In contrast, a mutant protein expressed in cells transfected with plasmid 
pDR.IVa2d3.5 DNA appears to localize predominantly in the cytoplasm of the transfected cells 
(Fig. 3.5b, panels, e1-e3). 
To determine influence of amino acid substitution with in IVa2 NLS on its localization, 
initially, we constructed plasmids expressing mutant IVa2 containing a substitution of a cluster 
(6RRK8) of basic residues (arginine or lysine) to glycines (Fig. 3.5c). As seen in Fig. 3.5d, 
mutant IVa2 encoded by plasmid pDR.IVa2M1 (panel b1-b3), plasmid pDR.IVa2M2 (panels 
c1-c3), plasmid pDR.IVa2M3 (panels d1 to d3) and plasmid pDR.IVa2.M4 (panels e1-e3) 
localized predominantly in the nucleolus of transfected cells. Since the substitution to glycine 
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residues may influence recognition of protein by transport proteins, sequential substitution of 
IVa2 NLS with poly alanine sequences carried out (Fig 3.5e). Vero cells were transfected with 
individual mutant plasmid DNA and analyzed by direct fluorescence. As seen in Fig. 3.5f, 
mutant IVa2 containing a substitution of amino acid 6-8 (RRK to AAA) encoded by plasmid 
pDR.IVa2d3.1a (Fig. 3.5f, panels b1-b3) or substitution of amino acids 4-8 (RGRRK to 
AAAAA) encoded by plasmid pDR.IVa2d3.2a (Fig. 3.5f, panels c1-c3) localized to the nucleus 
of the transfected cells. Mutant IVa2 protein-containing substitution of amino acids 4-11 
(RGRRKVRH to AAAAAAAA) encoded by plasmid pDR.IVa2d3.3a was localized both in the 
nucleus and cytoplasm of the transfected cells (Fig. 3.5f, panels d1-d3). Mutant IVa2 protein-
containing substitution of amino acid 4-15 (RGRRKVRHQQAQ to AAAAAAAAAAA A) 
encoded by plasmid pDR.IVa2d3.4a localized both in the nucleus (predominantly) and 
cytoplasm of the transfected cells (Fig. 3.5f, panels e1-e3). Mutant IVa2 protein-containing 
substitution of amino acids 4-18 (RGRRKVRHQQAQPEA to AAAAAAA AAAAAAAA) 
encoded by plasmid pDR.IVa2d3.5a 
was localized predominantly in the cytoplasm of the transfected cells (Fig. 3.5f, panels f1-f3).  
To determine if amino acids 4-18 were sufficient for nuclear localization of IVa2, plasmid 
pGFP/βgal.NLS1 containing N-terminus 4-18 amino acids of IVa2 fused in frame with a 
heterologous cytoplasmic green fluorescent protein-beta galactosidase (GFP/βGal) fusion 
protein (Fig. 3.5g). Vero cells transfected with plasmid pGFP/βgal.NLS DNA and analyzed by 
direct immunofluorescence. As expected, GFP/βGal protein expressed in the cells transfected 
with plasmid pCMV.GFP/βgal DNA localized predominantly in the cytoplasm of transfected 
cells (Fig. 3.5h, panels a1-a3). The fusion protein (containing N-terminus 25 amino acids of 
IVa2 fused to GFP/βGal) expressed in the cells transfected with plasmid pGFP/βgal.NLS DNA 
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localized predominantly to the nucleus of the transfected cells panels (Fig. 3.5h, panels b1-b3). 
In contrast, fusion protein (containing N-terminus 4-18 amino acids of IVa2 fused to 
GFP/βGal) expressed in the cells transfected with plasmid pGFP/βgal.NLS1 DNA localized 
predominantly to the cytoplasm of the transfected cells (Fig. 3.5h, panels c1-c3). 
 
3.3.5 Interaction of IVa2 with protein transport receptors 
To determine which of the import receptor (s) are involved in the transport of IVa2 across the 
nuclear pore complex, GST pull-down assay carried out. In-vitro transcribed/translated [35S] 
methionine labelled IVa2 (plasmid.pC.IVa2) was incubated with purified GST or GST fused to 
importin α-1, α-3, α-5, α-7, β-1 or TRN-SR2 (Fig. 3.6ab). Bound proteins were separated by 
12% SDS-PAGE and visualized by autoradiography using FX molecular imager. As seen in 
Fig. 3.6c, radiolabeled proteins appear to interact with importin α-1 (lane 3). No such 
interaction could be observed when radiolabeled IVa2 pulled down using purified GST fused to 
(lane 2), α-3 (lane 4), α-5 (lane 5), α-7 (lane 6), β-1 (lane 7) or TRN-SR2 (lane 8). 
Radiolabelled full-length IVa2 (Fig. 3.6c,d) lane 1 and or N terminus 25 amino acid truncated 
IVa2  (Fig. 3.8d) lane 4 were used as input control. 
To determine the domain of IVa2 involved in the interaction with importin receptor α-1, the 
GST pull-down assay was performed using radiolabeled mutant IVa2 (containing a deletion of 
amino acids1-25) and purified GST-importin α-1 fusion protein (Fig. 3.6a, b). As expected, 
radiolabeled IVa2 interacted with purified GST-importin α-1 fusion protein (Fig. 3.6c, lane 3) 
but not with purified GST alone (Fig. 3.6c, lane 2). Radiolabeled mutant IVad25 did not 
interact with either GST (Fig. 3.6d, lane 5) or GST-importin α-1 fusion protein (Fig. 3.6d, lane 
6). 
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Fig. 3.5. Sub-cellular localization of mutant IVa2 containing small deletions\ substitutions. (a). 
Schematic diagram of plasmid DNAs. Amino acid numbers are depicted. The name of the plasmid 
is depicted on the right of the panel. The thick line represents the deleted region(s). (b). Sub-
cellular localization. Vero cells were transfected with indicated plasmid DNA. At 36 hrs post 
transfection, the cells were fixed and the subcellular localization of IVa2 was observed by direct 
fluorescence using confocal microscope. DF (direct fluorescence). (c). Schematic diagram of 
plasmid DNAs. The name of the plasmid is depicted on the right of the panel. Amino acid numbers 
are depicted. The Basic residues RRK are shown in bold. The substituted amino acids of BAdV-3 
IVa2 are underlined. (d). Sub-cellular localization. Vero cells were transfected with indicated 
plasmid DNA. At 36 hrs post transfection, the cells were fixed and analysed by direct fluorescence 
using confocal microscope. 
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Fig. 3.5. Sub-cellular localization of mutant IVa2 containing small deletions\ substitutions. (e). 
Schematic diagram of plasmid DNAs. The name of the plasmid is depicted on the right of the panel. 
Amino acid numbers are depicted. The substituted amino acids of BAdV-3 IVa2 are underlined. (f). 
Sub-cellular localization. Vero cells were transfected with indicated plasmid DNA. At 36 hrs post 
transfection, the cells were fixed and analysed by direct fluorescence using confocal microscope. 
DF (direct fluorescence). 
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Fig. 3.5. Sub-cellular localization of mutant IVa2 containing small deletions\ 
substitutions.g) Schematic diagram of plasmid DNAs. The name of the plasmid is depicted on the 
right of the panel. Amino acid numbers are depicted. The substituted amino acids of BAdV-3 IVa2 
are underlined. NLS (nuclear localization signal) of IVa2; GFP (green fluorescent protein). (H). 
Sub-cellular localization. Vero cells were transfected with indicated plasmid DNA. At 36 hrs post 
transfection, the cells were fixed and analysed by direct immunofluorescence using confocal 
microscope. DF (direct fluorescence). 
 
 
 
 
 
 
 
 
 
	   79	  
Radiolabelled IVa2 (Fig. 3.6d, lane 1) and IVa2d25 (Fig. 3.6d, lane 4) were used as input 
control. Similarly, radiolabeled GFP/βgal.NLS1 did not interact with either GST-importin α-1 
fusion protein (Fig. 3.6e, lane 3) or GST (Fig. 3.6e, lane 4). In contrast, radiolabeled 
GFP/βgal.NLS interacted with GST-importin α-1 fusion protein (Fig. 3.6e, lane 2) but not with 
GST (Fig. 3.6e, lane 6). Radiolabeled GFP/βgal.NLS (Fig. 3.6e, lane 1) and GFP/βgal.NLS1 
(Fig. 3.6e, lane 5) was used as input control. 
 
3.3.6 Mapping of IVa2 nucleolar localization signal 
To map nucleolar localization signal (NoLS) of IVa2, plasmids expressing truncated or deleted 
mutant IVa2 were constructed and individually fused to gene encoding DsRed (Fig. 3.10a). 
Since mutant protein expressed in plasmid pDR.IVa2d2 DNA (Fig. 3.4b, panels c1-c3) 
transfected cell showed altered nucleolar localization; we constructed plasmids containing C-
terminal deletions\truncation (Fig. 3.7a). Vero cells transfected with individual plasmid DNA 
were analyzed by direct immunofluorescence. As seen in Fig. 3.7b, wild-type IVa2 expressed 
in cells transfected with plasmid pDR.IVa2 DNA localized to the nucleolus\nucleus of the 
transfected cells (panels, a1-a4). Mutant IVa2 protein expressed in cells transfected with 
plasmid pDR.IVa2d2 DNA showed altered nucleolar localization without affecting the nuclear 
localization (panels, b1-b4).  In contrast, a mutant protein expressed in the cells transfected 
with plasmid pDR.IVa2d5 localized predominantly in the nucleus of the transfected cells 
(panels, c1- c4). Mutant proteins expressed in cells transfected with plasmid pDR.IVa2d5.1 
DNA (panels, d1-d4), plasmid pDR.IVa2d5.2 DNA (panels, e1-e4), plasmid DNA 
pDR.IVa2d5.3 DNA (panels f1-f4), plasmid pDR.IVa2d5.4 DNA (panels, g1-g4), plasmid  	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Fig. 3.6. Interaction of IVa2 with nuclear transport receptors (a).  Schematic diagram of 
plasmid DNAs. The amino acid numbers of IVa2 are depicted. The name of the protein is depicted 
on left of the panel. The name of the plasmid is depicted on the right of the panel. GST (glutathione 
S-transferase); TRN-SR2 (transportin). (b). Commassie blue staining. Purified GST-transport 
receptor proteins were separated by 12% SDS-PAGE and the gels were stained with 0.25% 
Commassie blue. (c, d). GST pull-down assay. (c). In-vitro synthesized [35S]-labeled BAdV-3 IVa2 
was incubated with either purified individual GST fusion proteins (GST fused with importin α1, α3, 
α5, α7, β1, or TRN-SR2 or GST and pulled down with glutathione sepharose beads II. (d). In - vitro 
synthesized [35S]-labeled BAdV-3 IVa2  or IVa2d25 was incubated individually with either  
purified individual GST- importin α1 fusion protein or GST alone, and pulled down with 
glutathione sepharose beads II. (e) In - vitro synthesized [35S]-labeled GFP/βgal.NLS or 
GFP/βgal.NLS1 was incubated individually with either purified individual GST- importin α1 fusion 
protein or GST alone, and pulled down with glutathione sepharose beads II. The samples from (c), 
(d) and (e) were separated by 12% SDS-PAGE and visualized using phosphor screen. 
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Fig. 3.7 Mapping of IVa2 nucleolar localization signal. (a) Schematic diagram of plasmid 
DNAs.  The amino acid numbers of IVa2 protein are depicted. The name of the plasmid is 
depicted on the right of the panel. The thick line depicts deleted region(s). (b). Sub-cellular 
localization. Vero cells were transfected with indicated plasmid DNA. At thirty-six hrs post 
transfection, the slides were fixed, permeabilized, blocked and probed using anti-RPA 
antibodies followed by Alexa 633 conjugated goat anti- mouse antibodies. The nuclei were 
stained with DAPI. The sub-cellular localization was visualized by confocal microscope. Direct 
fluorescence (DF). 
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pDR.IVa2d5.5 DNA (panels, h1-h4) and plasmid pDR.IVa2d5.6 DNA (i1-i4) localized to the 
nucleolus of the transfected cells. 
 
 3.3.7 Isolation of recombinant BAdV-3 expressing IVa2 containing nucleolar localization  
   signal flanked by loxP sequence 
To conditionally knockdown BAdV-3 IVa2 nucleolar localization sequence, we constructed 
a full-length plasmid pUC304a.loxIVa2C.75 (appendix 1) expressing BAdV-3 IVa2 containing 
loxP sequence inserted in-frame at amino acid 373 and amino acid 448. The CRL cells were 
transfected with 5 ug of PacI digested plasmid pUC304a.loxIVa2C.75 DNA and monitored for 
the detection of EYFP expressing cells and the development of cytopathic effects. Although 
GFP expressing cells observed in cells transfected with plasmid pUC304a.loxIVa2C.75 DNA 
(data not shown), repeated transfections did not induce the development of cytopathic effects. 
 
3.3.8 Isolation and characterization of recombinant BAdV-3 expressing mutant IVa2  
To determine if a stretch of basic residues (6RRK9) in IVa2 NLS affect replication of BAdV-
3, we constructed full-length BAdV-3 genomic clones expressing mutant IVa2 containing a 
substitution of basic amino acids with glycine in NLS (Fig. 3.8a). Transfection of VIDO DT1 
cells (DU and Tikoo, 2010) with individual full-length plasmid DNAs lead to the detection of 
green fluorescent cells and cytopathic effects in 15 days (Fig. 3.8b). The infected cells were 
collected, freeze-thawed and recombinant viruses were purified by CsCl density gradient. The 
proper introduction of the desired mutation was confirmed by DNA sequencing of mutant viral 
DNA. The ability of recombinant BAdV-3 to express IVa2 was confirmed by Western blot 
using IVa2gst serum. 
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As seen in Fig.3.8, proteins of expected molecular weight could be detected in lysates of 
cells infected with mutant viruses (panel c).  
To assess the effect of amino acid substitutions on the nuclear location of IVa2, the cells 
infected with individual recombinant BAdV-3 were analyzed by immunofluorescence using a  
Confocal microscope. As seen in Fig. 3.8e, mutant IVa2 appears to be localized predominantly 
in the nucleoli of infected cells. 
To determine if amino acid substitution affected the replication of BAdV-3, we compared 
the growth kinetics of recombinant BAdV-3 in MDBK cells. As seen in Fig. 3.8d, there was no 
detectable difference in the titer of BAV304AM1, BAV304aM2, BAV304aM3, and BAV304a. 
In contrast, recombinant BAV304aM4 grew about 1 log less compared to other BAdV-3s.  
 
3.4 Discussion 
The different steps involved in the efficient production of progeny adenovirus, including 
nuclear translocation of individual adenovirus protein to produce stable adenovirus capsids, 
involve the interaction of adenovirus proteins with cellular and/ viral proteins (Flatt and 
Butcher, 2019). Recently, we reported that nuclear localization of some structural and non-
structural proteins encoded by L1-L7 regions of late transcriptional unit of BAdV-3 genome 
requires interaction with different importins\ transportin 3 receptors (Ayalew et al., 2014; 
Kulshreshtha et al., 2014; Paterson et al., 2012; Said et al., 2018a).  
Adenovirus IVa2, a multifunctional core protein, interacts with 52K (Gustin et al., 1996) and 
pVIII (Singh et al., 2005). Moreover, protein IVa2 encoded by HAdV-5 localizes to both 
nucleus and nucleolus in infected cells using amino acid 432-449 and amino acids 50-136 as 
nuclear and nucleolar localization signals respectively (Lutz et al., 1996). Since the structure \  
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Fig. 3.8 Isolation and characterization of mutant BAdV-3. (a). Schematic diagram of plasmid DNAs. 
The name of the plasmids is depicted on the right of the panel. The BAdV-3 sequence is represented by 
filled box. The thin line represents deleted region (E3). The numbers represent the amino acids of 
BAdV-3 IVa2. The glycines substituted for arginines are underlined. Human cytomegalovirus (CMV) 
immediate early promoter; Enhanced yellow fluorescent protein (EYFP). (b). Direct Fluorescence. 
Monolayers of VIDO DT1 cells were transfected with 5 µg of indicated plasmid DNA and visualized 
for EYFP expression and development of cytopathic effects using fluorescent microscope TCS SP5 
(Leica). Direct fluorescence (DF); Phase contrast (PC).	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Fig. 3.8 Isolation and characterization of mutant BAdV-3 (c). Western blot. Proteins from the lysates 
of CRL cells individually infected with BAV304a or mutant BAdV-3s were collected at indicated times 
post infection were separated by 12% SDS-PAGE, transferred to nitrocellulose and analysed by 
Western blot using IVa2gst serum. Molecular weight markers (M). (d). Determination of viral titer 
using TCID50. MDBK cells in 24 well plates infected with BAV304a, BAV304aM1, BAV304aM2, and 
BAV304aM3 or BAV304aM4 virus at MOI of 5. Cell lysates collected at different time points, freeze 
thawed and used to determine viral titer using TCID50. Displayed values are average values of two 
sepearte experiments. (e) Sub cellular localization of IVa2. MDBK cells infected with BAV304a (panel 
a1-a4), BAV304a M1 (panel b1-b4), BAV304aM2  (panel c1-c4), BAV304aM3 (panel d1-d4) or 
BAV304aM4 (panel e1-e4) with 2 MOI. At 36 hrs post transfection, the cells were fixed and the 
subcellular localization of IVa2 was visualized by confocal microscope after staining with IVa2gst 
serum and goat anti-rabbit alexa 647 antibodies..Cells nuclei stained withd DAPI (panels 
a3,b3,c3,d3,e3) and nucleoli were visualized by staining with anti-RPA antibody and Cy3 conjugated  
goat anti-mouse antibody (panels a2,b2,c2,d2,e2). A merge of the images is shown in (panels a4, b4, c4, 
d4 ,e4). 
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function of colinear proteins in members of the Mastadenvirus genus does not appear to be 
conserved (Blanchette et al., 2013; Cheng et al., 2013, Makadiya et al., 2015), the present study 
characterized and identified the functional domains of BAdV-3 IVa2. 
 
The IVa2 mRNA transcribed from the bottom strand of BAdV-3 genome encodes a protein 
of 448 amino acids, which is detected as 55 kDa protein between 18-24 hrs to 48 hrs post-
infection. Similarly, IVa2 specific 55 kDa protein could also be detected in immature and 
mature virions (Kulshreshtha et al., 2004). The IVa2 protein appears to be localized 
predominantly to the nucleus and nucleolus of BAdV-3 infected cells. Detection of IVa2 in the 
nucleus and nucleolus of plasmid DNA transfected cells in the absence of any other viral 
protein suggest that IVa2 protein may contain non-overlapping NLS \ NoLS, which are located 
in different domains of the protein (Cheng et al., 2002; Sheng et al., 2004) or overlapping NLS 
\ NoLS, which are located in the same domain of the protein (Cros et al. 2004).  
Active nuclear localization of a protein is regulated by NPC (Lin and Hoelz, 2019) and 
require an NLS, which can be a classical NLS, a bipartite NLS or a non-classical NLS 
(Christophe et al., 2000). Analysis of BAdV-3 IVa2 amino acid sequence did not identify any 
potential classical \ bipartite NLS. However, cNLS Mapper computer program (which predicts 
NLS specific to importin a\b by calculating NLS scores; (Kosugi et al., 2009a) transport 
pathway predicted amino acid 5-35 and 64-73 to act as potential NLS. Analysis of mutant 
BAdV-3 IVa2 proteins containing deletions or substitutions of amino acids suggested that 
amino acids 4-18 are essential for nuclear localization of BAdV-3 IVa2. However, residues 4-
18 of BAdV-3 IVa2 were not sufficient to direct nuclear localization of a fusion protein 
GFP/βgal, predominantly a cytoplasmic protein. Earlier reports have suggested that residues 
	   87	  
upstream or downstream of NLS motif may be involved in the efficient transport of a protein to 
the nucleus (Seki et al., 1997).  
Viral proteins utilize single (Ayalew et al., 2014; Makadiya et al., 2015; Paterson et al., 
2012) or multiple (Arnold et al., 2006; Ayalew et al., 2014; Kulshreshtha et al., 2014; Said et 
al., 2018a; Wodrich et al., 2006) transport receptors for localization to the nucleus, which may 
depend on the amount of importin available in a particular cell (Arnold et al., 2006). Our results 
suggest that BAdV-3 IVa2 utilizes importin α-1 as a nuclear receptor for transport to nucleus. 
Although three importins have been identified as nuclear receptors for translocation of HAdV-5 
pVII to nucleus (Wodrich et al., 2006), so far BAdV-3 proteins have been shown to use either 
single importin α -3 for nuclear transport of 52K (Paterson et al., 2012) 100K (Makadiya et al., 
2015) and pV ( Zhao and Tikoo, unpublished data) or two importins α -5 and α -7 for nuclear 
transport of 22K (Said et al., 2018a), and α -5 and transportin -3 for nuclear transport of 33K 
(Kulshreshtha et al., 2014). 
An earlier study suggested that basic residues appeared essential for the nuclear localization 
of BAdV-3 52K (Paterson et al., 2012). The NLS of BAdV-3 IVa2 contains a cluster of basic 
residues 6RRK8. Mutant IVa2 proteins containing a substitution of basic residues located 
predominantly to the nucleolus of the plasmid DNA transfected or recombinant BAdV-3 
infected cells suggesting that the cluster of basic residues in potential IVa2 NLS is not essential 
for the nuclear localization of BAdV-3 IVa2. Moreover, though mutation of a cluster of basic 
residues 6RRK8 to 6GGG8 appears to be responsible for a marginal reduction in virus yield of 
recombinant BAV304aM4, it does not appear to be required for the replication of BAdV-3. 
The nucleolar transport of a viral protein requires binding of nucleolar transport signal 
(NoLS) of a viral protein to nucleolar RNAs \ proteins. The NoLS is rich in basic residues and  
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is usually  at N-terminus or C-terminus of the protein (Reed et al., 2006; Scott et al., 2010). 
Analysis of BAdV-3 IVa2 truncations\deletion mutants suggested that amino acid 373-448 
contains multiple NoLSs, which appear to be functionally redundant. Interestingly, the deletion 
of IVa2 NoLs does not abrogate nuclear localization of IVa2, suggesting that IVa2 contains 
non-overlapping NoLS \ NLS. While NoLS appears to be located at the C-terminus of IVa2 
protein, NLS appears to be located at N-terminus of the IVa2 protein.  
In summary, we have demonstrated that BAdV-3 IVa2 localizes to nucleus and nucleolus 
utilizing amino acids 4-18 and 373-448, respectively. Moreover, 1-25 and amino acids of 
BAdV-3 IVa2 interacts with importin α-1 of the nuclear transport receptor.   
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4.0 Transition from 3.0 to 5.0  
By raising antibody against BAdV-3 IVa2 protein, its expression timeline was 
determined. Additionally, subcellular localization of BAdV-3 IVa2 shown to be predominantly 
in the nucleolus. Moreover, nuclear and nucleolar localization signals, as well as the 
mechanism of nuclear import also identified. Further analysis of the effect of basic amino acid 
in the nuclear localization of IVa2 also examined. Generally, in the course of an adenovirus life 
cycle, the viral proteins undergo viral- cellular and or viral-viral protein interaction to 
accomplish their duties. In the present work, we identified intra-viral proteins interaction 
between IVa2 and late adenoviral proteins. 
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5. BOVINE ADENOVIRUS (BAdV-3) IVA2 INTERACTS WITH VIRAL PROTEIN pV 
 
5.1 Introduction 
Protein IVa2 encoded by intermediate region of HAdV-5 is a protein of 449 amino acids, 
which is localized in the nucleus and nucleolus of the infected cells (lutz et al., 1996), and 
unique vertex of purified adenovirus particle (Christensen et al., 2008). Adenovirus IVa2, a 
multifunctional protein appears to be involved in different steps of viral replication including 
transactivation of major late promoter (MLP) and adenovirus genome packaging  (Ahi and 
Mittal, 2013), and virion stability (Singh et al., 2005). One way protein IVa2 performs multiple 
functions is by interacting with different viral proteins including 52/55K for cooperative 
packaging of viral genome (Gustin et al., 1996; Perez-Romero et al., 2006), with 22K, 33K and 
DBP  (Ahi et al., 2013) and pVIII for virion stability (Singh et al., 2005).   
The intermediate region of BAdV-3 encodes structural proteins pIX and IVa2 (Reddy et al., 
1998). The BAdV-3 IVa2, a protein of 448 amino acids is detected as a 50kDa protein in virus 
infected cells (Chapter 3). The IVa2 localizes to the nucleus and the nucleolus using amino 
acids 4-18 and 373-448, respectively. Moreover, IVa2 interacts with importin α-1 to cross the 
nuclear membrane (Chapter 3). 
Adenovirus genomes contain a positional homolog of BAdV-3 IVa2 (Reddy et al., 1998). 
Since the positional homologs of adenoviruses differ in structure and function (Blanchette et 
al., 2013; Cheng et al., 2013;Makadiya et al., 2015; Stracker et al., 2005), we have begun to 
characterize BAdV-3 IVa2 in detail. Here, we determined the interaction of BAdV-3 IVa2 with 
other viral proteins.   
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5.2 Materials and Methods 
 
5.2.1. Cells and viruses 
Madin-Darby bovine kidney (MDBK) (ATCC CCL22), cotton rat lung (CRL), (Papp et al., 
1997), and and VIDO	  DT1	  cells were propagated at 37°C in minimal essential medium (MEM; 
Sigma) with 5% CO2. The HEK 293T (ATCC CRL-11268) cells cultured using Dulbecco's 
modified minimal essential medium (DMEM; Sigma). All the cell lines supplemented with 
heat-inactivated 10% fetal bovine serum (FBS; SAFC industries, Sigma), 0.1mM nonessential 
amino acids (NEAA; Gibco), 10mM HEPES (Gibco) and 50ug/ml gentamicin (Bio Basics). 
Wild type and recombinant BAdV-3 propagated as described previously (Reddy et al., 1998). 
 
5.2.2 Antibodies.  
Anti-IVa2 antiserum (IVa2gst) raised against GST fused full-length IVa2 protein recognizes 
a protein of 50kDa kDa in BAdV-3 infected cells (section 3.3.2). Production of anti -pV sera 
has been described (Zhao, 2016). Anti-HA antibody (A1978) obtained from Sigma. Alkaline 
phosphatase-conjugated goat anti-mouse antibody (115-055-205) and goat anti-rabbit antibody  
(111-055-003) purchased from Jackson Immuno Research. 
 
5.2.3 Plasmid construction 
Plasmids were constructed using standard molecular techniques as described earlier 
(Sambrook and. Russell, 2000). 
PMCS.3821.Initially, a 7162 bp AarI DNA fragment containing IVa2 coding sequence was 
isolated by digestion of plasmid pUC304a+ DNA with AarI.  Finally, a 3821 bp SphI-SacII 
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DNA fragment (containing IVa2 coding sequence flanked by 1463 bps and 1022 bp) of 7162 
bp DNA fragment was isolated and ligated to SphI - SacII digested plasmid pMCS 
(Thanbichler et al., 2007) DNA creating a plasmid pMCS.3821. 
pUC304a.ST146. Using primers AflII FP and IRP146 (Table 2, Appendix 2) and plasmid 
pMCS.3821 DNA as template, a 595 bp DNA fragment (P1) was amplified by PCR. Similarly, 
using primers IFP146 and SacI RP (Table 2, Appendix 2), and plasmid pMCS.3821 (described 
above) DNA as a template, a 1177 bp DNA fragment (P2) was amplified. The P1 and P2 DNA 
fragments were annealed and a 1748 bp was amplified by PCR using primers AflII FP and SacI 
RP (Table 2, Appendix 2).  The 1748 bp DNA fragment was digested with AflII-SacI and 
ligated to AflII-SacI digested plasmid pMCS.3821 DNA creating plasmid pMCS.3821.ST146. 
Escherichia coli BJ5183 based homologous recombination between 3845 bp SphI-SacII 
fragment of plasmid pMCS.3821.STIVa2146 and SbfI linearized plasmid pUC304a.dIVA2SbfI 
(described above) DNA resulted in isolation of plasmid pUC304a.ST146 (pUC304a+ 
containing strep tag II (ST-II) sequence after amino acid 146 of IVa2). 
pUCK304a.ST242. Using primers SphI FP and IRP242 (Table 2, Appendix 2), and plasmid 
pMCS.3821 DNA as a template, a 2116 bp DNA fragment  (P1) was amplified by PCR. 
Similarly, using primers IFP242 and SacII RP (Table 2, Appendix 2), and plasmid pMCS.3821 
DNA as a template, a 1768 bp DNA fragment (P2) was amplified by PCR. The P1 and P2 DNA 
fragments were annealed and a 3860 bp DNA fragment was amplified by PCR using primers 
SphI FP and SacII RP (Table 2, Appendix 2). The 3860 bp DNA fragment was digested with 
SphI-SacII and ligated to SphI-SacII digested plasmid pMCS (Thanbichler et al., 2007) DNA 
creating plasmid pMCS.3821.ST242. 
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Escherichia coli BJ5183 based homologous recombination between 3845 bp SphI-SacII 
fragment of plasmid pMCS.3821.ST242 and SbfI linearized plasmid pUC304a.dIVa2SbfI DNA 
resulted in the isolation of plasmid pUC304a.ST242 (pUC304a+ containing STII sequence 
after amino acid 242 of IVa2). 
pUC304a.ST448. Using primers SphI FP and IRP448 (Table 2, Appendix 2) and plasmid 
pMCS.3821DNA as a template, a 1498 bp DNA fragment (P1) was amplified by PCR. 
Similarly, using primers IFP448 and SacII RP (Table 2, Appendix 2), and plasmid pMCS.3821 
DNA, a 2386 bp   DNA fragment (P2) was amplified. The P1 and P2 DNA fragments were 
annealed and a 3860 bp DNA fragment was amplified by PCR using primers SphI FP and SacII 
RP (Table 2, Appendix 2). The 3860 DNA fragment was digested with SphI-SacII and ligated 
to SphI-SacII digested plasmid pMS (Thanbichler et al., 2007) DNA creating plasmid 
pMCS.3821.ST448. 
Escherichia coli BJ5183 based homologous recombination between 3845 bp SphI-SacII 
fragment of plasmid pMCS.3821.ST448 and SbfI linearized plasmid pUCK304a.dIVa2SbfI  
DNA resulted in isolation of plasmid pUC304a.ST448 (pUC304a+ containing STII sequence 
IVa2 stop codon). 
 
5.2.4 Transfection 
The transfection of cells with plasmid DNA was performed as described in section 3.2.6. 
 
5.2.5 Isolation of recombinant BAdV-3 viruses 
The recombinant BAdV-3s were isolated using plasmid DNA transfection of cells as 
described in section 3.2.7.  
	   94	  
5.2.6 Western blotting 
Virus-infected cells, plasmid transfected cells, or purified proteins were analyzed by 
Western blotting (Kulshreshtha et al., 2004) as described in section 3.2.8 using protein-specific 
antiserum and alkaline phosphatase-conjugated secondary antibody. 
 
5.2.7. Sequence analysis of BAdV-3 IVa2  
To   identify specific protein– protein interacting motif within the full-length of IVa2, we 
analyzed the BAdV-3 IVa2 protein sequence by a coiled-coil program (Lupas et al., 1991). 
 
5.2.8 Bimolecular fluorescence complementation (BiFC) analysis 
BiFC assay (Kerppola, 2009) performed as described earlier (Levin et al., 2009; Rosenbluh 
et al., 2007; Said et al., 2018b).  The pGN and pGC plasmids were provided by Dr. Abraham 
Loyter (The Hebrew University of Jerusalem, Israel).  Preparation and transformation of 
competent S288c cells (yeast competent cells, a gift from Dr. Troy Harkness, University of 
Saskatchewan) were carried out according to the method outlined in the yeast protocols 
handbook (Clontech Laboratories 2009). Briefly, several 2-3mm colonies of yeast S288c cells 
inoculated into 1mL of yeast peptone dextrose adenine broth (YPDA). After dispensing clumps 
via vortexing, the inoculate was transferred into 50 mL YPDA and incubated at 300C for 18 hrs 
with shaking at 220 RPM until OD 600 value reaches ≥ 1.5. The culture was transferred to 
300mL of YPDA and further incubated at 300C with shaking at 220 RPM for 3hrs When OD 
600 value of the culture reached 0.5, the culture was pelleted at 1000 g for 5 min and 
resuspended in 30mL of sterile double distilled water. The supernatant removed by centrifuging 
at 1000g for 5 min, and cell pellets again resuspended in 1.5mL of 1X Tris-EDTA /lithium 
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acetate.  Transformation of yeast cells with indicated plasmid DNAs were carried out using 
polyethylene glycol–Lithium acetate (PEG-LiAc) method (Clontech Laboratories 2009). In a 
single Eppendorf tube, 0.4ug of each plasmid, 0.1mg of carrier DNA (salmon sperm), 0.1mL of 
a freshly prepared competent cell, and 0.6mL of PEG-LiAc (40% PEG, 1X TE, 1X LiAc) 
solution was mixed and incubated for 30 min on a shaker at 200RPM. After incubation, 70ul of 
dimethyl sulfoxide was added, mixed with gentle inversion before heat shocking for 15 min at 
420C followed by 2min chilling on ice. The supernatant was removed by centrifuging cells at 
14000 RPM for 5min, followed by suspension of cell pellet in 0.5mL of 1X TE. Finally, 100ul 
of the suspension was used to streak a plate containing selective dropout medium supplemented 
2% glucose in the absence of urease and histidine. The streaked plates incubated at 300C for 3 
days. The colonies were picked, spread, and fixed with 3.7% paraformaldehyde for 15min. The 
fixed slides were allowed to dry, mounted with mounting medium (Vectashield) containing 
DAPI examined using Zeiss LSM 5 Laser scanning confocal microscope. 
 
5.2.9 Co-Immunoprecipitation (Co-IP) assay 
The co-immunoprecipitation assay was performed as described (Said et al., 2018a).  Briefly, 
forty-eight hr post transfection, the cells were washed with ice-cold PBS, scraped off the 
culture plate in the presence of NP-40 lysis buffer containing protease inhibitor cocktail 
(Roche) and further incubated for 30 min at 40C on a shaker. After 30 min incubation, the cell 
lysate was centrifuged at 12000g for 10 min at 40C. The clarified lysates were transferred to an 
Eppendorf tube containing sepharose A beads conjugated to protein specific antibodies and 
incubated overnight at 40C on a rotator. After overnight incubation, the beads were pelleted and 
washed 4x with lysis buffer.  Next, 50ul of 2X SDS sample buffer added to the resin and 
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protein was denatured by heating at 1000C for 3 mins. Finally, the proteins were separated by 
12%  SDS-PAGE, transferred to nitrocellulose and probed in  Western blotting carried out 
using appropriate protein specific primary followed by appropriate secondary antibody. The 
protein bands were visualized by developing using specific substrate.  
Co-immunoprecipitation in the context of virus infection was carried out using (Co-IP) kit 
from Thermo Scientific as per the instruction of the manufacturer. Generally, the overall 
protocol involves purification of IgG, immobilization of antibodies with beads, cell lysis, and 
pre-clearing and actual Co-IP. IgG purification was carried out by passing anti pV antibody or 
pre-immune sera through an IgG purification column. The purified antibody, coupled with 
AminoLink Plus Resin beaded agarose, which is reactive towards primary amines (-NH2) 
found on antibodies. After antibody coupling, actual CO-IP proceeded by clarifying 
supernatant containing protein sample by incubating with Sepharose A beads and transferring 
to a spin column containing AminoLink Plus Resin coupled with anti PV IgG or pe immune 
sera.  After overnight incubation, at 40C on an orbital shaker, the spin column was centrifuged, 
and the resin washed 3x with lysis buffer. After the final wash, the protein sample was eluted 
using a gentle elution buffer mixed with SDS sample buffer. After boiling at 1000C for 3 min. 
the proteins in sample were sepatrated by 12% SDS-PAGE and probed in Western blot using 
an anti IVa2 antibody followed by an alkaline phosphatase-conjugated secondary antibody. 
Finally, the protein bands were visualized using Pierce™ ECL Western blotting substrate  
(Thermo Fisher), and the image captured using X-ray films (GE Healthcare).  
 
5.3 Results 
5.3.1 Isolation of mutant BAdV-3 containing insertion of Strep-tag 
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For isolation of recombinant BAdV-3 expressing IVa2 containing Step tag (Trp-Ser-His-
Pro-Gln-Phe-Glu-Lys) (Schmidt and Skerra, 2007), full-length plasmids pUC304a.ST146, 
pUC304a.ST242, and pUC304a.ST448 containing Strep tag sequence inserted in-frame after 
amino acid 146, 242, and 448, respectively (Fig. 5.1a). The selection of insertion sites was 
based on prior information in human IVa2 studies and also areas that appear to be less 
conserved. As seen in Fig. 5.1b (panel a1-a2), expression of EYFP, and development of 
cytopathic effects observed in cells transfected with plasmid pUC304a+ DNA.  Repeated 
transfection of VIDO DT1 cells with 5ug of mutant individual plasmid DNAs did show 
expression of EYFP, however cytopathic effects were not visible in the cells transfected with 
plasmid pUC304a.ST146 (panels, b1-b2) DNA, plasmid pUC304a.242 (panel, c1-c2) DNA or 
plasmid pUC304a.448 (panels, d1-d2) DNA up to 20 days post-transfection (Fig. 5.1, panel b). 
 
5.3.2 Interaction of IVa2 with BAdV-3 proteins 
   To determine the interaction of IVa2 with other viral proteins, we performed a BiFC assay. 
The competent S288c cells were co-transformed with indicated plasmid DNAs. Transformed  
yeast cells were plated out in a dropout medium devoid of histidine and uracil and incubated for 
3 days at 300C. Individual colonies were fixed, smeared out in the glass side, stained with 
DAPI and observed under a confocal microscope. As seen in Fig. 5.2, green fluorescence was 
observed in yeast cells co-transformed with plasmid pGN.IVa2 +pGC.pV DNAs (panels, a1-
a4); pGN.IVa2+ pGC.pVII DNAs (panels, b1-b4); pGN.IVa2 + pGC.pVIII DNAs (panels, c1-
c4); pGN.IVa2 + pGC.p22K DNAs (panels, d1-d4); pGN.IVa2 + pGC.52K DNAs (panels, e1-
e4); pGN.IVa2 + pGC.Fiber DNAs (panels, f1-f4) and pGN.IVa2 + pGC.hexon DNAs (panels, 
g1-g4). 
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Fig. 5.1 Isolation of mutant BAdV-3. (a). Schematic diagram of plasmid DNAs. The name of the 
plasmids is depicted on the right of the panel. The BAdV-3 sequence is represented by filled box. 
The thin line represents deleted region (E3). The amino acids of Strep tag II are indicated. The 
numbers represent the amino acids of BAdV-3 IVa2. Human cytomegalovirus (CMV) immediate 
early promoter; Enhanced yellow fluorescent protein (EYFP). (b) Direct Fluorescence. Monolayers 
of VIDO DT1 cells were transfected with 5 µg indicated plasmid DNA and visualized for EYFP 
expression and development of cytopathic effects using fluorescent microscope TCS SP5 (Leica). 
Direct fluorescence (DF). 
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Fig. 5.2 Interaction of IVa2 with BAdV-3 proteins. (a). Schematic diagram of plasmid DNAs.  
The name of the plasmid is depicted on the right of the panel.  Linker region (L). Green fluorescent 
protein N-terminus (GFP/N-terminus), Green fluorescent protein C-terminus ( GFP/C-terminus).  	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Fig. 5.2 Interaction of IVa2 with BAdV-3 proteins (b). Biomolecular fluorescence 
complementation assay (BiFC). Yeast S288c cells were co-transformed with indicated plasmid 
DNA, incubated on a selective media and observed under a confocal microscope. Direct 
fluorescence (DF), Phase contrast (PC). 
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5.3.3 Interaction of IVa2 with pV 
Earlier, mass spectrometry analysis of protein complexes, purified from recombinant BAV 
ST (pV containing an insertion of Strep Tag sequence) infected cells using Strep-Tactin 
Sepharose pull-down assay suggested that BAdV-3 IVa2 interacts with pV (Zhao, 2016). To 
confirm the interaction of IVa2 with pV, initially, we repeated BiFC assay. Yeast competent 
cells S288c-were co-transformed with plasmid pGN.IVa2 and pGC.pV DNA or plasmid 
pGN.IVa2 and pGC DNA or plasmid pGN and pGC DNA (Fig. 5.3, panel a,b). Transformed 
yeast cells plated out in a dropout medium devoid of histidine and uracil and allowed to grow 
for 3 days at 300C. Individual colonies were fixed, smeared out in the glass side, stained with 
DAPI, and observed under a confocal microscope. As seen in Fig. 5.3 (panel b), green 
fluorescence was observed in yeast cell co-transformed with plasmid pGC.pV and pGN.IVa2 
DNA (panel a1-a3). No such fluorescence could be observed in yeast cells co-transformed with 
plasmid pGN.IVa2 and pGC DNA (panels, b1-b3) or plasmid pGN and pGC (panels, c1-c3).  
To further confirm the interaction of IVa2 with pV, a co-immunoprecipitation assay performed.  
At 36 hrs post-transfection, the lysates of 293T cells co-transfected with indicated plasmid 
DNAs as seen in (Fig. 5.4a) were immune-precipitated using anti-HA MAb and co-
immunoprecipitated IVa2 protein was detected in Western blot using IVa2gst sera. As Fig. 5.4b 
IVa2 specific band could be observed in the cells co-transfected with plasmid pC.IVa2 + 
pC.HApV (Zhao, 2016) DNAs (panel b, lane 2). No such band could be observed in cells 
transfected with plasmid pC.IVa2 + pC.HA DNAs (panel b, lane 1).  
Finally, the interaction of IVa2 with pV was confirmed in BAdV-3 infected cells. The cell 
lysates from mock or BAdV-3 infected cells were immune-precipitated with anti-pV sera or  
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Fig. 5.3 Interaction of IVa2 with BAdV-3 pV. (a). Schematic diagram of plasmid DNAs.  The 
name of the plasmid is depicted on the right of the panel. Linker region (L). Green fluorescent 
protein N-terminus (GFP/N-terminus), Green fluorescent protein C-terminus (GFP/C-terminus). 
(b). Biomolecular fluorescence complementation assay (BiFC). Yeast S288c cells were co-
transformed with indicated plasmid DNA, incubated on a selective media and observed under a 
confocal microscope. Direct fluorescence (DF), Phase contrast (PC). 
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pre-immune sera and co-immunoprecipitated IVa2 protein detected in Western blot using 
IVa2gstsera. As seen in Fig. 5.4b, IVa2 specific band could be detected in BAdV-3 infected 
cells immunoprecipitated with anti-pV sera (panel c, lane 3). No such band could be detected in 
mock-infected cells with (panel c, lane 4) or without (panel c, lane 6) immunoprecipitation with 
anti-pV sera. Similarly, no such band could be observed in BAdV-3 infected cells (panel c, lane 
2) or mock-infected cells (panel b, lane 5) immunoprecipitated with pre-immune sera. Protein 
IVa2 detected in BAdV-3 infected cells act as a protein input control (panel c, lane 1). 
 
5.3.4 Mapping interacting region of IVa2 with PV 
To identify the domain of IVa2 interacting with pV, BiFC assay was performed using plasmids 
expressing mutant IVa2 containing truncations\deletions (Fig. 5.5, panel a). Green fluorescence 
could be observed in yeast cells co-transformed with plasmid pGN.IVa2 + pGC.pV DNA (Fig. 
5b, panels, a1-a4). Similarly, green fluorescence could be detected in yeast cells co-transformed 
with plasmid pGN.IVa2d6 + pGC.pV DNAs (Fig. 5.5b, panels, b1-b4) or plasmid pGN.IVa2d7 
+ pGC.pV DNAs (Fig. 5.5b, panels, c1-c4). No such fluorescence could  be observed in yeast 
cells co-transformed with plasmid pGN.IVa2d8 DNAs (Fig. 5.5b, panels, d1-d4), or plasmid 
pGN.IVa2d9 + pGC.pV DNAs (Fig. 5.5b, panels, e1-e4).  
To narrow down the domain of IVa2 interacting with pV, plasmids expressing mutant IVa2 
protein containing small deletions in amino acids 121-140 were constructed (Fig. 5.5, panel a). 
However, no fluorescence could be observed in yeast cells co-transformed with plasmid 
pGN.IVa2d9.1 + pGC.pV DNAs (Fig. 5.5b, panels f1-f4), plasmid pGN.IVa2d9.2 + pGC.pV 
DNAs (Fig. 5.5b, panels g1-g4) or plasmid pGN.IVa2d9.3 + pGC.pV DNAs (Fig. 5.5b, panel  
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Fig. 5.4 Interaction of IVa2 with pV. (a) Schematic diagram of plasmid DNAs. Amino acid 
numbers are depicted. The name of the plasmid is depicted on the right of the panel. Linker region 
(L). (b) Co-immunoprecipitation in transfected cells. Proteins from the lysates of indicated plasmid 
transfected HEK 293T cells were immunoprecipitated with anti-HA MAb, separated by 12 % SDS-
PAGE, transferred to nitrocellulose membrane and analyzed by Western blot using IVa2gst serum.  
(c) Co-immunoprecipitation in BAdV-3 infected cells. Proteins from the lysates of BAdV-3 infected 
cells were immunoprecipitated with anti-pV sera (Zhao, 2016) or pre immune sera, transferred to 
nitrocellulose and analysed by Western blot using IVa2gst sera. 
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Fig. 5.5 Identification of region of  IVa2 interacting  with BAdV-3 pV pV. (a). Schematic 
diagram of plasmid DNAs.  The name of the plasmid is depicted on the right of the panel. The 
amino acid numbers of IVa2 are depicted. The thin line represents deleted regions. Linker region 
(L). Green fluorescent protein N-terminus (GFP/N-terminus), Green fluorescent protein C-
terminus (GFP/C-terminus  
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Fig. 5.5 Identification of region of  IVa2 interacting  with BAdV-3 pV pV. (b). Biomolecular 
fluorescence complementation assay (BiFC). Yeast S288c cells were co-transformed with 
indicated plasmid DNA, incubated on a selective media and observed under a confocal 
microscope. Direct fluorescence (DF), Phase contrast (PC). 
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h1-h4). Similarly, no fluorescence could be observed in yeast cells co-transformed with 
plasmid pGN.IVa2 + pGC DNAs (Fig. 5.5b, panels, i1-i4) or plasmid pGN + pGC DNAs (Fig. 
5.5b, panels, j1-j4). 
 
5.3.5 Sequence analysis of IVa2 
Analysis of IVa2 sequence using coiled-coil program, Fig. 5.6, predicted the presence of a 
coil-coil region between amino acid 129 to 142.  
 
5.4 Discussion 
Successful interactions between viral protein-viral DNA, viral-viral proteins, and viral- 
cellular proteins appear essential for the production of an infectious progeny adenovirus. 
Several adenoviral proteins have reported interacting with viral (Ma and Hearing, 2011; Perez-
Romero et al., 2005; Wohl and Hearing, 2008; Zhang and Imperiale, 2000), cellular proteins 
(Inturi et al., 2013, Paterson, 2010, Zhao, 2016) and other viral proteins (Ahi et al., 2013, 
Gustin et al., 1996, Singh et al., 2005, Said et al., 2018b, Tyler et al., 2007) to facilitate virus  
assembly. An earlier report suggested the involvement of IVa2 in genome packaging, activation 
of transcription from MLP, and virion stability (Christensen et al., 2012; Pardo-Mateos and 
Young 2004; Perez-Romero et al., 2006; Ostapchuk et al., 2005; Singh et al., 2005).  
The multifunctional role played by IVa2 suggests that IVa2 may interact with other viral\ 
cellular proteins. Earlier reports have suggested that adenovirus IVa2 interacts with 33K and 
DBP (Ahi et al., 2013), 52K (Gustin et al., 1996), and pVIII (Singh et al., 2005). Our initial 
attempts to purify and identify proteins interacting with pC.IVa2 by affinity tag purification of  
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Fig. 5.6 Analysis of IVa2 protein sequence by Coiled-Coil program. Graphic presentation 
of IVa2  amino acid sequence showing coiled coil region. b) Numeric value of coiled coil 
region of IVa2 sequence. 
 
 
 
 
 
 
 
 
 
	  
	  121 G        a  0.000        a  0.000        a  0.000 
  122 G        a  0.003        a  0.019        a  0.000 
  123 A        b  0.003        b  0.019        b  0.000 
  124 T        c  0.003        c  0.019        c  0.000 
  125 L        a  0.014        a  0.019        a  0.000 
  126 L        b  0.014        b  0.019        b  0.000 
  127 N        c  0.014        c  0.019        c  0.000 
  128 A        d  0.014        d  0.019        d  0.000 
  129 L        a  0.200        a  0.019        a  0.000 
  130 S        b  0.200        b  0.019        b  0.000 
  131 D        c  0.200        c  0.019        c  0.000 
  132 Y        d  0.200        d  0.019        d  0.000 
  133 N        e  0.200        e  0.019        e  0.000 
  134 Q        f  0.200         f  0.019         f  0.000 
  135 A        g  0.200        g  0.019        g  0.000 
  136 I         a  0.200         a  0.019        a  0.000 
  137 R        b  0.200        b  0.019        b  0.000 
  138 D        c  0.200        c  0.019        c  0.000 
  139 A        d  0.200        d  0.019        d  0.000 
  140 M        e  0.200        e  0.019        e  0.000 
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   a)                                                                                            b) 
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protein complexes from recombinant BAdV-3 infected cells were not successful as the 
insertion  of strep tag II in IVa2 proved lethal for the replication of recombinant BAdV-3s. 
However, the bimolecular fluorescence complementation (BiFC) assay indicated that BAdV-3 
IVa2 protein might be interacting with hexon, fiber, pVII, pVIII, 22K, 52K and pV. Earlier, 
analysis of proteins co-immunoprecipitated with pV by LC-MS/MS also indicated that IVa2 
interacts with pV (Zhao, 2016). The specific interaction between BAdV-3 IVa2 and pV was 
confirmed by co-immunoprecipitation and BAdV-3 infected cells. Earlier observations in 
human adenovirus have speculated that IVa2 may indirectly interact with pV via other viral 
proteins (Ahi et al., 2015; Zhang and Arcos, 2005). The Co-immunoprecipitation analysis in 
plasmid DNA transfected cells confirms that BAdV-3 IVa2 interacts directly with pV protein. 
Analysis of mutant IVa2 proteins suggested that amino acids121-140 of BAdV-3 IVa2 
interact with pV. Interestingly, analysis of BAdV-3 IVa2 amino acid sequence identified a 
coiled-coil region (Lupas et al., 1991) located between amino acids 129 to 142, which acts as a 
protein-protein interaction motif that holds proteins together (Ali et al., 2007). However, the 
function of IVa2-pV interaction in the production of progeny adenovirus virions is not clear.  
DNA binding studies have suggested that binding of pV to DNA still leaves several 
regions of pV accessible for interaction with other adenoviral proteins (Perez-Vargas et al., 
2014).  
In fact, studies have suggested that pV interacts with pVI and pVII, which helps to act as a 
bridge between viral capsid and core (Perez-Vargas et al., 2014). We hypothesize that the 
interaction of IVa2 with pV further helps to stabilize the bridge between viral core and capsid. 
The stability of mature adenovirus virion requires interactions between different adenoviral 
capsid proteins (Reddy and Nemerow, 2014).  The BAdV-3 pV is essential for the production 
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of infectious progeny virion (Zhao and Tkoo, 2016) as the deletion of pV results in the 
production of progeny virions with fragile capsids (Zhao and Tikoo 2016). Given the 
significant role of pV in BAdV-3 life cycle, the interaction of pV and IVa2 could possibly 
contribute to linking the core with capsid structure or increasing the stability of the capsid 
structure.   
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6.0   TRANSITION FROM CHATER 5 TO 7 
Using a bimolecular fluorescent complementation assay, we found some late adenoviral 
proteins, including pV that interact with IVa2. Interaction of BAdV-3 IVa2 with pV confirmed 
in the context of infection and transfection using co-immunoprecipitation assay. Amino acid 
121-140 of IVa2 found to be responsible for its interaction with PV. A recent report on pV of 
BAdV-3 indicates that the viral protein found to be essential for the virus life cycle (Zhao and 
Tikoo 2016). Proteins involve viral-viral or viral-cellular protein-protein interaction during the 
course of virus infection to carry out their duty. In the following section, we demonstrate the 
role of IVa2 in the BAdV-3 life cycle. 	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7. BOVINE ADENOVIRUS-3 IVA2 IS ESSENTIAL FOR VIRAL REPLICATION  
 
7.1 Introduction 
Adenovirus contains double-stranded DNA genome (26-48 kbp) surrounded by a non- 
enveloped capsid (Harrach, 2014). The transcription of adenoviral mRNA is temporally 
regulated as early, intermediate, and late transcripts, which encode 23-46 proteins depending on 
the characteristics of an adenovirus genus (Ghebremedhin, 2014). Depending upon their 
function in the production of progeny adenovirus, these proteins designated as capsid protein 
(structural proteins, core proteins) and non-capsid proteins (non-structural proteins) (Kallsten et 
al., 2017). The capsids of members of genus Mastadenovirus contain thirteen proteins including 
major capsid proteins (penton, hexon, fiber), minor capsid proteins (IX, VI, IIIa, VIII,) and core 
proteins (Mu, V, TP, VII, IVa2, cysteine protease) (Russell, 2009; Vellinga et al., 2005). 
Earlier reports suggest that human adenovirus -5 (HAdV-5) protein IVa2 detected as a 50 kDa 
and 40 kDa proteins in infected cells (Pardo-Mateos and Young, 2004). Each purified virion 
contains 6-8 copies of IVa2 (Christensen et al., 2008). Protein IVa2 appears involved in the 
transcriptional activation of the adenovirus major late promoter and in adenovirus genome 
packaging (Lutz and Kedinger, 1996; Ostapchuk et al., 2011). 
Bovine adenovirus-3 (BAdV-3), a member of genus Mastadenovirus, contains a double-
stranded DNA genome of 34446 bps long, which encodes structural proteins, non -structural 
proteins and core proteins (Reddy et al., 1998). The core proteins of adenovirus attach to the 
genome and act as a bridge between viral core, including genome and viral capsid. Earlier, 
reports have shown that BAdV-3 core protein pVII is expressed as 26 kDa and 24 kDa proteins 
and localizes to mitochondria altering mitochondrial functions (Anand et al., 2014). Rec
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we detected a 55 kDa  BAdV-3 core protein,  pV in purified virions, which appears to be 
essential for the replication of BAdV-3 (Zhao and Tikoo, 2016). In addition, nucleolar 
localization of BAdV-3 pV appears essential for the replication of BAdV-3 (Zhao, 2016). 
            The intermediate region of BAdV-3 encodes minor core protein IVa2 of 376 amino 
acids, which show 29-69% amino acid identity to IVa2 proteins encoded by other adenoviruses 
(Baxi et al., 1998; Reddy et al., 1998). Earlier, we demonstrated that BAdV-3 IVa2 is a) 
expressed as 50 kDa protein in BAdV-3 infected cells, b) localized to the nucleus and nucleolus 
of BAdV-3 infected cells, and c) interacts with importin α-1 and BAdV-3 pV protein. Here, 
we demonstrate that BAdV-3 IVa2 appears essential for the replication of BAdV-3.  
 
7.2 Materials and Methods 
 
7.2.1 Cell lines and Viruses 
Madin-Darby bovine kidney (MDBK) (ATCC CCL22), cotton rat lung (CRL) (Papp, et al., 
1997), and CRL.IVa2 (CRL cells expressing BAdV-3 IVa2; in this study) cells were 
propagated at 37°C in minimal essential medium (MEM; Sigma) with 5% CO2. The HEK 293T 
cells cultured using Dulbecco's modified minimal essential medium (DMEM; Sigma). All the 
cell lines supplemented with heat-inactivated 10% fetal bovine serum (FBS; SAFC industries, 
Sigma), 0.1mM nonessential amino acids (NEAA; Gibco), and 10mM HEPES (Gibco) and 50 
ug/ml gentamicin (Bio Basics). Wild type and recombinant BAdV-3 propagated, as described 
previously (Reddy et al., 1998). 
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7.2.2 Antibodies 
Anti gstIVa2 antisera described in section 3.3.2, Cy3 conjugated goat-anti rabbit antibody 
(#111-165-003) and alkaline phosphatase-conjugated goat anti-Rabbit (111-055-003) 
antibodies bought from Jackson Immune Research. 
 
7.2.3 Plasmid construction 
Plasmids were constructed using standard molecular techniques as described earlier 
(Sambrook and. Russell, 2000). 
pTrip-IVa2-Puro.  A 1371 bp XhoI-BamHI DNA fragment of plasmid pDR-IVa2 (Appendix 1) 
was ligated to XhoI-BamHI digested plasmid pTrip-CMV-Puro (a gift from Dr R. Brownlie) 
creating a plasmid pTrip-IVa2 Puro. 
pMCS.3821. Initially, a 7162 bp AarI DNA fragment containing IVa2 coding sequence was 
isolated by digestion of plasmid pUC304a+ (Du & Tikoo., 2010) DNA with AarI.  Finally, a 
3821 bp SphI-SacII DNA fragment (containing IVa2 coding sequence flanked by 1463 bps and 
1022 bp) of 7162 bp DNA fragment was isolated and ligated to SphI - SacII digested plasmid 
pMCS (Thanbichler et al., 2007) DNA creating a plasmid pMCS.3821. 
pMCS3821.dIVA2SbfI. Using SphI FP and IRPΔIVa2 primers (Table 3, Appendix 3), and 
plasmid pMCS.3821 DNA as a template, a 1501 bp DNA fragment (P1) was amplified by PCR. 
Similarly, using primers IFPΔIVa2 and SacII RP (Table 3, Appendix 3), and plasmid pMCS-
3821 DNA as a template, a 1286 bp DNA fragment (P2) was amplified by PCR.The P1 and P2 
DNA fragments were annealed and a, 2635 bp DNA fragment was amplified by PCR using 
SphI FP and SacII RP as primers (Table 3, Appendix 3). The 2635 bp DNA fragment was 
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digested with SphI -SacII and ligated to SphI-SacII digested plasmid pMCS DNA creating 
plasmid pMCS3821.dIVA2SbfI (SbfI restriction site introduced in deleted region of IVa2). 
pUC304a.dIVa2SbfI. A 1240 bp SbfI DNA fragment of plasmid pUC4K (Taylor and Rose, 
1988) containing Kanamycin resistant gene was isolated and ligated to SbfI linearized plasmid 
pMCS.3821.dIVa2SbfI DNA creating plasmid pMCS.3821.dIVa2Kan.  
Homologous recombination in Escherichia coli BJ5183 (Chartier et al., 1996) between 3860 
bp  SphI - SacII DNA fragment of plasmid pMCS.3821dIVA2Kan and pUC304a+  DNA 
resulted in creating plasmid pUC304a.dIVA2Kan which could grow in LB plates containing 
ampicillin and kanamycin.  The plasmid pUC304a.dIVa2Kan was digested with SbfI and large 
fragment was religated resulting in creating plasmid pUC304a.dIVA 2SbfI (plasmid 
pUC304a+ containing unique SbfI site in place of deleted region of IVa2), which could only 
grow in LB plates containing ampicillin. 
pUC304a.IVa2s. Using primers SphI FP and IRP STC (Table 3, Appendix 3), and plasmid 
pMCS.3821 DNA as a template, a 2808 bp DNA fragment (P1) was amplified by PCR. 
Similarly, using primers IFPSTC and SacII RP (Table 3, Appendix 3), and plasmid pMCS-
3821 DNA as a template, a 1080 bp DNA fragment  (P2) amplified by PCR. The P1 and P2 
DNA fragments were annealed and a 3836 bp DNA fragment was amplified by PCR using 
SphI FP and SacII RP as primers (Table 3, Appendix 3). The 3836 bp DNA fragment was 
digested by SphI-SacI and ligated to SphI-SacII digested plasmid pMCS.3821 DNA creating 
plasmid pMCS.3821.SIVa2 (pMCS.3821 containing stop codon within IVa2). 
Escherichia coli BJ5183 based homologous recombination between 3821 bp SphI-SacII 
fragment of plasmid pMCS-SCIVA2 and SbfI linearized plasmid pUC304a.dIVa2SbfI DNA 
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resulted in isolating plasmid pUC304a.IVa2s (pUC304a+ containing stop codon within IVa2 
sequence). 
pMCSloxpIVa2.448. Using primers SphI FP and IRP loxp448 (Table 3, Appendix 3), and 
plasmid pMCS.3821 DNA as a template, a 1508 bp DNA fragment (P1) was amplified by PCR. 
Similarly, using primers IFPloxp448 and SacII RP (Table 3, Appendix 3), and plasmid 
pMCS.3821 DNA as a template, a 2134 bp DNA fragment (P2) was amplified by PCR. The P1 
and P2 DNA fragments were annealed and a 3606 DNA fragment was amplified by PCR using 
primers SphI FP and SacII RP (Table 3, Appendix 3). The 3606 DNA fragment was digested 
with SphI-SacII and ligated to SphI-SacII digested plasmid pMCS DNA creating plasmid 
pMCSloxpIVa2.448 (loxP sequence introduced at the end of IVa2). 
pUCK304A.loxPIVa2. Using primers SphI FP and IRP loxp79 (Table 3, Appendix 3), and 
plasmid pMCS-loxpIVa2 448 DNA as a template, a 2591 bp DNA fragment (P1) was amplified 
by PCR. Similarly, using primers IFPloxp79 and SacII RP (Table 3, Appendix 3), and plasmid 
pMCS-loxpIVa2448 DNA as a template, a 1292 bp DNA fragment (P2) was amplified by PCR. 
The P1 and P2 DNA fragments were annealed and a 3915 bp DNA fragment was amplified by 
PCR using SphI FP and SacII RP as primers (Table 3, Appendix 3). The 3915 bp DNA 
fragment was digested bu SphI-SacII and ligated to SphI-SacII digested plasmid pMCS creating 
plasmid pMCS.3821loxpIVa2 (loxP flanked non polymerase overlapping IVa2). 
Escherichia coli BJ5183 based homologous recombination between 3900 bp SphI-SacII 
fragment of plasmid pMCS.3821loxpIVa2 and SbfI linearized plasmid pUC304a.dIVa2SbfI 
DNA resulted in isolation of plasmid pUC304a.loxPIVa2 (pUCK304a+ containing loxP 
flanked IVa2). 
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7.2.4 Transfection 
The transfection of the cells with plasmid DNA was performed as described in 3.2.6. 
 
7.2.5 Transient complementation of IVa2 deleted BAdV-3 genomic clone 
For the complementation assay, VIDO DT1 cells were co-transfected using plasmids 
pC.IVa2 and pUC304a.dIVA2 DNAs or plasmids pCDNA3 and pUC304a.dIVa2 DNAs. After 
5 hrs post transfection, the media was replaced with MEM supplemented with 2% FBS. The 
co-transfected cells were monitored under the fluorescent microscope for the appearance of 
green fluorescent protein (GFP) positive cells/foci. At day 3 and day 10-post transfection, the 
GFP positive cells/foci per well were counted. Fluorescent focus units (FFUs) per field were 
taken from average number of GFP positive cell foci from three independent co-transfection 
experiments. 
 
7.2.6 Generation of BAdV-3 IVa2 expressing cell line 
For the generation of a cell line stably expressing IVa2, second-generation lentivirus system 
used as described in  (Du and Tikoo, 2010). Briefly, HEK293T cells grown to 70-80% 
confluency in 100mm dish were co-transfected with plasmid pTrip-IVa2-Puro expressing IVa2, 
plasmid pMD2.G expressing vesicular stomatitis virus G protein and plasmid pSPAX 
expressing human immunodeficiency virus Gag/Pol proteins. Briefly, the plasmids were diluted 
with water up to a total volume of 0.5mL followed by the addition of 0.5ml 2x HEPES buffer 
saline (HBS). Finally, 50µl 2.5M CaCl2 added, the mixture was shaken and kept at room 
temperature for 30 min. After half an hour incubation, the DNA mixture added in a drop wise 
manner on to the surface of HEK293T cells. The medium replaced after 16 hrs. After 48 hrs of 
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incubation, the medium was collected, centrifuged briefly to remove gross materials and 
filtered with 0.45-micron filter. After centrifugation at 25000 RPM for 2hrs, the pellet 
containing lentivirus particles (designated Trip.IVa2) reconstituted with 1 ml of sterile water 
and lentivirus concentration was measured using Lenti-X GoStix Kits (Clontech).  
Finally, CRL cells transduced with lentivirus Trip.IVa2 expressing BAdV-3 IVa2 in the 
presence of 10ug/mL polybrene (Sigma). After 24 hrs post-transduction, the media replaced 
with MEM containing 5% fetal bovine serum and 10ug/mL of puromycin (Gibco). After 10-15 
days post-transduction, the puromycin resistant clones were picked, expanded in media 
containing puromycin, and tested for the expression of IVa2. 
 
7.2.7 Isolation of Cre recombinase expressing cell line 
For isolation of Cre recombinase expressing cell line, a second-generation lentivirus system 
used as described  in (Du and Tikoo, 2010). Initially, lentivirus Trip.Cre was isolated as 
described above, using plasmid pCre-IRES-PuroR DNA (addgene # 30205). The CRL cells 
transduced with lentivirus Trip.Cre and grown in the presence of puromycin. The puromycin 
resistant CRL clones isolated after the transduction of CRL cells with lentivirus Trip.Cre 
analyzed for the expression of Cre recombinase.  
 
7.2.8 Isolation of recombinant BAdV-3 
The recombinant BAdV-3s were isolated using plasmid DNA transfection of cells, as 
described in section 3.2.7.  
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7.2.9 Western blotting 
Proteins from the cell lysates of IVa2 expressing cell lines were separated by 12 % SDS-
PAGE, transferred to nitrocellulose and analyzed by Western blot using IVa2gst sera as 
described in section 3.2.8.   
 
7.2.10 Immunofluorescence assay 
Immunofluorescence assays were performed as described in section 3.2.9. 
 
7.2.11 Transmission electron microscopy 
Monolayers of CRL cells in 6 well plates were either infected with BAV304a at MOI of 5 or 
transfected with 5ug of plasmid pUC304a.dIVa2 DNA. Two or ten days post-infection or 
transfection, respectively, the cells were rinsed with ice-cold PBS, fixed using cold 2.5% 
glutaraldehyde containing 0.1M cacodylate buffer at 40C . After 5 hrs of fixation, the cells were 
harvested, centrifuged at 1500 RPM, and suspended in 1% osmium tetroxide (OsO4).  
Subsequent to dehydration in a graded ethanol series and propylene oxide, sample embedded 
using propylene oxide and Epon-812 (Sigma), and polymerized at 600C for 24 hrs. Finally, the 
ultrathin section were obtained with Reichert ultra cut-ultramicrotome, counterstained with 
alkaline lead citrate, and observed under Philips CM10 transmission electron microscope 
(TEM).  
 
7.3 Results 
 
7.3.1 Isolation of mutant BAV304.dIVa2 \ BAV304.IVa2s  
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To determine the role of IVa2 in BAdV-3 lifecycle, initially we constructed a plasmid 
pUC304a.dIVa2 (Fig. 7.1a) containing full-length BAV304a genomic DNA with deletion of 
non polymerase overlapping region of IVa2 (amino acid 81-448). VIDO DT1 (Du and Tikoo, 
2010) cells transfected with either plasmid pUC304a.dIVa2 DNA or plasmid pUC304a+ DNA 
observed for the development of cytopathic effects. Although cells transfected with plasmid 
pUC304a+ DNA showed expression of EYFP and developed cytopathic effects in 7 days post 
transfection, repeated transfection of cells with plasmid pUC304a.dIVa2 DNA did show 
expression of EYFP without showing development of any cytopathic effect even 25 days post 
transfection (Fig. 7.1b). 
Next, we constructed a plasmid pUC304a.IVa2s (Fig. 7.1a) containing full-length BAV304a 
genomic DNA with insertion of stop codon after 12 amino acids of IVa2 without affecting the 
amino acid sequence of DNA polymerase. However, repeated transfection of VIDO DT1 cells 
with 5 ug of plasmid pUC304a.IVa2s DNA did show expression of EYFP without showing the 
development of any detectable cytopathic effects after 25 days post transfection (Fig. 7.1b). 
 
7.3.2 Transient complementation of BAV304.dIVa2  
To determine if IVa2 can complement the defect of BAV304a.dIVa2, VIDO DT1 cells were 
co-transfected using plasmids pC.IVa2 and pUC304a.dIVa2 DNAs or plasmids pCDNA3 and 
pUC304a.dIVa2 DNAs. As expected, co-transfection of VIDO DT1 cells with plasmid 
pCDNA3 and pUC304a.dIVa2 DNAs did not produce progeny virus as indicated by the 
absence of increase of foci of fluorescent cells from 3 day to 10 day post transfection (Fig. 7.2). 
In contrast, co-transfection of VIDO DT1 cells with plasmids pC. IVa2 and pUC304a.dIVa2  
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     Fig. 7.1 Isolation mutant BAdV-3s. (a) Schematics of BAdV-3  DNA sequence showing 
introduction of   stop codon as well as deletion of non-polymerase overlapping regions of IVa2 
without affecting the polymerase (pol). Arrows show the direction of transcription of pol and IVa2 
from the complementary DNA strand. (b). Schematic diagram of plasmid DNAs. The name of the 
plasmids is depicted on the right of the panel. The name of the recombinant BAdV-3 is depicted on 
the left of the panel. The BAdV-3 sequence is represented by open box. The thin line represents 
deleted region (E3). The arrow show the direction of transcription. Human cytomegalovirus (CMV) 
immediate early promoter; Enhanced yellow fluorescent protein (EYFP). (c) Direct Fluorescence. 
Monolayers of VIDO DT1 cells were transfected with indicated plasmid DNA and visualized for 
EYFP expression and development of cytopathic effects using fluorescent microscope TCS SP5 
(Leica). Direct fluorescence (DF). (c,d) Amino acid sequence of IVa2 and polymerase protein. The 
substituted nucleotides are underlined. 
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DNAs produced progeny virus as indicated by significant increase in the number of foci of 
fluorescent cells from 3 day to 10 day post transfection (Fig. 7.2).   
 
7.3.3 Generation of IVa2 expressing cell line 
 To construct a stable cell line expressing BAdV-3 IVa2 protein, the lentivirus TRIP.IVa2  
was constructed (Du and Tikoo, 2010) and used to transduce CRL cells in the presence of 
10ug/ml of polybrene (Zhao and Tikoo, 2016). The transduced cells were grown in the 
presence of 10ug/mL of puromycin (Gibco). The puromycin resistant clones were further 
propagated and analyzed for the expression of IVa2. 
First, Western blotting assay used to detect the expression of IVa2 in CRL.IVa2 cell line. As 
seen in Fig. 7.3a, IVa2gst sera detected a protein of 50 kDa in BAdV-3 infected cells (lane 1). 
Similarly, IVa2gst sera detected a protein of 50 kDa in CRL.IVa2 cells (Fig. 7.3a, lane 2). No 
such protein could be detected in CRL cells (Fig. 7.3a, lane 3). Secondly, indirect 
immunofluorescence used to determine the localization of recombinant IVa2 in CRL.IVa2 
cells. As seen in Fig.7.3b, IVa2 localized to nucleus\nucleolus of the cells infected with BAdV-
3 (panels, a1-a3). Similarly, recombinant IVa2 localized to both nucleus and nucleolus of IVa2 
expressing CRL.IVa2 cells (panels b1-b3) No such protein could be detected in the 
nucleus\nucleolus of CRL cells (panels, c1-c3). 
 
7.3.4 Isolation of mutant BAdV-3 in CRL.IVa2 cells 
To isolate mutant BAdV-3, CRL.IVa2 cells were transfected with individual plasmid DNAs 
and observed for the expression of GFP and the development of cytopathic effects. As seen in 
Fig. 7.4 CRL.IVa2 cells transfected with plasmid pUC304a+ (panel a), pUC304a.dIVa2 (panel 
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Fig. 7.2 Marker rescue. (a). Schematic diagram of plasmid DNAs. The name of the plasmids is 
depicted on the right of the panel. The name of the recombinant BAdV-3 is depicted on the left of 
the panel. The BAdV-3 sequence is represented by filled box. The thin line represents deleted 
region (E3). The arrow show the direction of transcription. Cytomegalovirus (CMV) immediate 
early promoter; Enhanced yellow fluorescent protein (EYFP). (b). Complementation of 
pUC304a.dIVa2 genome. VIDO DT1 cells were co-transfected with indicated plasmid DNAs and 
the fluorescent foci forming units were counted at indicated times post transfection. The number 
on X axis denote the days post transfection. The results depict the average of three experiments. 
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Fig. 7.3 Isolation of BAdV-3 expressing cell line (CRL.IVa2). (a) Western blot. Proteins from the 
lysates of BAdV-3 infected cells (lane 1), CRL.IVa2 cells (lane2) or CRL cells (lane 3) were 
separated by 12 % SDS-PAGE, transferred to nitrocellulose membrane and analyzed by Western 
blot using IVa2gst serum and alkaline phosphatase conjugated goat-anti rabbit serum. The position 
of the molecular weights in kDa is shown on the right. Molecular weight markers (M). (b). Indirect 
immunofluorescence. The BAdV-3 infected CRL cells (panels a1-a3), mock infected CRL.IVa2 
cells (panels, b1-b3) or mock infected CRL cells (panels, c1-c3) were visualized by indirect 
immunofluorescence using IVa2gst serum and  Cy3 conjugated goat anti-rabbit serum (panels, 
a1,b1,c1). The nuclei were stained with DAPI (panels, a2, b2, c2).A merge of the images is shown 
in panels, a3, b3 and c3. 
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b) or pUC304a.IVa2s (panel c) DNA showed expression of GFP in 15 days post-transfection. 
As expected, an increase in the intensity of GFP along with detectable development of 
cytopathic effects could be observed in cells transfected with plasmid pUC304a+ (panel a1) 
DNA. In contrast, though, the intensity of GFP expression increased in the cells transfected 
with plasmid pUC304a.dIVa2 (panel b1) or pUC304a+IVa2s (panel c1) DNAs, no typical 
cytopathic, could be observed in transfected cells. 
To determine if transfection of CRL.IVa2 cells with plasmid pUC304a.dIVa2 DNA or 
plasmid pUC304a.IVa2s DNA leads to the formation of BAdV-3 particles, transfected cells 
analyzed by transmission electron microscopy (TEM). Monolayers of CRL.IVa2 cells were 
transfected with individual plasmid DNA or infected with BAV304a at MOI of 2. Two days 
and fifteen days post-infection and transfection, respectively, the cells were collected and 
processed for TEM. As seen in fig. Fig. 7.4, the appearance of uniform icosahedral virus 
particles could be observed in CRL.IVa2 cells (panel a2) infected with BAdV-3. No such 
particles could be detected in CRL.IVa2 cells transfected with plasmid pUC304a.dIVa2 DNA 
(panel b2) or plasmid pUC304a.IVa2s DNA (panel c2).  
Moreover, the analysis of virus-infected cells by electron microscope detected progeny 
virions in the cells transfected with plasmid pUC304a+ DNA (panel a). No such virions could 
be detected in the cells transfected with plasmid pUC304a.dIVa2 (Fig. 7.4, panel b) DNA or 
plasmid pUC304a.IVa2s (Fig. 7.4, panel c) DNA. 
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Fig. 7.4 Isolation of mutant BAdV-3 in CRL.IVa2 cells. (a,b). Schematic diagram of plasmid 
DNAs. The name of the plasmids is depicted. The BAdV-3 sequence is represented by filled box. 
The V marked thin represents deleted region. The amino acid numbers of IVa2 are indicated in 
panel c. The arrow show the direction of transcription. Human cytomegalovirus (CMV) immediate 
early promoter; Enhanced yellow fluorescent protein (EYFP). Ampicillin (Amp). (a1, b1) Direct 
Fluorescence. Monolayers of CRL.IVa2 cells were transfected with indicated plasmid DNA and 
visualized for EYFP expression and development of cytopathic effects using fluorescent 
microscope TCS SP5 (Leica). (a2, b2) Electron microscopic analysis. CRL.IVa2 cells transfected 
with plasmid pUC304a+ (panel a2) DNA or plasmid pUC304a.dIVa2 (panel b2) DNA are shown at 
a magnification of X100000 Transmission electron microscopy (TEM). 
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Fig. 7.4 Isolation of mutant BAdV-3 in CRL.IVa2 cells. (a,c). Schematic diagram of plasmid 
DNAs. The name of the plasmids is depicted. The BAdV-3 sequence is represented by filled box. 
The V marked thin lines represents deleted region. The amino acid numbers of IVa2 are indicated 
in panel c. The arrow show the direction of transcription. Human cytomegalovirus (CMV) 
immediate early promoter; Enhanced yellow fluorescent protein (EYFP). Ampicillin (Amp). 
(a1,c1) Direct Fluorescence. Monolayers of CRL.IVa2 cells were transfected with indicated 
plasmid DNA and visualized for EYFP expression and development of cytopathic effects using 
fluorescent microscope TCS SP5 (Leica). (a2,c2) Electron microscopic analysis. CRL.IVa2 cells 
transfected with plasmid pUC304a+ (panel a2) DNA, plasmid or plasmid pUC304a.IVa2s (panel 
c2) DNA are shown at a magnification of X100000. Transmission electron microscopy (TEM). 
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7.3.5 Generation of Cre expressing cell line 
 To obtain a cell line expressing Cre recombinase, CRL cells were transduced with lentivirus 
Trip.Cre expressing Cre recombinase and grown in the media containing puromycin. After 12 
days, puromycin resistant clones were analyzed for the expression of Cre recombinase by  
visualizing the Cre recombinase-dependent inducible expression of GFP in puromycin resistant 
cells transfected with plasmid pCALNL-GFP DNA expressing GFP Orf containing a 
transcription stop  flanked by loxP sequence. As seen in Fig. 7.5, no GFP could be detected in 
mock-transfected CRL cells  (panel a1-a3). Similarly, no GFP expression could be detected in 
CRL cell transfected with plasmid pCALNL-GFP DNA (panels, b1-b3). In contrast, expression 
of GFP could be detected in CRL.Cre cells transfected with plasmid pCALNL-GFP DNA 
(panels, c1-c3). 
 
7.3.6 Isolation of recombinant BAdV-3 expressing loxP flanked IVa2 
Since we could not isolate mutant BAdV-3 containing a deletion of IVa2 in CRL.IVa2 cells, 
we attempted to conditionally knock out IVa2 in BAdV-3 using the Cre-loxP system 
(Ostapchuk et al., 2017; Sengupta et al., 2017). Since N-terminus 79 amino acid of BAdV-3 
IVa2 overlap with the C-terminus region of the polymerase protein, we constructed a plasmid 
pUC304a.loxPIVa2 by inserting loxP sequence (34 bp) in- frame after BAdV-3 IVa2 amino 
acid 79 and 448 amino acids (Fig. 7.6a).  
To isolate recombinant BAdV304a containing insertion of loxP sequences in IVa2, CRL 
cells transfected with Pac I digested plasmid pUC304a.loxPIVa2 DNA using lipofectamine 
2000 reagent and observed for the expression of EYFP and development of cytopathic effect.  
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Fig. 7.5 Isolation of cre expressing cell line (CRL.Cre).  Direct fluorescence. Monolayers of 
CRL cells mock-transfected (a1-a3) or transfected with pCALNL-GFP (GFP expressing plasmid 
whose Orf contains a transcription stop flanked by loxP sequence) (b1-b3). Similarly, monolayers 
of CRL.Cre cells (c1-c3) transfected with pCALNL-GFP. After 36 hrs of transfection, cells 
processed and observed for the expression of GFP using fluorescent microscope TCS SP5 (Leica).   
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Although EYFP expressing cells observed after 3 days (Fig. 7.6b), repeated transfection did 
not induce the development of cytopathic effects in 22 days post-transfection (Fig. 7.6b). 
 
7.4. Discussion 
Viral proteins are involved in different steps of the viral replication cycle leading to the 
production of progeny virions. Though most viral genomes encode proteins which appear 
essential for the efficient virus replication (den Boon et al., 2010; Le Rouzic and Benichou, 
2005; Moss, 2013; Narayanan et al., 2003), viral genomes also encode proteins, which are not 
essentialfor the efficient replication of  virus (Van Vliet et al., 2009). 
Like other viruses, the adenovirus genome also encodes proteins that are non-essential or 
essential for efficient replication of the virus (Reddy et al., 2000; Saha et al., 2014; 
Zakhartchouk et al., 1998; Zhou and Tikoo, 2001).	  
Earlier, we demonstrated that core protein pV appears to be essential for the production of 
infectious BAdV-3 virion (Zhao and Tikoo, 2016). Here, we report that protein IVa2 appears to 
be critical for the replication of BAdV-3. 
Several lines of evidences support that IVa2 is essential for the replication of BAdV-3. First, 
viable infectious mutant BAdV-3 containing an insertion of an in-frame stop codon or partial 
deletion of IVa2 could not be isolated in non-complementing CRL cells. Second, no capsid 
formation could be observed in the cells transfected with plasmid pUC304a.dIVa2 DNA or 
plasmid pUC304a.IVa2s DNA by TEM. Thirdly, providing IVa2 in-trans (in the cells co-
transfected with plasmid pUC304a.dIVa2 DNA and plasmid pC.IVA2 DNA) produced viable 
mutant BAdV-3.  
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While CRL cells expressing IVa2 (CRL.IVa2) could be isolated, the use of CRL.IVa2 cells 
did not lead to the isolation of BAV304a.dIVa2 (IVa2 deleted BAdV-3). It is possible that 
plasmid pUC304a.dIVa2 contains a mutation in addition to the deletion of IVa2. However, in 
the complementation assay, viable BAV304a.dIVa2 could be isolated by providing IVa2 in 
trans. Alternativly, it is possible that the level of IVa2 expressed in CRL.IVa2 is not enough to 
complement the defect of IVa2 expression in BAV304a.dIVa2. Earlier reports also have 
concluded that the amount of IVa2 is critical for efficient replication of BAdV-3 (Zhang and 
Imperiale, 2003). However, the failure of the CRL.IVa2 cells to complement the IVa2 defect of 
BAV304a.dIVa2 due to the lack of proper folding or absence of any translational modification 
of IVa2 could not be ruled out. 
An earlier report indicated that the substitution of a single amino acid from lysine to arginine 
or alanine of IVa2 proved lethal for replication of HAdV-5 (Pardo-Mateos and Young, 2004). 
Insertion of 8 amino acid Strep II tag between amino acids 146-147, 242-243, and after amino 
acid 448 of IVa2 proved lethal for the replication of BAdV-3 (Chapter 5). Similarly, the 
addition of loxP sequences between amino acid 373-374 and after amino acid 448 (Chapter 3) 
and between amino acids 79-80 and after amino acids 448 of BAdV-3 IVa2 also proved lethal 
for the replication of BAdV-3. Our results confirm earlier observations that adenovirus protein 
IVa2 appears sensitive to minor insertions or deletions of amino acids (Pardo-Mateos and 
Young, 2004; Zhang and Imperiale, 2003). 
Cre-Lox technology is an important tool for editing genes and studying protein function 
(Sengupta et al., 2017). It has been employed to analayze the role of viral protein in a virus life 
cycle (Ostapchuk et al., 2017). Despite the successful generation of CRL.Cre cell line (Cre-
expressing cells), the rescue of recombinant BAdV-3 containing a deletion of IVa2 was not  
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Fig. 7.6 Isolation of recombinant BAdV-3 expressing loxP flanked IVa2. (a) Schematic diagram 
of plasmid DNAs. The name of the plasmids is depicted on the right of the panel. The BAdV-3 
sequence is represented by filled box. The thin line represents deleted region. The amino acids 
numbers of IVa2 are indicated. The arrow show the direction of transcription. Human 
cytomegalovirus (CMV) immediate early promoter; Enhanced yellow fluorescent protein (EYFP). 
Ampicillin (Amp). (b) Direct Fluorescence. Monolayers of CRL cells were transfected indicated 
plasmid DNA after digested with Pac I and visualized for EYFP expression and development of 
cytopathic effects at indicated days post transfection using fluorescent microscope TCS SP5 
(Leica). 
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possible as BAV304a.IVa2loxP (IVa2 containing an insertion of loxP sequence) could not be 
isolated in CRL cells. 
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8.0 GENERAL DISCUSSION 
About 32% of the total clinical trials for gene delivery currently conducted around the world 
are using adenovirus vectors (Goswami et al., 2019). Interestingly, human adenoviruses are 
used widely as a viral vector for both vaccinations as well as gene therapy (Wold et al., 2013). 
Despite the greater share of human adenoviruses as a viral vector, there are limitations 
associated with their use (Appaiahgari et al., 2015). To overcome  limitations associated with 
the use of human adenoviral vectors, non-human adenoviral vectors are considered as potential 
alternatives (Bangari and Mittal 2006; Lopez-Gordo et al., 2014). More importantly, there is a 
need to make use of species-specific adenoviruses as a viral vector for veterinary vaccination 
where cost and maintenance of cold chains are some of the limiting factors for the currently 
used veterinary vaccines (Ayalew et al., 2015; Baron et al., 2018; Ndi et al., 2013).  
Earlier reports on the use of bovine adenovirus-3 (BAdV-3) as a viral vector have 
demonstrated the potential of the BAdV-3 as a viral vector for animal vaccination (reviewed in 
Ayalew et al., 2015). However, the development of improved BAdV-3 vectors needs more 
detailed knowledge about the structure and function of BAdV-3 proteins. Earlier, analysis of 
the intermediate region of BAdV-3 predicted to encode protein pIX and IVa2. The objective of 
this work was to portray BAdV-3 IVa2, identify the interaction of IVa2 with other viral 
proteins, and determine the role of the IVa2 protein in BAdV-3 life cycle. 
Many viral proteins synthesized in the cytoplasm localize to the nucleus and \or nucleolus to 
perform their function in the production of progeny virus, including in viral mRNA 
transcription, capsid formation, and genome encapsidation (Li et al., 2019). Antiserum raised in 
rabbits against GST-IVa2 fusion protein detected a protein of 50 kDa in plasmid DNA 
transfected cells and BAdV-3 infected cells, which localized to nucleus\nucleolus. Sub cellular 
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localization of IVa2 in transfected cells suggested that other viral proteins are not involved in 
the nuclear\nucleolar localization of IVa2. Deletion analysis identified amino acids 4-18 and 
amino acids 373-448 to be involved in the nuclear and the nucleolar localization of the IVa2 
protein, respectively suggesting that IVa2 contains non-overlapping NLS\NoLS. Like other 
BAdV-3 proteins (Ayalew et al., 2014; Kulshrestha et al., 2014; Makadiya et al., 2015; 
Paterson, 2012; Said et al., 2018; Zhao, 2016) IVa2 also utilizes importin α\β transport pathway 
preferentially using importin α-1 as a nuclear receptor for transport to the nucleus.   
Earlier, it was demonstrated that ribosomal RNA processing is affected at late times post 
BAdV-3 infection (Paterson, 2010). Ribosomal RNA processing occurs in the nucleolus 
(Boisvert et al., 2007). We speculate that like BAdV-3 pV (Zhao, 2016), nucleolar IVa2 may be 
involved in modulating ribosomal RNA processing. Further work should prove or disprove our 
speculation. 
Earlier reports have demonstrated that nuclear (Brock et al., 2013) or nucleolar (Zhao, 2016) 
localization of a protein is required for efficient viral replication. Although substitution of a 
cluster of basic residues 6RRK8 showed no significant effect on the localization of IVa2 to 
nucleus\nucleolus and BAdV-3 replication, it will be interesting to determine the importance of 
other residues of NLS and NoLs(s) in BAdV-3 replication by creating and evaluating 
recombinant BAdV-3 expressing IVa2 containing substitutions\mutations in NLS\NoLs. 
A better understanding of basic virology is crucial to exploit viruses for different 
applications, including using as vaccine delivery vehicles (Enquist, 2009). Although 
adenoviruses encode 23 to 46 proteins, the various functions performed by each protein require 
protein-protein interactions (Arnberg, 2012; Gustin et al., 1996; Matthews and Russell, 1994; 
Ostapchuk et al., 2005). Earlier report regarding mass spectrophotometry analysis of purified 
	   136	  
proteins from BAdV-3 infected cells detected interaction of BAdV-3 pV with IVa2. We 
confirmed the interaction of BAdV-3 IVa2 with pV using different assays in plasmid DNA 
transfected cells and BAdV-3 infected cells. Recently, it has been shown that BAdV-3 pV plays 
a role in maintaining the stability of BAdV-3 virions (Zhao and Tikoo, 2016). We postulate that 
the interaction of IVa2 with pV may also be associated with the maintenance of capsid 
integrity. Since BAdV-3 IVa2 amino acids 121-140 are involved in the interaction with pV, 
isolation and characterization of recombinant BAdV-3 containing substitution \deletion of the 
interacting domain should help in determining the biological function of IVa2-pV interaction in 
BAdV-3 replication. 
While the deletion of HAdV-5 IVa2 did not produce progeny virions, there was no 
effect on the formation of empty capsids (Ostapchuk et al., 2011). However, repeated attempts 
to rescue recombinant BAdV-3 containing a deletion of IVa2 proved futile with the absence of 
any potential capsid formation in plasmid pUC304a.dIVa2 DNA transfected cells. Similarly, 
while introduction of a stop codon at HAdV-5 IVa2 amino acids 17, 19, or 86 did not result in 
the isolation of a viable virus, insertion of a stop codon at HAdV-5 amino acid 6 resulted in the 
isolation of a viable HAdV-5. However, the inclusion of a stop codon at BAdV-3 IVa2 amino 
acid 12 shown to be lethal for the replication of BAdV-3 in plasmid pUC304a.IVa2s DNA 
transfected cells. It is possible that IVa2 may be functionally different from HAdV-5 IVa2; 
alternatively, it is possible that this could be due to differences in the cells used to isolate 
recombinant adenoviruses. Further studies are required to settle this issue. 
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APPENDIX  
 
 
                                                              Appendix 1 
  
Plasmid Construction 
 
pC.IVa2 and pHA.IVa2.  A 1364 bp DNA fragment was amplified by PCR using primers KpnI 
FP (including 13 nucleotide splice sequence) and XhoI RP (Table 1) and plasmid pUC304a+ 
(Du and Tikoo, 2010). DNA as a template The PCR product was digested with KpnI-XhoI and 
ligated to KpnI-XhoI digested plasmid pCDNA3 Invitrogen) creating plasmid pC.IVa2. A 1365 
bp DNA fragment was amplified by PCR using primers EcoRI FP and NotI RP (Table 1), and 
plasmid pC.IVa2 DNA as a template. The PCR product was digested using EcoRI and NotI and 
ligated to EcoRI and NotI digested plasmid pC3HA (plasmid pCDNA3 containing HA tag 
obtained from Dr. Joyce Wilson) creating plasmid pHA.IVa2. 
 
pC.IVa2d25. A 1288 bp DNA fragment was amplified by PCR using primers EcorIΔN25 FP 
and XhoI RP (Table 1), and plasmid pC.IVa2  DNA as a template. The PCR product was 
digested with EcoRI-XhoI and ligated to EcoRI-XhoI digested plasmid pCDNA3 DNA creating 
plasmid pC.IVa2d25 plasmid (N-terminus 25 amino acid truncated IVa2). 
 
pDR.IVa2. A1363bbp DNA fragment was amplified using primers SacI FP and KpnI RP 
(Table 1), and plasmiud pC.IVa2 DNA as a template. The PCR product was digested with SacI-
KpnI and ligated to SacI-KpnI digested plasmid pDsRed-monomer-C1 (pDR) (Clontech, 
632466) DNA, creating plasmid pDR.IVa2. 
 
pDR.IVa2d1. A 1272bp DNA fragment amplified using primers SacI FP and RPΔ25C (Table 
1) and plasmid pDR-IVa2 DNA as a template. The PCR product was digested with SacI-KpnI 
and ligated to SacI-KpnI digested plasmid pDR DNA creating plasmid pDR.IVa2d1 
(containing deletion of IVa2 amino acid 424-448). 
 
pDR-IVa2d2. A1219-bp DNA fragment was amplified by PCR using primers SacI FP and 
RPΔ50C (Table 1), and plasmid pDR-IVa2 DNA as a template.  The PCR product was digested 
with SacI-KpnI and ligated to SacI-KpnI digested plasmid pDR DNA creating plasmid 
pDR.IVa2d2 (containing deletion of IVa2 amino acid 398-448). 
 
 pDR.IVa2d3. A 1288bp DNA fragment amplified using primers FPΔN25 and KpnI RP  (Table 
1), and plasmid pDR-IVa2  DNA as a template. The PCR product was digested with SacI-KpnI 
and  ligated to SacI-KpnI digested plasmid pDR DNA creating plasmid pDR.IVa2d3 
(containing deletion of IVa2 amino acid 2-25). 
 
pDR.IVa2d4. A 1138 bp DNA fragment was amplified by PCR using primers FPΔN75 and 
KpnI RP2  (Table 1), and plasmid pDR-IVa2 DNA as a template. The PCR product was 
digested with SacI-KpnI and ligated to SacI-KpnI digested plasmid pDR DNA creating plasmid 
pDR.IVa2d4 (containing a deletion of IVa2 amino acid 2-75). 
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pGFP/β  gal.NLS. Using primers NotI FP and ApaI RP (Table 1), and plasmid pC-IVa2 DNA 
as a template, a  96 bp DNA fragment was amplified by PCR  digested with NotI-ApaI and  
ligated to NotI-ApaI digested plasmid pCMVGFP/βgal (Wu and Tikoo, 2004) DNA creating 
plasmid pGFP/βgal1.NLS (GFP/Bgal fused with N-terminus 25 amino acids of IVa2). 
 
pGFP/βgal1.NLS1. A 1116bp PCR product amplified using primers NotI 4-18FP and AVRII 
RP (Table 1), and plasmid pGFP/β gal.NLS DNA as template. The 1116 bp DNA fragment 
digested with NotI 4-18-AVRII and ligated to NotI-AvrII  pCMV_GFP/βgal (Wu and Tikoo, 
2004)  creating plasmid pGFP/βgal1.NLS1 (GFP/Bgal fused with N-terminus 4-18 amino acids 
of IVa2). 
 
pDR.IVa2d3.1. A 1373 bp DNA fragment was amplified by PCR using primers FPΔ6-8 and 
BamHI RP (Table 1), and plasmid pDR-IVa2 DNA as a template. The PCR product was 
digested with XhoI-BamHI and ligated to XhoI-BamHI digested plasmid pDR DNA creating 
plasmid pDR.IVa2d3.1 (containing a deletion of IVa2 amino acid 6-8). 
 
pDR.IVa2d3.2. A 1367 bp DNA fragment amplified by PCR using primers FPΔ4-8 and BamHI 
RP  (Table 1), and plasmid pDR-IVa2 DNA as a template was digested with XhoI-BamHI   and 
ligated to XhoI-BamHI digested plasmid pDR DNA creating plasmid pDR.IVa2d3.2 
(containing a deletion of IVa2 amino acid 4-8). 
 
pDR.IVa2d3.3. A 1358 bp DNA fragment amplified by PCR using primers FPΔ4-11 and 
BamHI RP   (Table 1), and plasmid pDR-IVa2 DNA as a template was digested with XhoI-
BamHI and  ligated to XhoI-BamHI digested plasmid pDR DNA creating plasmid 
pDR.IVa2d3.3 (containing a deletion of IVa2 amino acid 4-11). 
 
pDR.IVa2d3.4. A 1346 bp DNA fragment amplified by PCR using primers FPΔ4-15 and 
BamHI RP (Table 1) and plasmid pDRIVa2 DNA as a template was digested with XhoI-BamHI 
and  ligated to XhoI-BamHI digested plasmid pDR DNA creating plasmid pDR.IVa2d3.4 
(containing a deletion of IVa2 amino acid 4-15). 
 
pDR.IVa2d3.5. A 1382 bp DNA fragment amplified by PCR using primers FPΔ4-18 and 
BamHI RP   (Table 1), and plasmid pDR-IVa2 DNA as a template was digested with XhoI-
BamHI and  ligated to XhoI-BamHI digested plasmid pDR DNA creating plasmid 
pDR.IVa2d3.5 (containing a deletion of IVa2 amino acid 4-18). 
 
 pDIVa2.M1. Using primers FP6M and KpnI RP2 (Table 1), and plasmid pDR-IVa2 DNA as a 
template a 1364 bp DNA fragment was amplified by PCR, digested with SacI-KpnI  and ligated  
to SacI-KpnI digested plasmid pDR DNA creating  plasmid pDIVa2.M1 (containing  
substitution of 6th amino acid of IVa2 in pDR-IVa2  from R to G). 
 
pDIVa2.M2. Using primers FP7M and KpnI RP2 (Table 1), and plasmid  pDR-IVa2 DNA as a 
template, a 1364 bp DNA fragment was  amplified by PCR, digested with SacI-KpnI and 
ligated to SacI-KpnI digested plasmid pDR DNA creating plasmid pDIVa2.R2M (containing 
substitution of 7th amino acid of IVa2 in pDR.IVa2  from R to G). 
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pDIVa2.M3. Using primers FP8M and KpnI RP2 (Table 1), and plasmid pDR-IVa2 DNA as a 
template, a 1364 bp DNA fragment was amplified by PCR,  digested with SacI-KpnI and 
ligated  to SacI-KpnI digested plasmid pDR DNA creating plasmid pDIVa2.KM (containing  
substitution of 8th amino acid of IVa2 in pDR.IVa2  from K to G) 
 
pDIVa2.M4.  Using primers FP6-8M and KpnI RP2 (Table 1), plasmid pDR-IVa2 DNA as a 
template, a 1364 bp DNA fragment was  amplified, digested with SacI-KpnI and  ligated  to 
SacI-KpnI digested plasmid pDR DNA creating  plasmid pDIVa2.RRKM (containing 
substitution of 6 to 8 amino acid of IVa2  in  pDR.IVa2  from RRK to GGG). 
 
pDR.IVa2d3.1a. A 1382 bp DNA fragment amplified by PCR using primers FPM6-8, and 
BamHI RP  (Table 1), and plasmid pDR-IVa2 DNA as a  template was digested with  XhoI-
BamHI and  ligated to XhoI-BamHI digested plasmid pDR DNA creating plasmid 
pDR.IVa2d3a (containing substitution of IVa2 amino acid 6-8 from RRK to AAA). 
 
pDR.IVa2d3.2a. A 1382 bp DNA fragment amplified by PCR using primers FPM4-8 and 
BamHI RP  (Table 1), and plasmid pDR-IVa2 DNA as a template was digested with  XhoI-
BamHI  and  ligated to XhoI-BamHI digested plasmid pDR DNA creating plasmid 
pDR.IVa2d3.2a (containing a substitution of IVa2 amino acid 4-8 from RGRRK to AAAAA). 
 
pDR.IVa2d3.3a. A 1382 bp DNA fragment amplified by PCR using primers FPM4-11 and 
BamHI RP (Table 1), and plasmid pDR-IVa2 DNA as a template was digested with  XhoI-
BamHI  and  ligated to XhoI-BamHI digested plasmid pDR DNA creating plasmid 
pDR.IVa2d3.3a (containing a substitution  of IVa2 amino acid 4-11 from RGRRKVRH to 
AAAAAAAA). 
 
pDR.IVa2d3.4a. A 1382 bp DNA fragment amplified by PCR using primers FPM4-15 and 
BamHI RP   (Table 1), and plasmid pDR-IVa2 DNA as a template was digested with XhoI-
BamHI and ligated to XhoI-BamHI digested plasmid pDR DNA creating plasmid 
pDR.IVa2d3.4a (containing a substitution of IVa2 amino acid 4-15 from RGRRKVRHQQAQ to 
AAAAAAAAAAAA). 
 
pDR.IVa2d3.5a. Using primers NheI FP and IRP M4-18 (Table 1), and plasmid pDR-IVa2 
DNA as a template  a 775 bp DNA fragment (P1) was amplified by PCR. Similarly, using 
primers IFPM4-18 and BamHI RP (Table 1), and plasmid pDR-IVa2 DNA as a template a 
1362 bp DNA Fragment (P2) was amplified by PCR. The P1 and P2 DNA fragments were 
annealed and a 2094 bp DNA fragment was amplified by PCR using primers NheI-FP and 
BamHI-RP (Table 1). The 2094 bp DNA fragment was digested with NheI-BamHI and ligated 
to NheI-BamHI digested plasmid pDR DNA creating a plasmid pDR.IVa2d3.5a (containing a 
substitution of IVa2 amino acid 4-18 from RGRRKVRHQQAQPEA to AAAAAAAAAAAAAAA). 
 
pDR.IVa2d5. A 1144 bp DNA fragment amplified by PCR using primers SacI FP and RPΔ75C 
(Table 1), and plasmid pDR.IVa2 DNA as a template was digested with SacI-KpnI and ligated 
to SacI-KpnI digested plasmid pDR DNA creating plasmid pDR.IVa2d5 (containing a deletion 
of IVa2 amino acid 373-448).  
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pDR.IVa2d5.1. A 1150 bp DNA fragment (P1) was amplified by PCR  using primers XhoI FP 
and IRP10-75 (Table 1), and plasmid pDR.IVa2  DNA  as a template. Similarly, a 327 bp DNA 
fragment (P2) was amplified by PCR using primers IFP10-75 and MluI RP (Table 1), and 
plasmid pDR.IVa2 DNA as a template. The P1 and P2 DNA fragments were annealed and a 
1437 bp DNA fragment was amplified by PCR using primers XhoI FP and MluI RP (Table 1). 
The 1437 bp DNA fragment was digested with XhoI-MluI and ligated to XhoI-MluI digested 
plasmid pDR DNA creating plasmid pDR.IVa2d5.1 (containing a deletion of IVa2 amino acid 
373-438).  
 
pDR.IVa2d5.2. A 1150 bp DNA fragment (P1) was amplified by PCR  using primers XhoI FP 
and IRP20-75 (Table 1), and plasmid pDR.IVa2 DNA as a template. Similarly, a 357 bp DNA 
fragment (P2) was amplified by PCR using primers IFP20-75 and MluI RP (Table 1), and 
plasmid pDR-IVa2 DNA as a template. The P1 and P2 DNA fragments were annealed and a 
1467 bp DNA fragment was amplified by PCR using primers XhoI FP and Mlu-RP (Table 1). . 
The 1467 bp DNA fragment was digested with XhoI-MluI and ligated to XhoI- MluI digested 
plasmid pDR DNA creating plasmid pDR.IVa2d5.2 (containing a deletion of IVa2 amino acid 
373-428).  
 
pDR.IVa2d5.3. A 1150 bp DNA fragment (P1) was amplified by PCR using primers XhoI FP 
and IRP30-75  (Table 1), and template and plasmid pDR.IVa2 DNA as a template. Similarly, a 
387 bp DNA fragment was (P2) was amplified by PCR using IFP30-75 and MluI RP (Table 1) 
as primers, and plasmid pDR.IVa2 DNA as a template The P1 and P2 DNA fragments were 
annealed and a 1497 bp DNA fragment was amplified by PCR ,   using XhoI FP and MluI RP 
as primers (Table 1) . The 1497 bp DNA fragment was digested with XhoI-MluI and ligated to 
XhoI- MluI digested plasmid pDR DNA creating plasmid pDR.IVa2d5.3 (containing a deletion 
of IVa2 amino acid 373-418).  
 
 pDR.IVa2d5.4. A 1142 bp DNA fragment (P1) was amplified by PCR  using primers XhoI FP 
and IRP40-75 (Table 1), and plasmid pDR.IVa2 DNA as a template. Similarly, a 417 bp DNA 
fragment (P2) was amplified by PCR using IFP40-75 and MluI RP (Table 1) as primers, and 
plasmid pDR-IVa2 DNA as a template.  The P1 and P2 DNA fragments were annealed and a 
1527 bp DNA fragment was amplified using XhoI FP and MluI RP as primers. The 1527 bp 
DNA fragment was digested withg XhoI-MluI and ligated to XhoI-MluI digested plasmid pDR 
DNA creating plasmid pDR.IVa2d5.4 (containing a deletion of IVa2 amino acid 373-408).  
 
pDR.IVa2d5.5. A 1150 bp PCR product (P1) was amplified by PCR  using primers XhoI FP 
and IRP53-75 (Table 1), and plasmid pDR.IVa2 DNA as a template. Similarly, a 456 bp DNA 
fragment (P2) was amplified by PCR using primers IFP53-75 and MluI RP (Table 1), and 
plasmids pDR.IVa2 DNA as a template. The P1 and P2 DNA fragments were annealed and a 
1566 bp DNA fragment was amplified by PCR using XhoI FP and MluI RP as primers (Table 
1)(The 1566 bp DNA fragment was digested with and  ligated to XhoI-MluI digested plasmid 
pDR DNA creating plasmid pDR.IVa2d5.4 (containing a deletion of  IVa2 amino acid 373-
395). 
 
pDR.IVa2d5.6. Using plasmid pDR.IVa2.DNA as a template, and primers XhoI FP and 
RP411-448 (Table 1), a1249 bp DNA fragment amplified by PCR was digested with XhoI-
	   175	  
BamHI and  ligated to XhoI-BamHI digested plasmid pDR DNA creating plasmid 
pDR.IVa2d5.6 (containing a deletion of IVa2 amino acid 411-448). 
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Table 1. List of primer                                                                                                                            
_______________________________________________________________________________________ 
Primer sequence (5’-----3’)                    Primer name 
_____________________________________________________________________________________________ 
CGCTCGAGTCAATAAAATTCTTTATTTTTCCTGTGATAATAC   XhoI FP 
GACGGTACCATGGACACCCGAGGGCGACGAAAAGTTCGG   KpnI RP  
GCGAATTCATGGACACCCGAGGGCGACGAAA    EcorI FP   
GCGAATTCATGTCAGCAGCCCTTCACGGTC     EcorIΔN25 FP  
GCCTCGAGTCAATAAAATTCTTTATTTTTCCTGTGATAATACCGTGTCCAGCG 
TGCTCTGTC           XhoI RP  
TGGCGGCCGCTCAATAAAATTCTTTATTTTTCCTGTGATAATACC   Not I RP 
GCGAGCTCATGGACACCCGAGGGCGACGAAAAG    SacI FP  
GCGGTACCTCAATAAAATTCTTTATTTTTCCTGTGATAATAC   KpnI RP2 
GCGGTACCCTAAGGGCCTCATATACCATGGCATGAATATTAAGATACATGGG   RPΔ25C 
GCGGTACCCTACTGCAGACTTTCGTGGGGAGGTAAGGTGTTG    RPΔ50C 
GCGAGCTCATGTCAGCAGCCCTTCACGGTC      FPΔN25 
GCGAGCTCATGGATGTACTAGACCACGTCTCTGAG     FPΔN75 
GGGCGGCCGCATGGACACCCGAGGGCGACGAAAAG     NotI FP   
CGGGGCCCCTCATCAATAAAATTCTTTATTTTTCCTG      ApaI RP 
AGGCGGCCG CCGAGGGCGACGAAAAGTTCGGCACCAGCAGGCTCA GCCTGAGGC   NotI 4-18 FP 
AAG CCT AGG CCT CCA AAA AAG        AvrII RP 
GCGAATTCATGTCAGCAGCCCTTCACGGTC      EcorIΔN25 
GGTGGATCCCGGGCCCGCGGTACCTCAATAAAATTC       BamHI RP    
CCGCTAGCGCTACCGGTCGCCACCATGGACAA     NheI FP 
ATCTCGAGCTCATGGACACCCGAGGGGTTCGGCACCAGCAGGCTCAG    FPΔ6-8 
ATCTCGAGCTCATGGACACCGTTCGGCACCAGCAGGCTCAGC    FPΔ 4-8 
ATCTCGAGCTCATGGACACCCAGCAGGCTCAGCCTGAG      FPΔ 4-11 
ATCTCGAGCTCATGGACACCCCTGAGGCGCTCGCTGGTC     FPΔ 4-15 
ATCTCGAGCTCATGGACACCCCTCGCTGGTCAGCAGACAGAC    FPΔ 4-18 
GAGCCTGCTGGTGCCGAACTTTTCGTCCCCTAGCTGTTCAGTGGAATAATAACAAG IFP6M 
TATTCCACTGAACAGCTAGGGGACGAAAAGTTCGGCACCAGCAGGCTCA  RP6M 
GAGCCTGCTGGTGCCGAACTTTTCCTCGCCTAGCTGTTCAGTGGAATAATAACAAG IFP7M 
TATTCCACTGAACAGCTAGGCGAGGAAAAGTTCGGCACCAGCAGGCTCA  IRP7M 
GAGCCTGCTGGTGCCGAACTTCTCGTCGCCTAGCTGTTCAGTGGAATAATAACAAG IFP8M 
TATTCCACTGAACAGCTAGGCGACGAGAAGTTCGGCACCAGCAGGCTCA  IRP8M 
GAGCCTGCTGGTGCCGAACTTCTCCTCCCCTAGCTGTTCAGTGGAATAATAACAAG IFP6-8M 
TATTCCACTGAACAGCTAGGGGAGGAGAAGTTCGGCACCAGCAGGCTCA  IFP6-8M 
CTCGAGCTCATGGACACCCGAGGGGGACGAAAAGTTCGGCACCAGCAGGCTCAG   FP 6M  
CTCGAGCTCATGGACACCCGAGGGCGAGGAAAAGTTCGGCACCAGCAGGCTCAG   FP 7M 
CTCGAGCTCATGGACACCCGAGGGCGACGAGAAGTTCGGCACCAGCAGGCTCAGCCTGAG  FP 8M 
CTCGAGCTCATGGACACCCAGGGGGGAGGAGAAGTTCGGCACCAGCAGGCTCAGCCTGAG  FP 6-8M 
ATCTCGAGCTCATGGACACCCGAGGGGCAGCAGCAGTTCGGCACCAGCAGGCTCAG  FPM6-8 
ATCTCGAGCTCATGGACACCGCAGCGGCAGCAGCAGTTCGGCACCAGCAGGCTCAG  FPM4-8 
ATCTCGAGCTCATGGACACCGCAGCGGCAGCAGCAGCTGCGGCCCAGCAGGCTCAG 
CCTGAG                                                                                                                                   FPM4-11 
ATCTCGAGCTCATGGACACCGCAGCGGCAGCAGCAGCTGCGGCCGCGGCGGCTGCG 
CCTGAGGCGCTCGCTGGTC                                                                                                     FPM4-15 
GCAGCGGCCGCCGCAGCTGCCGCAGCCGCAGCTGCCGCTGCGGCGCTCGCTGGTCA 
GCAGACAGA                                                                                                         IFPM 4-18 
CGCCGCAGCGGCAGCTGCGGCTGCGGCAGCTGCGGCGGCCGCTGCGGTGTCCATGA 
GCTCGAGAT                                                                                                    IRP M4-18   
ATCTCGAGCTCATGGACACCCGAGGGCGACGAAAAG     XhoI FP2  
GCGGTACCTCAGATGTCTTTTAGAAGAAGGGTGATTGGCAAAGGGAGGCTCTTA  RPΔ75C 
TTACGCGTTAAGATACATTGATGAG         MluI RP 
CCCTTCTTCTAAAAGACATCTATTATCACAGGAAAAATAAAGAATTTTATT   IFP 10-75 
 TTATTTTTCCTGTGATAATAGATGTCTTTTAGAAGAAGGGTGATTG    IRP 10-75 
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CCCTTCTTCTAAAAGACATCACCCTTATTGACAGAGCACGCTGGA    IFP 20-75 
CGTGCTCTGTCAATAAGGGTGATGTCTTTTAGAAGAAGGGTGATTGG    IRP 20-75 
CCCTTCTTCTAAAAGACATCGTATATGAGGCCCTTCTCAGGATG    IFP 30-75  
CTGAGAAGGGCCTCATATACGATGTCTTTTAGAAGAAGGGTGATTGG   IRP 30-75 
ATATTAAGATACATGGGCATGATGTCTTTTAGAAGAAGGGTGATTGG   IRP 40-75   
CCCTTCTTCTAAAAGACATCATGCCCATGTATCTTAATATTCATGCCATG   IFP 40-75 
TCTTCTAAAAGACATCTTTTCCAGTCTGCAGTGGCTCTACCTCAAC   IFP 375-395  
TTGAGGTAGAGCCACTGCAGACTGGAAAAGATGTCTTTTAGAAGAAGGGTGATT IRP 375-395  
GTGGATCCGGGCATAAGGCCCTCAGAAGG      RP411-448   
TCACCAGCAATAACTTCGTATAATGTATGCTATACGAAGTTATTCAATA 
AAATTCTTTATTTTTCCTGTGATAA       IFP loxp 448 
   ATAACTTCGTATAGCATACATTATACGAAGTTATTGCTGGTGACAGCATA 
  ATAAACTGTATGAGTGTATTTTT       IRP loxp 448 
  GTATAACTTCGTATAATGTATGCTATACGAAGTTATGTCTTTTAGAAGA 
  AGGGTGATTGGCAAAG        IFP loxp373 
  ATAACTTCGTATAGCATACATTATACGAAGTTATACATCTTTTCC 
  TTCCACGCCCAGCAC         IFP loxp373 
______________________________________________________________________________________________ 
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Appendix 2 	  
Plasmid Construction 
 
pGN.IVa2. A 1367 bp DNA fragment containing IVa2 coding region was amplified by PCR 
using primers FP IVa2 and RP IVa2  (Table 2) and plasmid pCIVa2 as DNA template. The 
1367 bp DNA fragment was digested with SacI-NotI and ligated to SacI and NotI plasmid pGN 
(Levin et al., 2009) DNA creating plasmid pGN-IVa2. 
 
pGC-VII. A 532 bp PCR product containing VII coding region was amplified by PCR using 
primers FP VII and RP VII (Table 2) and pC-VII (Anand et al., 2014) DNA as a template. The 
532 bp DNA fragment was digested with SalI-EcoRI and ligated to SalI-EcoRI plasmid pGC 
(Levin et al., 2009) DNA creating plasmid pGC- VII. 
 
pGC-VIII. A 664 bp PCR product containing VIII coding region was amplified by PCR using 
primers FP VIII and RP VIII (Table 2) and pC-VIII  (Ayalew et al., 2016) DNA as a template. 
The 664 bp DNA fragment was digested with SalI-EcoRI and ligated to SalI-EcoRI plasmid 
pGC DNA creating plasmid pGC-VIII. 
 
pGC-22K. A 841 bp PCR product containing 33K coding region was amplified by PCR using 
primers FP 22K and RP 22K (Table 2) and pC-22K (Kulshreshtha et al., 2015) DNA as a 
template. The 841 bp DNA fragment was digested with SalI-SpeI and ligated to SalI-SpeI 
plasmid pGC DNA creating plasmid pGC-22K. 
 
pGC-52K. A 1145 bp PCR product containing 52K coding region was amplified by PCR using 
primers FP 52K and RP 52K (Table 2) and pC-52K (Paterson et al., 2012) DNA as a template. 
The 1145 bp DNA fragment was digested with SacI-EcorI and ligated to SacI-EcorI plasmid 
pGC DNA creating plasmid pGC-52K. 
 
pGC-Fiber. A 2947 bp PCR product containing Fiber coding region was amplified by PCR 
using primers FP Fiber, and RP Fiber (Table 2) and pBAV304 (Wu et al., 2004) DNA as a 
template. The 2947 bp DNA fragment was digested with SalI-SpeI and ligated to SalI-SpeI 
plasmid pGC DNA creating plasmid  pGC-Fiber. 
 
pGC-Hexon. A 2726 bp PCR product containing hexon coding region was amplified by PCR 
using primers FP hexon and RP hexon (Table 2) and pDR-Hexon (Makadiya et al 2015) DNA 
as a template. The 2726 bp DNA fragment was digested with SalI-XmaI and ligated to SalI-
XmaI plasmid pGC DNA creating plasmid pGC- Hexon. 
 
pGC-DBP. A 1315 bp PCR product containing DBP coding region was amplified by PCR 
using primers FP DBP and RP DBP (Table 2) and pGADT7-DBP (Kulshreshtha et al., 2008) 
DNA as a template. The 1315 bp DNA fragment was digested with SalI-SpeI and ligated to 
SalI-SpeI plasmid pGC DNA creating plasmid pGC-DBP. 
 
pGC-TP. A 1990 bp PCR product containing TP coding region was amplified by PCR using 
primers FP TP and RP TP (Table 2) and pGADT7-TP (Kulshreshtha et al., 2008) DNA as a 
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template. The 1990 bp DNA fragment was digested with BglII and EcoRI and ligated to BglII 
and EcoRI plasmid pGC DNA creating plasmid pGC-TP. 
 
pGC- IIIa. A 1723 bp PCR product containing IIIa coding region was amplified by PCR using 
primers FP IIIa and RP IIIa (Table 2)  and pGADT7-IIIa (Kulshreshtha et al., 2008) DNA as a 
template. The 1723 bp DNA fragment was digested with SalI-SpeI and ligated to SalI-SpeI 
plasmid pGC DNA creating plasmid pGC- IIIa. 
 
pGC-X. A 259 bp PCR product containing X (mu) coding region was amplified by PCR using 
primers FP X and RP X (Table 2) and pGADT7-X (Kulshreshtha et al., 2008) DNA as a 
template. The 259 bp DNA fragment was digested with SalI-SpeI and ligated to SalI-SpeI 
plasmid pGC DNA creating plasmid pGC-X. 
 
pGC-Protease. A 631 bp PCR product containing protease coding region was amplified by 
PCR using primers FP protease and RP protease (Table 2) and pDR.bProt (Makadiya et al., 
2015) DNA as a template. The 631 bp DNA fragment was digested with SalI-SpeI and ligated 
to SalI-SpeI plasmid pGC DNA creating plasmid pGC-Protease. 
 
pGC-33K. A 856 bp PCR product containing 33K coding region was amplified by PCR using 
primers FP 33K and RP 33K (Table 2) and pC-33K (Kulshreshtha et al., 2015) DNA as a 
template. The 856 bp DNA fragment was digested with SalI-SpeI and ligated to SalI-SpeI 
plasmid pGC DNA creating plasmid pGC- 33K. 
 
pGN.IVa2 d6 (Δ151-300). A 480 bp PCR product (P1) amplified using primers SacI FP and 
IRPM150 (Table 2), and pGN-IVa2 DNA as a template. Similarly, 483 bp PCR product (P2) 
amplified using primers IFPM150 and NotI RP (Table 2), and pGN-IVa2 DNA as a template. 
A 913 bp final PCR product (P3) amplified using, primers SacI FP and NotI RP (Table 2) and 
P1 and P2 DNA mix as a template. The 913 bp bp DNA fragment was digested with SacI-NotI 
digested and ligated in to SacI-NotI digested pGN creating plasmid   pGN-IVa2 d6 (Δ151-300). 
 
pGN.IVa2 d7 (151-448). A 918 bp PCR product (P1) amplified using primers FP ST and NotI 
RP (Table 2), and pGN-IVa2 DNA as a template. The 918 bp DNA fragment was digested with 
SacI-NotI and ligated in to SacI-NotI pGN creating plasmid   pGN-IVa2 d7 (151-448). 
 
pGN.IVa2d8 (1-150). A 468 bp PCR product amplified using primers SacI FP and RPF150 
(Table 2), and pGN-IVa2 DNA as a template. The 468 bp DNA fragment was digested with 
SacI-NotI and ligated in to SacI-NotI pGN creating pGN. IVa2d8 (1-150). 
 
pGN.IVa2d9 (Δ121-140). A 388 bp PCR product (P1) amplified using primers SacI FP and 
IRP121-140 (Table 2) and pGN-IVa2 DNA as a template. Likewise, a 957 bp PCR product 
(P2) amplified using primers IFP121-140 and NotI RP (Table 2) and pGN-IVa2 DNA as a 
template. A 1305 bp PCR product (P3) amplified using primers SacI FP and NotI RP (Table 2) 
and  The 1305 bp  DNA fragment was digested with SacI-NotI and ligated in to SacI-NotI  
pGN creating plasmid   pGN.IVa2d9 (Δ 121-140). 
 
	   180	  
pGN-IVa2d9.1 (Δ 121-130).  A 388 bp PCR product (P1) amplified using primers SacI FP and 
IRP121-130 (Table 2) and pGN-IVa2 DNA as template. Likewise, a 987 bp PCR product (P2) 
amplified using primers IFP121-130 and NotI RP (Table 2) and pGN-IVa2 DNA as template.  
A 1335 bp PCR product (P3) amplified using primers SacI FP and NotI RP (Table 2), and P1 
and P2 DNA mix as a template. The 1335 bp DNA fragment was digested with SacI-NotI and 
ligated in to SacI-NotI pGN creating plasmid   pGN-IVa2d9.1 (Δ 121-130). 
 
pGN-IVa2d9.2 (Δ 131-140).  A 418 bp PCR product (P1) amplified using primers SacI FP and 
IRP131-140 (table) and pGN-IVa2 DNA as template. Likewise, a 957 bp PCR product (P2) 
amplified using primers IFP121-140 and NotI RP (table) and pGN-IVa2 DNA as template.  A 
1335 bp PCR product (P3) amplified using primers SacI FP and NotI RP (table), and P1 and P2 
DNA mix as a template. The 1335 bp DNA fragment was digested with SacI-NotI and ligated 
in to SacI-NotI pGN DNA creating plasmid   pGN-IVa2d9.2 (Δ 131-140).   
 
pGN-IVa2d9.3 ( Δ d1.d2). A 398 bp PCR product (P1) amplified using primers SacI FP and 
IRP121-125 (Table 2) and pGN-IVa2 DNA as template. Likewise, 967 bp PCR product (P2) 
amplified using primers IFP136-140 and NotI RP (Table 2) and pGN-IVa2 DNA as template.   
1335 bp PCR product (P3) amplified using primers SacI FP and NotI RP (Table 2) and P1 and 
P2 DNA mix as a template. The 1335 bp DNA fragment was digested with SacI-NotI and 
ligated in to SacI-NotI pGN DNA creating plasmid   pGN-IVa2d9.2 (Δ 121-125, 136-140).   
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Table 2. List of primers                                                                                                                            
_____________________________________________________________________________________________ 
Primer sequence (5’-----3’)                                         Primer name 
_____________________________________________________________________________________________ 
GCGCATGCTAAAATCAAGCTGCTG       SphI FP 
GTCCGCGGCTGGAGAGTC        SacII RP 
ATATCTGCGCCCTGACGGTCATGATAAATTCCCCAAATGCACAGGCTACTCTGTTTTTGTG  IFPM150 
GCATTTGGGGAATTTATCATGACCGTCAGGGCGCAGATATGGCATGG   IRPM150 
GGGCGGCCGCTCAGTCAGGGCGCAGATATGGCATGGTG    RPF150 
GCGAGCTCATGGGTTCATGCAAATCTTTAAACTTTACC    FP ST 
TGGACGAGCTACTGGCTATGGAATGCCACCATGCCATATC     121-140 IFP  
 GATATGGCATGGTGGCATTCCATAGCCAGTAGCTCGTCCAA    121-140IRP   
TGGACGAGCTACTGGCTATGGACTATAATCAGGCGATAAGAGATG   121-130IFP  
CTTATCGCCTGATTATAGTCCATAGCCAGTAGCTCGTCCAA    121-130IRP   
CCCTACTCAATGCCCTCTCAAATGCCACCATGCCATATCTG    131-140IFP  
AGATATGGCATGGTGGCATTTGAGAGGGCATTGAGTAGGG    131-140IRP   
CTCAATGCCCTCTCAGACTATAATCAGGCGAATGCCACCATGCCATATCT        IFP121-125, 136-140  
CGCCTGATTATAGTCTGAGAGGGCATTGAGCATAGCCAGTAGCTCGTCCAA    IRP121-125, 136-140 
GCGAGCTCATGGACACCCGAGGGCGACGAAAAGTT    FP IVa2 
GAGCGGCCGCGGGCCCGCGGTACCTCAATAAAATTCTTTATTTTTCC  RP IVA2 
GTGTCGACATGAATCGCAGCGGTGACTT      FP DBP 
TCACTAGTTTAAAACAAAGAGTCATCTGCATCGTACTGATC    RP DBP 
GTGTCGACATGGCCATTCTAATCTCTCC       FP PVII 
CTGAATTCTCAAACGGTGTTGCTGAC        RP PVII 
ACCCCGGGATGAGCAAAGAAATTCCCACAC      FP PVIII 
CTGAATTCCTATAACCGCTCACAGAGTTGCTG      RP PVIII 
GTGTCGACATGAAACCCCGCAGCATGTC      FP 22K 
TCACTAGTCTATTTTTCACTTTGAGGTGACACCGCTGAGC    RP 22K 
TCACTAGTTTAGGCGGGTCCGGATTCGT       RP 33K 
GTGTCGACCCCGGGGACCAGTGAGCTCATGCATCCCGCTTTACGGCAAAT  FP 52K 
CTGAATTCTCATTCGTCGACTTCATCGT       RP 52K 
GTGTCGACATGAGTGATGCGGACCCC       FP IIIa 
TCACTAGTTTACCAAAACTGGCGGGGACCC      RP IIIa 
GTGTCGACATGAGTCCCCGCGGAAATCT       FP X 
TCACTAGTCTATTTGTTGTGGGCCGCCTGA     RP X 
GTGTCGACATGGGTTCTCGGGAAGAGG       FP protease 
TCACTAGTCTAATTTGTTAACATTTTATCAAAGGCGGTGTCAG      RP protease 
GTGTCGACATGAAGAGAAGTGTGCCCCAGGAC      FP Fiber 
TCACTAGTTTAAGTCCAGTAAGAAAAAGTAAGTGTAGAG     RP Fiber 
GTGTCGACATGGTCCTACTGCACATC       FP Hexon 
GATCCCGGGTTATGTGGTAGCGTTGCC      RP Hexon 
CCCCGGGGACTAGCGAGCTCTCTAGAAGATCTATGTTTTTTGCAGAGCGCGAGAG   FP TP     
CTGAATTCTTAAAGGGGACGTCGAGGG       RP TP    
GCATGAACCGTCAGGGCGCAGCTTCTCGAATTGTGGGTGTGACCAATATGGC 
ATGGTGGCATTCATGG          IFP 146 
GAATGCCACCATGCCATATTGGTCACACCCACAATTCGAGAAGCTGC 
GCCCTGACGGTTCAT         IRP146 
TCATACAGTTTATTATGCTGCCTGCAGGCTAGTACATCTC 
CATCCAGCAT          IFPΔIVa2  
GCTGGATGGAGATGTACTAGCCTGCAGGCAGCATAA 
TAAACTGTATGA         IRPΔIVa2 
 CATGATCTTTTCGAACTGCGGGTGGCTCCACTTAAAGGCAGGTT 
TTAGGGTGCTGCTTTG        IRP242 
 TTTAAGTGGAGCCACCCGCAGTTCGAAAAGATCATGTCCTATGA 
AGACCTGACCATGGACTAC       IRP242 
 CTGTCACTTTTCGAACTGCGGGTGGCTCCAATAAAATTCTTTATTTT 
TCCTGTGATAATAC        IFP448 
 TTTTATTGGAGCCACCCGCAGTTCGAAAAGGACAG 
CATAATAAACTGTATGAG        IRP448 
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Appendix 3  
 
Table 3. List of Primers 
 
 
Primer Sequence                                                                                                                  Name of Primer 
 
        
GCGCATGCTAAAATCAAGCTGCTG      SphI FP 
GTCCGCGGCTGGAGAGTC       SacII RP 
CCAGCGAGCGCCTCAGGCTGAGCCTACTGGTGCCGAACTTTTCGTCGCCTAGC       IFPSTC   
CTAGGCGACGAAAAGTTCGGCACCAGTAGGCTCAGCCTGAGGCGCTCGCTG  IRP STC  
TCACCAGCAATAACTTCGTATAATGTATGCTATACGAAGTTATTCAATAAAATT 
CTTTATTTTTCCTGTGATAA              IFP loxp 448 
ATAACTTCGTATAGCATACATTATACGAAGTTATTGCTGGTGACAGCATA 
ATAAACTGTATGAGTGTATTTTT             IRP loxp 448 
ATAACTTCGTATAATGTATGCTATACGAAGTTATGTCTAGTACATCTCCA 
TCCAGCATAGC          IFP loxp 79 
ACATAACTTCGTATAGCATACATTATACGAAGTTATACCACGTCTCT 
GAGCTTTGG            RP loxp 79 
TCATACAGTTTATTATGCTGCCTGCAGGCTAGTACATCTCCATCCAGCAT             IFPΔIVa2  
GCTGGATGGAGATGTACTAGCCTGCAGGCAGCATAATAAACTGTATGA    IRPΔIVa2 
 
 
 
 
 
 	  
